<SEC-DOCUMENT>0001193125-24-000161.txt : 20240102
<SEC-HEADER>0001193125-24-000161.hdr.sgml : 20240102
<ACCEPTANCE-DATETIME>20240102060628
ACCESSION NUMBER:		0001193125-24-000161
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20231227
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240102
DATE AS OF CHANGE:		20240102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MANNKIND CORP
		CENTRAL INDEX KEY:			0000899460
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				133607736
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50865
		FILM NUMBER:		24500054

	BUSINESS ADDRESS:	
		STREET 1:		1 CASPER STREET
		CITY:			DANBURY
		STATE:			CT
		ZIP:			06810
		BUSINESS PHONE:		818-661-5000

	MAIL ADDRESS:	
		STREET 1:		1 CASPER STREET
		CITY:			DANBURY
		STATE:			CT
		ZIP:			06810
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d575512d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mnkd="http://www.mannkindcorp.com/20231227" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-12-27_to_2023-12-27">MANNKIND CORP</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-12-27_to_2023-12-27">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-12-27_to_2023-12-27">0000899460</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="mnkd-20231227.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-12-27_to_2023-12-27"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-12-27</xbrli:startDate> <xbrli:endDate>2023-12-27</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-12-27_to_2023-12-27">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-12-27_to_2023-12-27" format="ixt:datemonthdayyearen">December&#160;27, 2023</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">MannKind Corporation</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-12-27_to_2023-12-27" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-12-27_to_2023-12-27">000-50865</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-12-27_to_2023-12-27">13-3607736</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction of</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">incorporation or organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-12-27_to_2023-12-27">1 Casper Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-12-27_to_2023-12-27">Danbury</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-12-27_to_2023-12-27" format="ixt-sec:stateprovnameen">Connecticut</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-12-27_to_2023-12-27">06810</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-12-27_to_2023-12-27">(818)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-12-27_to_2023-12-27">661-5000</ix:nonNumeric></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-12-27_to_2023-12-27" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-12-27_to_2023-12-27" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-12-27_to_2023-12-27" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-12-27_to_2023-12-27" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-12-27_to_2023-12-27">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-12-27_to_2023-12-27">MNKD</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-12-27_to_2023-12-27" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167; <span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-12-27_to_2023-12-27" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry Into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;27, 2023, MannKind Corporation (the &#8220;Company&#8221;) entered into a Purchase and Sale Agreement (the &#8220;Purchase Agreement&#8221;) with Sagard Healthcare Funding Partners Borrower 2 SPE, LP (&#8220;Sagard&#8221;) for the sale to Sagard of a 1% royalty on global net sales of Tyvaso DPI<sup style="font-size:75%; vertical-align:top">&#174;</sup> (treprostinil) inhalation powder (&#8220;Tyvaso DPI&#8221;) occurring on and after October&#160;1, 2023 through December&#160;31, 2042 under the Company&#8217;s License and Collaboration Agreement dated as of September&#160;3, 2018, as amended (the &#8220;License Agreement&#8221;), with United Therapeutics Corporation. The Company will retain a 9% royalty on such sales. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In consideration for the sale, Sagard paid the Company $150&#160;million, less certain legal expenses, and the Company is entitled to receive from Sagard a milestone payment as follows: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) $50&#160;million in the event that trailing <span style="white-space:nowrap">12-month</span> net sales of Tyvaso DPI equal or exceed $1.9&#160;billion on or before December&#160;31, 2026; or </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) if the foregoing milestone event does not occur, $45&#160;million in the event that trailing <span style="white-space:nowrap">12-month</span> net sales of Tyvaso DPI equal or exceed $2.3&#160;billion on or before September&#160;30, 2027. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that the conditions for the milestone payment are not met, then the Company will not receive a milestone payment and Sagard will not be entitled to any portion of the royalties payable to MannKind for net sales of Tyvaso DPI in excess of $3.5&#160;billion in any calendar year. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Purchase Agreement contains customary representations, warranties and agreements by the Company and Sagard, indemnification obligations of the parties and other obligations of the parties. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the Purchase Agreement, a copy of which is attached as Exhibit 99.1 to this report. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d575512dex991.htm">Purchase and Sale Agreement, dated December&#160;27, 2023, by and between MannKind Corporation and Sagard Healthcare Funding Partners Borrower 2 SPE, LP </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the inline XBRL document)</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">#</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-style:italic">Schedules have been omitted pursuant to Item 601(a)(5) of Regulation</span><span style="font-style:italic"></span><span style="font-style:italic"><span style="white-space:nowrap">&#160;S-K.</span></span><span style="font-style:italic"> </span> </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">MannKind Corporation</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: January&#160;2, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Thomson, Ph.D., J.D.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">David Thomson, Ph.D., J.D.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, General Counsel and</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d575512dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE AND SALE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>dated as of December&nbsp;27, 2023 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>between </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MANNKIND
CORPORATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SAGARD HEALTHCARE PARTNERS FUNDING BORROWER SPE 2, LP </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table of Contents </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ARTICLE I DEFINED TERMS AND RULES OF CONSTRUCTION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Defined Terms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;1.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rules of Construction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ARTICLE II PURCHASE AND SALE OF THE PURCHASED ASSETS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase and Sale; Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Assumed Obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Excluded Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Sale Transactions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment of Purchaser Applicable Percentage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ARTICLE III REPRESENTATIONS AND WARRANTIES OF SELLER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existence; Organization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Conflicts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authorization; Enforceability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ownership</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental and Third Party Authorizations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Brokers&#146; Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compliance with Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual Property Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">License Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UCC Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Permitted</FONT>
<FONT STYLE="white-space:nowrap">Set-Off</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regulatory, Commercialization and Manufacture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Solvency</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disclosure</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF PURCHASER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Organization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Conflicts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authorization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental and Third Party Authorizations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Funds Available</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Implied Representations and Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Access to Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ARTICLE V COVENANTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public Announcement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Further Assurances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Royalty Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Misdirected Payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maintenance of Material Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enforcement of Material Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Liens</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC Filings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Instruction Letter and UT Consent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller&#146;s Commercially Reasonable Efforts and Judgment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in Name or Organization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Royalty Control Shift Representative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ARTICLE VI THE CLOSING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;6.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;6.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment of Upfront Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;6.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Deliverables</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ARTICLE VII INDEMNIFICATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by Seller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by Purchaser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Procedures for Third Party Claims</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Claims</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Time Limitations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Limitations on Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exclusive Remedy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ARTICLE VIII CONFIDENTIALITY</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;8.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;8.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disclosures to Certain Affiliates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;8.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination of Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;8.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permitted Disclosure</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;8.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Use of Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;8.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seller Certificates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ARTICLE IX TERMINATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;9.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination of Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;9.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ARTICLE X MISCELLANEOUS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Specific Performance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Successors and Assigns</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Independent Nature of Relationship</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Personal Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Third Party Beneficiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governing Law; Jurisdiction; Venue; Consent to Service</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver of Jury Trial</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Counterparts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendments; No Waivers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cumulative Remedies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;10.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Table of Contents and Headings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Bill of Sale</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Instruction Letter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit C</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Escrow Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit D</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Purchaser Account</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit E</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Seller Account</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Disclosure Schedules</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit G</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">License Agreement and Royalty Reports</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit H</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Supply Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit I</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit J</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">UT Consent</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule 1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Knowledge Parties</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE AND SALE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This PURCHASE AND SALE AGREEMENT (this &#147;<U>Agreement</U>&#148;) dated as of December&nbsp;27, 2023 is between MannKind Corporation, a
Delaware corporation (the &#147;<U>Seller</U>&#148;), and Sagard Healthcare Partners Funding Borrower SPE 2, LP, a Delaware limited partnership (the &#147;<U>Purchaser</U>&#148;) (each of Seller and Purchaser a &#147;<U>Party</U>&#148; and
collectively, the &#147;<U>Parties</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>W</U> <U>I</U> <U>T</U> <U>N</U> <U>E</U> <U>S</U> <U>S</U> <U>E</U> <U>T</U> <U>H</U> :
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Seller has the right to receive royalties based on Net Sales (as defined below) of the Royalty Product (as defined below) under
the License Agreement (as defined below); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Seller desires to sell, assign, transfer, convey and grant to Purchaser, and
Purchaser desires to purchase, acquire and accept from Seller, the Purchased Assets (as defined below), upon and subject to the terms and conditions set forth in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and the mutual agreements, representations and warranties set forth herein and of other good
and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties covenant and agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE
I </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>DEFINED TERMS AND RULES OF CONSTRUCTION </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>Defined Terms</U>. The following terms, as used herein, shall have the following respective meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Action</U>&#148; means any claim, action, cause of action, suit, litigation, charge, summons, arbitration, mediation, investigation,
opposition, interference, hearing, complaint, or other legal proceeding (whether sounding in statute, contract, tort or otherwise, whether administrative, civil or criminal, and whether brought at law or in equity). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means, with respect to any designated Person, any other Person that, directly or indirectly, controls, is
controlled by or is under common control with such designated Person. For purposes of this definition, &#147;<U>control</U>&#148; of a Person means the possession, directly or indirectly, of greater than fifty percent (50%) of the outstanding voting
securities of such Person, on an as converted basis, or otherwise the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise, and the terms
&#147;<U>controlled</U>&#148; and &#147;<U>controlling</U>&#148; have meanings correlative to the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Agreed
Amount</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;7.4</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Agreement</U>&#148; has the meaning set
forth in the preamble. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Ancillary Agreements</U>&#148; means, collectively, the Supply Agreement, the Pharmacovigilance
Agreement, the Quality Agreement and the Letter Agreements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>API</U>&#148; has the meaning set forth in Section&nbsp;1.4 of the License
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable Percentage</U>&#148; means on any date, with respect to any Royalty Party, such Royalty Party&#146;s
percentage interest in the aggregate Royalty Interests on such date. For the avoidance of doubt, Purchaser&#146;s Applicable Percentage in the aggregate Royalty Interests, on any date, equals the Purchaser Applicable Percentage on such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Article V Knowledge</U>&#148; means the actual knowledge of any of the officers of Seller identified on <U>Schedule 1.1(b)</U> or
their direct reports, including, in each case the successors of such individuals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bill of Sale</U>&#148; means that certain bill
of sale, dated as of the Closing Date, executed by Seller and Purchaser, substantially in the form attached hereto as <U>Exhibit A</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day that is not a Saturday, Sunday or other day on which commercial banks in New York City or
Toronto, Ontario are authorized or required by applicable Law to remain closed. For the avoidance of doubt, solely with respect to any notice or other communication required to be given or delivered hereunder, limitations on the operations of
commercial banks due to the outbreak of a contagious disease, epidemic or pandemic (including <FONT STYLE="white-space:nowrap">COVID-19),</FONT> or any quarantine,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">shelter-in-place</FONT></FONT> or similar or related directive, shall not prevent a day that would otherwise be a Business Day hereunder from so being a Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Calendar Year</U>&#148; means each twelve (12)&nbsp;month period ending on December 31; provided that the first Calendar Year under
this Agreement shall begin on the Closing Date and end on December&nbsp;31, 2023 and the last Calendar Year under this Agreement shall end on the date of expiration or termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Claim Amount</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;7.4</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Claim Notice</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;7.4</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the U.S. Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Competing Product</U>&#148; has the meaning set forth in Section&nbsp;1.19 of the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Confidential Information</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;8.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Confidentiality Agreement</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;8.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Confidentiality Restriction</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;8.6</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disclosing Party</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;8.1</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disclosure Schedules</U>&#148; means the disclosure schedules of the Seller
attached hereto as <U>Exhibit F</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Escrow Account</U>&#148; means the segregated account established pursuant to the Escrow
Agreement, into which payments of the Purchased Assets are to be remitted, including payments of amounts payable by UT pursuant to the Instruction Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Escrow Agent</U>&#148; means Wilmington Trust, National Association, as escrow agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Escrow Agreement</U>&#148; means that certain escrow agreement, dated as of the Closing Date, executed by Seller, Purchaser and the
Escrow Agent, substantially in the form attached hereto as <U>Exhibit C</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Evaluation Period</U>&#148; has the meaning set
forth in <U>Section</U><U></U><U>&nbsp;2.1(b)(i)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Excluded Assets</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.3</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Excluded Liabilities and Obligations</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Executive Officer</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.1(b)(ii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>FDA</U>&#148; means the U.S. Food and Drug Administration and any successor agency
thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fee Reimbursement</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Field</U>&#148; has the meaning set forth in Section&nbsp;1.38 of the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Formulation</U>&#148; has the meaning set forth in Section&nbsp;1.41 of the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; means generally accepted accounting principles in effect in the United States from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Authority</U>&#148; means the government of the United States, any other nation or any political subdivision thereof,
whether state or local, and any agency, authority (including supranational authority), commission, instrumentality, regulatory body, court, central bank or other Person exercising executive, legislative, judicial, taxing, regulatory or
administrative powers or functions of or pertaining to government, including each Patent Office, the FDA and any other government authority in any jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Instruction Letter</U>&#148; means the direction letter to UT in the form attached hereto as <U>Exhibit B</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>IRS</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.11(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>IRS Withholding Form</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.11(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Joint Patents</U>&#148; has the meaning set forth in Section&nbsp;1.60 of the License Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Judgment</U>&#148; means any judgment, order, writ, assessment, ruling, verdict,
injunction, stipulation, citation, award, or decree of any nature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Knowledge of Purchaser</U>&#148; means the actual knowledge
after due and diligent inquiry (including, if applicable, an inquiry of direct reports), as of the date of this Agreement, of any of the officers of Purchaser identified on <U>Schedule 1.1(a)</U>; provided, however, that, for purposes of clarity,
&#147;due and diligent inquiry&#148; may not require any specific inquiry of other individuals, their direct reports or outside counsel, and will be assessed on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis, and shall not require an inquiry of public records or other experts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Knowledge of Seller</U>&#148; means the actual knowledge after due and diligent inquiry (including, if applicable, an inquiry of
direct reports), as of the date of this Agreement, of any of the officers of Seller identified on <U>Schedule 1.1(b)</U>; provided, however, that, for purposes of clarity, &#147;due and diligent inquiry&#148; may not require any specific inquiry of
other individuals, their direct reports or outside counsel, and will be assessed on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis, and shall not require an inquiry of UT, public records or other
experts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Law</U>&#148; means, with respect to any Person, all laws (including common law), statutes, rules, regulations and
orders of Governmental Authorities applicable to such Person or any of its properties or assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Letter Agreements</U>&#148;
means, collectively, the letter agreements by and between Seller and UT dated September&nbsp;3, 2018, May&nbsp;6, 2019, December&nbsp;21, 2020, May&nbsp;14, 2021, June&nbsp;16, 2021, April&nbsp;7, 2022 and December&nbsp;22, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>License Agreement</U>&#148; means the License and Collaboration Agreement dated as of September&nbsp;3, 2018, by and between Seller
and UT, as and to the extent amended by any of the Letter Agreements, and as may be further amended, amended and restated or otherwise modified from time to time prior to the Closing Date, and following the Closing Date, as and to the extent
amended, amended and restated or otherwise modified in compliance with this Agreement (including <U>Section</U><U></U><U>&nbsp;5.5</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>License Agreement Termination Date</U>&#148; means the earliest to occur of (i)&nbsp;the effective date of the termination of the
entire License Agreement following delivery of written notice to Seller by UT pursuant to Section&nbsp;12.3(a) of the License Agreement or (ii)&nbsp;the effective date of the termination of the License Agreement solely as to the Royalty Product
following delivery of written notice to Seller by UT pursuant to Section&nbsp;12.3(a) of the License Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lien</U>&#148;
means any security interest, mortgage, pledge, hypothecation, assignment, deposit arrangement, encumbrance, lien (statutory or otherwise), option, right of first offer or first refusal, charge against or interest in property or other priority or
preferential arrangement of any kind or nature whatsoever, in each case to secure payment of a debt or performance of an obligation, including any conditional sale or any sale with recourse; provided that Seller&#146;s recoupment rights pursuant to
<U>Section</U><U></U><U>&nbsp;2.1(b)</U>, <U>Section</U><U></U><U>&nbsp;5.6(b)</U>, <U>Section</U><U></U><U>&nbsp;5.6(c)</U>, <U>Section</U><U></U><U>&nbsp;5.6(d)</U>, <U>Section</U><U></U><U>&nbsp;5.8(b)</U> and
<U>Section</U><U></U><U>&nbsp;5.8(c)</U> are expressly excluded from this definition and shall not be deemed to be a &#147;Lien&#148; for purposes of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Loss</U>&#148; means any loss, assessment, charge, cost, expense (including
expenses of investigation and reasonable attorneys&#146; fees), fine, Judgment, obligation, or penalty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Majority
Holders</U>&#148; means, as of any time of determination, <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties holding, collectively, Applicable Percentages representing more than 50% of the aggregate Royalty Interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>MannKind Patents</U>&#148; has the meaning set forth in Section&nbsp;1.66 of the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>MannKind Technology</U>&#148; has the meaning set forth in Section&nbsp;1.67 of the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Marketing Approval</U>&#148; has the meaning set forth in Section&nbsp;1.69 of the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Adverse Effect</U>&#148; means, when considered individually or in the aggregate, (a)&nbsp;a material adverse effect on the
legality, validity or enforceability of any of the Transaction Documents or the License Agreement, (b)&nbsp;a material adverse effect on the ability of Seller to perform its obligations under any of the Transaction Documents or under the License
Agreement, (c)&nbsp;a material adverse effect on the rights of Seller under the License Agreement that relate to, or involve or otherwise affect, the Purchased Assets, (d)&nbsp;an adverse effect on the timing, amount or duration of the Purchased
Assets or (e)&nbsp;a material adverse effect on the rights or remedies of Purchaser under any of the Transaction Documents, including the right of Purchaser to receive the Purchased Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Agreements</U>&#148; means the License Agreement and the Supply Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Patent</U>&#148; has the meaning set forth in Section&nbsp;10.2(a)(iv) of the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>MidCap</U>&#148; means MidCap Financial Trust. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>MidCap Consent</U>&#148; means that certain consent dated December&nbsp;27, 2023 by and between Seller and MidCap, as administrative
agent for the lenders under Seller&#146;s Credit and Security Agreement dated as of August&nbsp;6, 2019, as amended, modified, supplemented and restated from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Milestone Event</U>&#148; means either (i)&nbsp;Net Sales Threshold A, or (ii)&nbsp;Net Sales Threshold B. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Milestone Payment</U>&#148; means either (i) $50,000,000 (&#147;<U>Net Sales Threshold A Milestone Payment</U>&#148;), or (ii)
$45,000,000 (&#147;<U>Net Sales Threshold B Milestone Payment</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Sales</U>&#148; has the meaning set forth in
Section&nbsp;1.71 of the License Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Sales Threshold A</U>&#148; means that on or prior to December&nbsp;31, 2026,
the Net Sales of the Royalty Product for any twelve (12)&nbsp;consecutive month period (including, for clarity, the twelve (12)&nbsp;consecutive month period ending on December&nbsp;31, 2026), equals or exceeds One Billion Nine Hundred Million
Dollars ($1,900,000,000). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Sales Threshold B</U>&#148; means, if (and only if) Net Sales Threshold A is
not achieved, that on or prior to September&nbsp;30, 2027, the Net Sales of the Royalty Product for any twelve (12)&nbsp;consecutive month period (including, for clarity, the twelve (12)&nbsp;consecutive month period ending on September&nbsp;30,
2027), equals or exceeds Two Billion Three Hundred Million Dollars ($2,300,000,000). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Sales Threshold C</U>&#148; means, if
(and only if) Net Sales Threshold A and Net Sales Threshold B are not achieved, Net Sales of the Royalty Product during any Calendar Year in excess of Three Billion Five Hundred Million Dollars ($3,500,000,000). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>New Arrangement</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.5(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>New Arrangement Escrow Account</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.5(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Permitted</FONT> <FONT STYLE="white-space:nowrap">Set-Off</FONT></U>&#148; means any right of <FONT
STYLE="white-space:nowrap">set-off,</FONT> counterclaim, credit, reduction or deduction, in each case by contract and exercised by UT in respect of a claim against Seller, including any amounts owed by Seller to UT, other than a Royalty Reduction or
a deduction for taxes required to be withheld. For purposes of clarity, the Parties acknowledge and agree that any deduction taken by UT in calculating Net Sales in accordance with the definition of Net Sales set forth in the License Agreement will
not be (i)&nbsp;a <FONT STYLE="white-space:nowrap">Non-Permitted</FONT> <FONT STYLE="white-space:nowrap">Set-Off</FONT> for any purposes of this Agreement (including, for clarity, pursuant to clause (f)&nbsp;of the definition of Net Sales set forth
in the License Agreement) or (ii)&nbsp;a breach of Section&nbsp;7.4(a) of the License Agreement for any purposes of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties</U>&#148; means the Royalty Parties other than Seller and its
Affiliates, except that, solely for purposes of <U>Section</U><U></U><U>&nbsp;5.4(a)</U> and the first sentence of <U>Section</U><U></U><U>&nbsp;5.15</U>, Purchaser shall be excluded from the definition of
&#147;<U><FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties</U>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-Warranting</FONT> Parties</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;10.5(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Option</U>&#148; has the meaning set forth in Section&nbsp;2.6(a) of the License
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Party</U>&#148; or &#147;<U>Parties</U>&#148; has the meaning set forth in the preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Patent Office</U>&#148; means the applicable patent office, including the United States Patent and Trademark Office and any
comparable foreign patent office. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Payment Date</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.4(e)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Payor</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.11(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means any natural person, firm, corporation, limited liability company, partnership, joint venture, association,
joint-stock company, trust, unincorporated organization, Governmental Authority or any other legal entity, including public bodies, whether acting in an individual, fiduciary or other capacity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Pharmacovigilance Agreement</U>&#148; means the Pharmacovigilance Agreement dated
as of February&nbsp;13, 2019, by and between Seller and UT, as may be amended, amended and restated or otherwise modified from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Product</U>&#148; has the meaning set forth in Section&nbsp;1.80 of the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Price</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchased Assets</U>&#148; means that (a)&nbsp;portion of the aggregate Royalty Interests determined as the product of the aggregate
Royalty Interests multiplied by the Purchaser Applicable Percentage and (b)&nbsp;to the extent Seller commercializes the Royalty Product or enters into a New Arrangement in accordance with <U>Section</U><U></U><U>&nbsp;5.5(c)</U>, the Seller
Commercialization Royalty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser</U>&#148; has the meaning set forth in the preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser Account</U>&#148; means the account set forth on <U>Exhibit D</U> or such other account as may be designated by Purchaser
in writing from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser Applicable Percentage</U>&#148; means, as of the Closing Date, ten percent (10%) and as
of any other date, the Applicable Percentage held by Purchaser as of the date of determination, subject to adjustment as provided in <U>Section</U><U></U><U>&nbsp;2.</U>5; provided that if a Milestone Event does not occur, then, solely for purposes
of calculating the amount of Purchased Assets, the amount of any Seller Commercialization Royalty and <U>Section</U><U></U><U>&nbsp;5.6(e)</U>, zero percent (0%) only for the remainder of any Calendar Year after September&nbsp;30, 2027 (and, for
purposes of clarity, including the 2027 Calendar Year) following the date on which Net Sales Threshold C occurs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchaser
Indemnified Party</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;7.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Quality Agreement</U>&#148;
means the Quality Agreement dated as of June&nbsp;29, 2022, by and between Seller and UT, as may be amended, amended and restated or otherwise modified from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Receiving Party</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;8.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Recipient Confidentiality Breach</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;8.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Recoupment Instruction</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representatives</U>&#148; means, collectively, with respect to any Person, the directors, general partners, managers, officers,
employees, agents, advisors or other representatives (including attorneys, accountants, consultants, and financial advisors) of such Person; provided that, with respect to Purchaser or its Affiliates, Representatives also include their respective
limited partners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Requested Audit</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.8(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Requester</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.8(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Royalty Control Shift</U>&#148; means, as of any time of determination,
(A)&nbsp;any time when the sum of (i)&nbsp;the Purchaser Applicable Percentage and (ii)&nbsp;the aggregate Applicable Percentages then held by <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties other than Purchaser exceeds 50%, or
(B)&nbsp;any time when UT (x)&nbsp;acquires all of the Royalty Interests then held by Seller or (y)&nbsp;acquires all or substantially all of Seller&#146;s business or assets, whether by merger, sale of assets or otherwise as provided in
<U>Section</U><U></U><U>&nbsp;10.3(b)(ii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Royalty Control Shift Representative</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5.14(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Royalty Interests</U>&#148; means (a)&nbsp;all amounts owed to Seller with respect to
Net Sales of the Royalty Product (or deemed Net Sales of the Royalty Product under Section&nbsp;9.3(b)(iv) of the License Agreement) occurring during the Royalty Interests Term under Section&nbsp;6.3 of the License Agreement (for clarity, after
giving effect to all Royalty Reductions and deductions for withholding taxes pursuant to Section&nbsp;7.4(b) of the License Agreement applicable thereto, but excluding any <FONT STYLE="white-space:nowrap">Non-Permitted</FONT> <FONT
STYLE="white-space:nowrap">Set-Off),</FONT> (b) all proceeds (as defined under UCC) of the amounts described in (a), (c) any interest on any amounts described in clause (a)&nbsp;owed to Seller under Section&nbsp;7.7 of the License Agreement and
(d)&nbsp;any payment made in lieu of any amounts referred to in the immediately preceding clauses, whether under the License Agreement or otherwise (and whether at Law or in equity). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Royalty Interests Commencement Date</U>&#148; means October&nbsp;1, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Royalty Interests Term</U>&#148; means the period commencing on and including the Royalty Interests Commencement Date and ending on
and including the Royalty Interests Termination Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Royalty Interests Termination Date</U>&#148; means December&nbsp;31, 2042.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Royalty Parties</U>&#148; means Purchaser, Seller, any Person(s) to whom Seller may sell, transfer, assign, contribute or convey
any right, title or interest in or to all or a portion of the Royalty Interests that are not the Purchased Assets, and their respective permitted assignees pursuant to <U>Section</U><U></U><U>&nbsp;10.3</U> (but, for purposes of clarity, not
including UT or any of its Affiliates in any circumstances). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Royalty Product</U>&#148; means Tyvaso DPI<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (treprostinil) Inhalation Powder, or any other Product that contains a Formulation in which treprostinil is an active pharmaceutical ingredient.<B><I> </I></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Royalty Reduction</U>&#148; means any adjustments, modifications, credits, offsets, reductions or deductions to payments made under
Section&nbsp;6.3 of the License Agreement pursuant to Section&nbsp;6.3(b), Section&nbsp;6.3(c) or Section&nbsp;6.3(d) of the License Agreement (and subject to the limitation imposed by Section&nbsp;6.3(e) of the License Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Royalty Report</U>&#148; has the meaning set forth in Section&nbsp;1.88 of the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC</U>&#148; means the U.S. Securities and Exchange Commission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC Documents</U>&#148; means all reports, schedules, forms, statements, and other
documents (including exhibits (including without limitation this Agreement) and all other information incorporated therein) required to be filed by Seller or, if applicable, Purchaser with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller</U>&#148; has the meaning set forth in the preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller 5.6(d) </U><U>Notice</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.6(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Account</U>&#148; means the account set forth on <U>Exhibit E</U> hereto or such other account as may be designated by Seller
in writing from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Commercialization Royalty</U>&#148; means, for each Calendar Year or portion thereof during
the Royalty Interests Term following the License Agreement Termination Date in which Seller, pursuant to <U>Section</U><U></U><U>&nbsp;5.5(c)</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) commercializes the Royalty Product at any time while UT&#146;s obligation to make royalty payments pursuant to
Section&nbsp;6.3 of the License Agreement would still have been in effect had the event giving rise to the License Agreement Termination Date not occurred; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) enters into a New Arrangement that provides for royalties (on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">country-by-country</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> basis) payable to Seller with respect to the Royalty Product at any time while
UT&#146;s obligation to make royalty payments pursuant to Section&nbsp;6.3 of the License Agreement would still have been in effect had the event giving rise to the License Agreement Termination Date not occurred, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">an amount equal to the Purchaser Applicable Percentage of all amounts that would have been due to Seller under the License Agreement as Royalty Interests as
if the event giving rise to the License Agreement Termination Date did not occur. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Indemnified Party</U>&#148; has the
meaning set forth in <U>Section</U><U></U><U>&nbsp;7.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Solvent</U>&#148; means, with respect to any Person on any date of
determination, that on such date (a)&nbsp;the fair value of the assets of such Person is greater than the total amount of liabilities, including contingent liabilities, of such Person, (b)&nbsp;the present fair saleable value of the assets of such
Person is not less than the amount that will be required to pay the probable liability of such Person on its debts as they become absolute and matured, (c)&nbsp;such Person does not intend to, and does not believe that it will, incur debts or
liabilities beyond such Person&#146;s ability to pay such debts and liabilities as they mature, (d)&nbsp;such Person is not engaged in business or a transaction, and is not about to engage in business or a transaction, for which such Person&#146;s
property would constitute an unreasonably small capital and (e)&nbsp;such Person is able to pay its debts and liabilities, contingent obligations and other commitments as they mature in the ordinary course of business. The amount of contingent
obligations or contingent liabilities, as applicable, at any time shall be computed as the amount that, in light of all the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or
matured liability or obligation, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Specified Rights</U>&#148; means (i)&nbsp;Seller&#146;s right to receive Royalty
Reports pursuant to Section&nbsp;7.1 of the License Agreement (including at the time specified therein), (ii) Purchaser&#146;s right to receive copies of Royalty Reports pursuant to <U>Section</U><U></U><U>&nbsp;5.3</U>, (iii) Seller&#146;s audit
and inspection rights pursuant to Section&nbsp;7.6 of the License Agreement and (iv)&nbsp;Purchaser&#146;s rights pursuant to <U>Section</U><U></U><U>&nbsp;5.8</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Supply Agreement</U>&#148; means the Commercial Supply Agreement dated as of August&nbsp;12, 2021, by and between Seller and UT, as
amended, and as may be further amended, amended and restated or otherwise modified from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Territory</U>&#148; has
the meaning set forth in Section&nbsp;1.93 of the License Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Third Party</U>&#148; has the meaning set forth in
Section&nbsp;1.94 of the License Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Third Party Claim</U>&#148; has the meaning set forth in
<U>Section</U><U></U><U>&nbsp;7.3(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tier 1 Fundamental Representations</U>&#148; means the representations and warranties
contained in <U>Section</U><U></U><U>&nbsp;3.1</U> (<I>Existence; Organization</I>), <U>Section</U><U></U><U>&nbsp;3.2</U> (<I>No Conflicts</I>), <U>Section</U><U></U><U>&nbsp;3.3</U> (<I>Authorization; Enforceability</I>),
<U>Section</U><U></U><U>&nbsp;3.4</U> (<I>Ownership</I>), <U>Section</U><U></U><U>&nbsp;3.8</U> (<I>Compliance with Laws</I>), <U>Section</U><U></U><U>&nbsp;3.9</U> (<I>Intellectual Property Matters</I>), <U>Section</U><U></U><U>&nbsp;3.10</U>
(<I>License Agreement</I>), <U>Section</U><U></U><U>&nbsp;3.11</U> (<I>UCC Matters</I>), and <U>Section</U><U></U><U>&nbsp;3.13(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tier 2 Fundamental Representations</U>&#148; means the representations and warranties contained in
<U>Section</U><U></U><U>&nbsp;3.5</U> (<I>Governmental and Third Party Authorizations</I>), <U>Section</U><U></U><U>&nbsp;3.6</U> (<I>No Litigation</I>),<U> Section</U><U></U><U>&nbsp;3.7</U> (<I>No Brokers&#146; Fees</I>),
<U>Section</U><U></U><U>&nbsp;3.12</U> (<I><FONT STYLE="white-space:nowrap">Non-Permitted</FONT> <FONT STYLE="white-space:nowrap">Set-Off</FONT></I>) and <U>Section</U><U></U><U>&nbsp;3.16</U> (<I>Disclosure</I>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Documents</U>&#148; means this Agreement, the Escrow Agreement, the Bill of Sale, the UT Consent and the Instruction
Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>UCC</U>&#148; means the Uniform Commercial Code as in effect from time to time in the State of New York;
<U>provided</U>, that, if, with respect to any financing statement or by reason of any provisions of applicable Law, the perfection or the effect of perfection or <FONT STYLE="white-space:nowrap">non-perfection</FONT> of the <FONT
STYLE="white-space:nowrap">back-up</FONT> security interest or any portion thereof granted pursuant to <U>Section</U><U></U><U>&nbsp;2.1(c)</U> is governed by the Uniform Commercial Code as in effect in a jurisdiction of the United States other than
the State of New York, then &#147;<U>UCC</U>&#148; means the Uniform Commercial Code as in effect from time to time in such other jurisdiction for purposes of the provisions of this Agreement and any financing statement relating to such perfection
or effect of perfection or <FONT STYLE="white-space:nowrap">non-perfection.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Unanimous Holder Consent</U>&#148; means, as
of any time of determination, the unanimous consent of all <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties, including Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Upfront Payment</U>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.1(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>U.S.</U>&#148; or &#147;<U>United States</U>&#148; means the United States of America, each territory thereof and the District of
Columbia. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>UT</U>&#148; means United Therapeutics Corporation, a Delaware corporation, and its
successors and permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>UT Confidential Information</U>&#148; means, collectively, (a)&nbsp;the terms of the License
Agreement and the Ancillary Agreements, (b)&nbsp;any and all Confidential Information (as defined in the License Agreement) disclosed by or on behalf of UT under the License Agreement (including the Royalty Reports and any audit reports disclosed to
Seller pursuant to Section&nbsp;7.6 of the License Agreement) or under any Ancillary Agreement, and (c)&nbsp;any and all other information that is otherwise disclosed by or on behalf of UT to Purchaser or Seller on a confidential basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>UT Consent</U>&#148; means the letter agreement dated December&nbsp;27, 2023, by and between Seller and UT, a copy of which is
attached as <U>Exhibit J</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Rules of Construction</U>. Unless the context otherwise requires, in this Agreement:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) a term has the meaning assigned to it and an accounting term not otherwise defined has the meaning assigned to it in accordance with
GAAP; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) words of the masculine, feminine or neuter gender shall mean and include the correlative words of other genders; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the definitions of terms shall apply equally to the singular and plural forms of the terms defined; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) references to the term &#147;or&#148; will be interpreted in the inclusive sense commonly associated with the term &#147;and/or&#148;;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the terms &#147;include&#148;, &#147;including&#148; and similar terms shall be construed as if followed by the phrase &#147;without
limitation&#148;; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) unless otherwise specified, references to an agreement or other document include references to such agreement or
document as from time to time amended, restated, reformed, supplemented or otherwise modified in accordance with the terms thereof (subject to any restrictions on such amendments, restatements, reformations, supplements or modifications set forth
herein) and include any annexes, exhibits and schedules attached thereto; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) references to any Law shall include such Law as from time
to time in effect, including any amendment, modification, codification, replacement or reenactment thereof or any substitution therefor; provided that, for purposes of <U>Article III</U> and <U>Article IV</U>, reference to a Law shall mean such Law
as in effect as of the date hereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) references to any Person shall be construed to include such Person&#146;s successors and
permitted assigns (subject to any restrictions on assignment, transfer or delegation set forth herein or in any of the other Transaction Documents), and any reference to a Person in a particular capacity excludes such Person in other capacities;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the word &#147;will&#148; shall be construed to have the same meaning and effect as the
word &#147;shall&#148;; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) the words &#147;hereof&#148;, &#147;herein&#148;, &#147;hereunder&#148; and similar terms when used in this
Agreement shall refer to this Agreement as a whole and not to any particular provision hereof, and Article, Section and Exhibit references herein are references to Articles and Sections of, and Exhibits to, this Agreement unless otherwise specified;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) except as otherwise set forth in this Agreement, in the computation of a period of time from a specified date to a later specified
date, the word &#147;from&#148; means &#147;from and including&#148; and each of the words &#147;to&#148; and &#147;until&#148; means &#147;to but excluding&#148;; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) where any payment is to be made, any funds are to be applied or any calculation is to be made under this Agreement on a day that is not a
Business Day, unless this Agreement otherwise provides, such payment shall be made, such funds shall be applied and such calculation shall be made on the succeeding Business Day, and payments shall be adjusted accordingly. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>PURCHASE AND SALE
OF THE PURCHASED ASSETS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>Purchase and Sale; Purchase Price</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Upon the terms and subject to the conditions of this Agreement, Seller shall sell, assign, transfer and convey to Purchaser, and Purchaser
shall purchase, acquire and accept from Seller, all of Seller&#146;s right, title and interest in and to the Purchased Assets, free and clear of any and all Liens, other than those Liens created in favor of Purchaser by this Agreement and the Escrow
Agreement. Without limiting the foregoing, it is understood and agreed that Purchaser shall not, by purchase of the Purchased Assets, acquire any assets or rights of Seller under, or relating to, the License Agreement other than those specified in
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The purchase price to be paid as the full consideration for the sale, assignment, transfer and conveyance of the Purchased
Assets by Seller to Purchaser is comprised of (i)&nbsp;One Hundred Fifty Million Dollars ($150,000,000) (the &#147;<U>Upfront Payment</U>&#148;), provided that Four Hundred Thousand Dollars ($400,000) (the &#147;<U>Fee Reimbursement</U>&#148;) of
the Upfront Payment shall be deducted as reimbursement of Purchaser&#146;s fees and expenses in connection with the transactions contemplated by the Transaction Documents and (ii)&nbsp;the Milestone Payment, to the extent the same becomes due and
payable hereunder (collectively, the &#147;<U>Purchase Price</U>&#148;). Purchaser shall pay the amount equal to the Upfront Payment <I>minus</I> the Fee Reimbursement to Seller at the Closing in immediately available funds by wire transfer to the
Seller Account. Upon the occurrence of a Milestone Event, Seller shall send written notice to Purchaser notifying Purchaser of the occurrence of that Milestone Event, and then Purchaser shall within fifteen (15)&nbsp;Business Days following its
receipt of Seller&#146;s written notice (the &#147;<U>Evaluation Period</U>&#148;) send written notice to Seller either confirming or disputing the occurrence of that Milestone Event; provided that Seller and Purchaser acknowledge and agree that
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
quarterly calculations of Net Sales (as reported in the Royalty Reports) may be used by Seller to demonstrate the occurrence of a Milestone Event (and Purchaser will not be precluded from
disputing the occurrence of such Milestone Event because of Seller&#146;s use of quarterly Net Sales calculations as reported in Royalty Reports). If Purchaser confirms the occurrence of the Milestone Event or fails to confirm or dispute the
occurrence of the Milestone Event prior to the expiration of the Evaluation Period, Purchaser shall pay the applicable Milestone Payment to Seller in immediately available funds by wire transfer to the Seller Account within the earlier of three
(3)&nbsp;Business Days following (x)&nbsp;Purchaser&#146;s written notice to Seller confirming the occurrence of the Milestone Event or (y)&nbsp;the expiration of the Evaluation Period. In accordance with the provisions of this
<U>Section</U><U></U><U>&nbsp;2.1(b)</U>, upon the occurrence of Net Sales Threshold A, the Net Sales Threshold A Milestone Payment shall be owed, or upon the occurrence of Net Sales Threshold B, the Net Sales Threshold B Milestone Payment shall be
owed. For clarity, only the Net Sales Threshold A Milestone Payment or the Net Sales Threshold B Milestone Payment shall be owed, and in no event shall both payments be owed. If Purchaser delivers to Seller written notice disputing the occurrence of
the applicable Milestone Event prior to the expiration of the Evaluation Period, the Parties shall in good faith seek to resolve any dispute relating to that Milestone Event pursuant to <U>Section</U><U></U><U>&nbsp;2.1(b)(ii)</U>. In the event that
Purchaser fails to pay Seller the applicable Milestone Payment when due as provided herein, Seller shall be entitled to recoup an amount equal to the portion of the applicable Milestone Payment not paid to Seller by Purchaser, together with any late
fee in respect thereof in accordance with <U>Section</U><U></U><U>&nbsp;5.4(e)</U>, from the Purchased Assets by giving one or more unilateral written instructions to the Escrow Agent to deduct from amounts deposited into the Escrow Account that
would otherwise be distributable to Purchaser in respect of the Purchased Assets (each, a &#147;<U>Recoupment Instruction</U>&#148;) an amount equal to the sum of the unpaid amount of the applicable Milestone Payment and any late fee in respect
thereof calculated in accordance with <U>Section</U><U></U><U>&nbsp;5.4(e)</U> and to cause the Escrow Agent to distribute such amounts to Seller, until the full amount of the applicable Milestone Payment and such late fees have been distributed to
Seller; provided, however, that Seller shall not give any Recoupment Instruction to the Escrow Agent until any dispute relating to the applicable Milestone Event and noticed by Purchaser to Seller during the applicable Evaluation Period has been
resolved pursuant to <U>Section</U><U></U><U>&nbsp;2.1(b)(ii)</U>. Unless there is a dispute relating to that Milestone Event that was noticed by Purchaser to Seller during the applicable Evaluation Period and that has not been resolved pursuant to
<U>Section</U><U></U><U>&nbsp;2.1(b)(ii)</U>, Purchaser shall not object to a Recoupment Instruction given by Seller to the Escrow Agent pursuant to this <U>Section</U><U></U><U>&nbsp;2.1(b)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) In the event of any dispute relating to a Milestone Event, the Parties shall submit such dispute to the Parties&#146;
Executive Officers, and then the Executive Officers shall use good faith efforts to promptly resolve such dispute, which good faith efforts shall include at least one (1)&nbsp;in-person, video or telephonic meeting between such Executive Officers
within ten (10)&nbsp;Business Days after the submission of such matter to them. If the Executive Officers are unable to resolve such dispute within thirty (30)&nbsp;Business Days after its submission to them, then either Party may pursue resolution
of such dispute in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;10.8</U>. &#147;<U>Executive Officer</U>&#148; means, with respect to either Party, a senior executive designated by such Party for purposes of resolving a dispute
pursuant to this <U>Section</U><U></U><U>&nbsp;2.1(b)(ii)</U>, and who shall be expressly authorized by such Party to resolve such dispute. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) It is the intention of the Parties that the sale, transfer, assignment and conveyance
contemplated by this Agreement be, and is, a true, complete, absolute and irrevocable sale, transfer, assignment and conveyance by Seller to Purchaser of all of Seller&#146;s right, title and interest in, to, and under the Purchased Assets free and
clear of all Liens, other than those created in favor of Purchaser by this Agreement and the Escrow Agreement. Neither Seller nor Purchaser intends the transactions contemplated by this Agreement to be, or for any purpose characterized as, a loan
from Purchaser to Seller or a pledge, a security interest, a financing transaction or a borrowing. Each of Seller and Purchaser hereby waives, to the maximum extent permitted by applicable Law, any right to contest or otherwise assert that this
Agreement does not constitute a true, complete, absolute and irrevocable sale, transfer, assignment and conveyance by Seller to Purchaser of all of Seller&#146;s right, title and interest in, to, and under the Purchased Assets under applicable Law,
which waiver shall, to the maximum extent permitted by applicable Law, be enforceable against Seller in any bankruptcy or insolvency proceeding relating to Seller. Not in derogation of the foregoing statement of the intent of the Parties in this
regard, and for the purposes of providing additional assurance to Purchaser in the event that, despite the intent of the Parties, the sale, transfer, assignment and conveyance contemplated hereby is hereafter held not to be a sale, Seller does
hereby grant to Purchaser, as security for the payment of amounts to Purchaser equal to the Purchased Assets as it becomes due and payable and as may be necessary to perfect the sale of the Purchased Assets to Purchaser, a security interest in, to,
and under all right, title and interest of Seller, in, to and under the Purchased Assets and any &#147;proceeds&#148; (as such term is defined in the UCC) thereof, and Seller does hereby authorize Purchaser, from and after the Closing, to file such
financing statements (and continuation statements with respect to such financing statements when applicable) in such manner and such jurisdictions as are necessary or appropriate to perfect such security interest; provided that such financing
statements shall not describe as collateral anything other than the Purchased Assets and any &#147;proceeds&#148; thereof (as defined in the UCC), whether now existing or hereafter created by Seller, and shall not contain an &#147;all asset&#148;
(or words of similar effect) collateral description. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>No Assumed Obligations</U>. Notwithstanding any provision in
this Agreement or any other writing to the contrary, Purchaser is purchasing, acquiring and accepting only the Purchased Assets and is not assuming any liability or obligation of Seller or any of Seller&#146;s Affiliates of whatever nature, whether
presently in existence or arising or asserted hereafter (including any liability or obligation of Seller under the License Agreement). All such liabilities and obligations shall be retained by and remain liabilities and obligations of Seller or
Seller&#146;s Affiliates, as the case may be (the &#147;<U>Excluded Liabilities and Obligations</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Excluded
Assets</U>. Other than the Purchased Assets, Purchaser does not, by purchase, acquisition or acceptance of the right, title or interest granted hereunder or otherwise pursuant to any of the Transaction Documents, purchase, acquire or accept any
assets or contract rights of Seller (the &#147;<U>Excluded Assets</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4 <U>Other Sale Transactions</U>. Purchaser acknowledges and agrees that,
subject to Purchaser&#146;s rights set forth in that certain letter agreement, dated as of the date hereof, by and between Seller and Purchaser, Seller shall have the right, at any time, to sell, assign, contribute or otherwise transfer all or any
portions of the Royalty Interests that are not the Purchased Assets (and/or grant, incur or suffer to exist Liens on such Royalty Interests) to one or more third parties, including UT on such terms as Seller may determine in its sole discretion. In
the event of any sale, assignment, contribution or other transfer of Royalty Interests by Seller to a <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party under this <U>Section</U><U></U><U>&nbsp;2.4</U>, then Seller will, promptly (and
in any event within five (5)&nbsp;Business Days) following the closing of such sale, assignment, contribution or other transfer, provide Purchaser with written notice informing Purchaser of such transaction, and shall disclose to Purchaser the
identity of such <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party and the Applicable Percentage of the Royalty Interests sold, assigned, contributed or transferred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5 <U>Adjustment of Purchaser Applicable Percentage</U>. In the event of any sale, assignment, contribution or other transfer by
Seller to UT of all or any portion of the Royalty Interests that are not the Purchased Assets pursuant to <U>Section</U><U></U><U>&nbsp;2.4</U> that has the effect of reducing the aggregate Royalty Interests, the Purchaser Applicable Percentage
shall be adjusted as necessary so that the amount payable to Purchaser in respect of the Purchased Assets will be the amount that would have been payable to Purchaser as if such Royalty Interests had not been sold, assigned, contributed or
transferred by Seller to UT. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE III </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>REPRESENTATIONS AND WARRANTIES OF SELLER </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth on, or disclosed in, the Disclosure Schedules, Seller hereby represents and warrants to Purchaser as of the date hereof as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Existence; Organization</U>. Seller is a corporation duly organized, validly existing and in good standing
under the Laws of Delaware. Seller is duly licensed or qualified to do business in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned, leased, or operated by it makes
such licensing or qualification necessary, except where the failure to be so licensed or qualified has not and would not reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>No Conflicts</U>. The execution, delivery and performance by Seller of the Transaction Documents and the consummation of
the transactions contemplated thereby do not (a)&nbsp;violate any provision of the certificate of incorporation or bylaws of Seller, (b)&nbsp;violate any provision of any Judgment applicable to Seller, to which it is a party, or by which it or any
of its properties or assets are bound, (c)&nbsp;violate any provision of any Law applicable to Seller; nor (d)&nbsp;violate, breach, conflict with, constitute a default (or an event which with notice or lapse of time or both would become a default),
or require consent under any provision of, or give to any Person any rights of termination, cancellation or acceleration of (i)&nbsp;the License Agreement or (ii)&nbsp;any other material contract (other than the License Agreement) to which Seller is
a party or by which Seller is bound, including the Supply Agreement, except in the case of this clause (ii)&nbsp;for such violations, breaches, conflicts or defaults that, individually or in the aggregate and with or without the passage of time,
would not reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Authorization; Enforceability</U>. Seller has all necessary corporate
power and authority to (a)&nbsp;conduct its affairs as currently conducted, including to exercise its rights and perform its obligations under the License Agreement and (b)&nbsp;execute, deliver and perform the Transaction Documents and to
consummate the transactions contemplated thereby. The execution, delivery and performance of the Transaction Documents, and the consummation of the transactions contemplated thereby, have been duly authorized by Seller. Each of the Transaction
Documents has been duly executed and delivered by Seller and constitutes the legal, valid and binding obligation of Seller, enforceable against Seller in accordance with its terms, except as may be limited by general principles of equity (regardless
of whether considered in a proceeding at law or in equity) and by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#146; rights generally, general equitable principles and principles of public policy.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Ownership</U>. Seller has good and valid title to the Purchased Assets, free and clear of all Liens (other than those
created in favor of Purchaser and expressly contemplated by this Agreement and the Escrow Agreement), and is the exclusive owner of the entire right, title (legal and equitable), and interest in the Purchased Assets. Immediately following the
Closing, Purchaser will have acquired, subject to the terms and conditions set forth in this Agreement, good and valid title to the Purchased Assets, free and clear of all Liens (other than those created in favor of Purchaser and expressly
contemplated by this Agreement and the Escrow Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5 <U>Governmental and Third Party Authorizations</U>. The
execution, delivery, and performance by Seller of the Transaction Documents and the consummation of any of the transactions contemplated thereby do not require Seller to obtain any consent, approval, license, order, authorization or declaration
from, or Seller to give any notice to, or take any action or make any registration or filing with any Governmental Authority or any other Person, except for (a)&nbsp;the Instruction Letter, (b)&nbsp;a Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> by Seller with the U.S. Securities and Exchange Commission, (c)&nbsp;the UT Consent, and (d)&nbsp;the MidCap Consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6 <U>No Litigation</U>. There is no Action pending or, to the Knowledge of Seller, threatened, by or against Seller
(a)&nbsp;that, individually or in the aggregate, (i)&nbsp;challenges or seeks to prevent or delay the consummation of any of the transactions contemplated by any of the Transaction Documents to which Seller is a party or (ii)&nbsp;would reasonably
be expected to result in a Material Adverse Effect, (b)&nbsp;in respect of the Purchased Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7 <U>No
Brokers</U><U>&#146;</U><U> Fees</U>. Seller has not taken any action that would entitle any Person or entity other than Morgan Stanley&nbsp;&amp; Co. LLC, whose fee will be paid by Seller, to any commission or broker&#146;s fee in connection with
the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8 <U>Compliance with Laws</U>. Seller (a)&nbsp;has not violated, nor is
it in violation of, has not been given notice of any violation of, and, to the Knowledge of Seller, is not under investigation with respect to nor has it been threatened to be charged with, any violation of, any applicable Law or any Judgment,
permit, or license granted, issued or entered by any Governmental Authority, other than any such violations that would not reasonably be expected to have a Material Adverse Effect, and (b)&nbsp;is not subject to any Judgment of any Governmental
Authority that would reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.9 <U>Intellectual Property Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) MannKind is the sole and exclusive owner of the entire right, title and interest in the MannKind Patents, free of any Liens other than
Liens held by MidCap and the rights granted to UT under the License Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Person who has or has had any rights in or to any
MannKind Patents has assigned and has executed an agreement assigning its entire right, title, and interest in and to such MannKind Patents to Seller or its Affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Neither Seller nor any of its Affiliates has previously entered into any agreement, whether written or oral, with respect to the
assignment, transfer, license, conveyance or encumbrance of, or otherwise assigned, transferred, licensed, conveyed or encumbered its right, title, or interest in or to any Material Patent (including by granting any covenant not to sue with respect
thereto) that would otherwise be included in the MannKind Patents but for such assignment, transfer, license, conveyance, or encumbrance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As of the date hereof, (i)&nbsp;all issued MannKind Patents are in full force and effect and subsisting; (ii)&nbsp;none of the MannKind
Patents is currently involved in any interference, reissue, reexamination, or opposition proceeding; and (iii)&nbsp;neither Seller nor any of its Affiliates has received any written notice from any Person of any such proceeding, or, to the Knowledge
of Seller, is any such proceeding threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To the Knowledge of Seller, as of the date hereof, except as permitted under the
licenses granted to UT under the License Agreement, there are no activities by third parties relating to the MannKind Patents (whether actual or threatened) that would constitute infringement of the MannKind Patents or would reasonably be expected
to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Neither Seller nor any of its Affiliates has received any written notice from any Person of any
claim or potential claim, whether or not asserted, that: (i)&nbsp;any of the MannKind Patents are invalid or unenforceable, (ii)&nbsp;the disclosing, copying, assigning, or licensing of the MannKind Patents does or would be reasonably expected to
violate, infringe or misappropriate the valid intellectual property rights of a third party, or (iii)&nbsp;the use or practice of the MannKind Patents would be reasonably expected to, based on the development or commercialization of the Royalty
Product in the Field as currently conducted by UT, violate, infringe or misappropriate the valid intellectual property rights of a third party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10 <U>License Agreement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Attached hereto as <U>Exhibit G</U> are true, correct, and complete copies of the License Agreement and all Royalty Reports received by
Seller from UT as of the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Other than the Transaction Documents and except as set forth in Section&nbsp;3.10(b) of the
Disclosure Schedules, there is no contract, agreement or other arrangement (whether written or oral) between Seller, on the one hand, and a Third Party, on the other hand, that creates a Lien on the Purchased Assets, the Royalty Interests, the
License Agreement, the Supply Agreement or the MannKind Patents.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The License Agreement is in full force and effect and is the legal, valid, and binding
obligation of Seller and UT, and is enforceable against Seller and UT, in accordance with its terms, except as may be limited by general principles of equity (regardless of whether considered in a proceeding at law or in equity) and by applicable
bankruptcy, insolvency, moratorium and other similar Laws of general application relating to or affecting creditors&#146; rights generally. Seller has not received any written notice from or on behalf of UT challenging or threatening to challenge
the validity or enforceability of the License Agreement or any obligation of UT thereunder, including any obligation to pay the Royalty Interests or any other payment thereunder, or to terminate the License Agreement or alleging that Seller is in
default of any of its obligations under the License Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Seller has not breached, and is not in violation or default under, any
of its obligations in the License Agreement. To the Knowledge of Seller, UT has not breached, and is not in violation or default under, any of its obligations in the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Other than the UT Consent, Seller has not granted or been granted any written waiver under the License Agreement or released UT, in whole
or in part, from any of its obligations under the License Agreement. Other than the UT Consent, there are no modifications (or pending requests therefor) in respect of the License Agreement. Other than the UT Consent, Seller has not received from UT
any proposal, and has not made any proposal to UT, to amend or waive any provision of the License Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To the Knowledge of
Seller, no event has occurred that, upon notice or the passage of time or both, would reasonably be expected to give rise to a breach of any of the obligations of Seller or UT under the License Agreement, or, to the Knowledge of Seller, that would
otherwise give Seller or such party the right to terminate the License Agreement or give UT the right to cease paying the Royalty Interests thereunder. Seller has not given UT any notice of termination of the License Agreement, in whole or in part.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Neither Seller nor, to the Knowledge of Seller, UT, has sublicensed, assigned, sold, or transferred the License Agreement or any of
its rights, interests, or obligations thereunder (including with respect to the Royalty Interests) to any Person, and Seller has not consented to any such sublicense, assignment, sale or transfer by UT. Except as contemplated by the Transaction
Documents, Seller has not encumbered, assigned, sold or transferred, in whole or in part, any of Seller&#146;s right, title, or interest in or to the Royalty Interests under the License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) UT has not exercised the Option under Section&nbsp;2.6 of the License Agreement. Seller has not exercised its rights to conduct an audit
under Section&nbsp;7.6 of the License Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Neither Seller nor any of its Affiliates has developed, manufactured,
commercialized, or authorized any third party to develop, manufacture or commercialize a Competing Product in violation of Section&nbsp;2.5(a) of the License Agreement. To the Knowledge of Seller, neither UT nor any of its Affiliates has developed,
manufactured, commercialized or authorized any Third Party to develop, manufacture or commercialize any product (other than Product) containing or comprising any dry powder formulation of API that is or is intended to be primarily administered in or
through the lungs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Seller has received all amounts indicated on Royalty Reports received to date as being
owed to Seller under Section&nbsp;6.3 of the License Agreement, to the extent such amounts have come due. To the Knowledge of Seller, the amounts indicated on such Royalty Reports as payable to Seller under Section&nbsp;6.3 of the License Agreement
are accurate for the periods covered by such Royalty Reports. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Seller has not sent or received any written notice of any dispute to or
from UT for resolution pursuant to <U>Article 14</U> of the License Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) There are no agreements between Seller or, to the
Knowledge of Seller, UT, and any Third Party (including UT) that would give rise to a right of UT to reduce any payment under Section&nbsp;6.3 of the License Agreement pursuant to Section&nbsp;6.3(b) of the License Agreement, and to the Knowledge of
Seller, there are no ongoing discussions related to any such agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) The Royalty Product is a Product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) Neither Seller nor UT has made any claim of indemnification under the License Agreement or the Supply Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) The agreement listed in Section&nbsp;3.10(o) of the Disclosure Schedules does not contain terms or provisions related to the timing,
amount or duration of the Purchased Assets or any of the Specified Rights. Seller&#146;s and UT&#146;s continued performance of their respective obligations under each of the Ancillary Agreements, and the agreement listed in Section&nbsp;3.10(o) of
the Disclosure Schedules would not reasonably be expected to have an adverse effect on (A)&nbsp;the timing, amount or duration of the Purchased Assets or (B)&nbsp;the Specified Rights or otherwise reasonably be expected to result in a Material
Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11 <U>UCC Matters</U>. Seller&#146;s exact legal name is, and since 2001 has been, &#147;MannKind
Corporation&#148;. Seller&#146;s principal place of business is, and since 2021 has been, located in the State of Connecticut. Seller&#146;s jurisdiction of organization is, and since 1991 has been, the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12 <U><FONT STYLE="white-space:nowrap">Non-Permitted</FONT> <FONT STYLE="white-space:nowrap">Set-Off</FONT></U>. UT has not
exercised, and, to the Knowledge of Seller, has not had and does not have the right to exercise, and, to the Knowledge of Seller, no event or condition exists that, upon notice or passage of time or both, would reasonably be expected to permit UT to
exercise, any <FONT STYLE="white-space:nowrap">Non-Permitted</FONT> <FONT STYLE="white-space:nowrap">Set-Off</FONT> against the Purchased Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13 <U>Regulatory, Commercialization and Manufacture</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as provided in Section&nbsp;4.1(b) of the License Agreement, UT has been solely responsible for the development of the Royalty
Product, including the conduct of clinical trials. Seller has complied with its obligations under Section&nbsp;4.1(b) of the License Agreement, except as, individually or in the aggregate, would not reasonably be expected to have a Material Adverse
Effect. To the Knowledge of Seller, UT has complied with its obligations to develop the Royalty Product and seek and obtain Marketing Approval for the Royalty Product as set forth in Section&nbsp;4.2(b) of the License Agreement, except in each case
as, individually or in the aggregate, would not, reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) UT has been, and continues to be, and Seller is not, responsible for the marketing,
promotion and commercialization of the Royalty Product under the License Agreement. To the Knowledge of Seller, UT has complied with its obligations related to the marketing, promotion and commercialization of the Royalty Product set forth in
Section&nbsp;5.1 of the License Agreement, except in each case as, individually or in the aggregate, would not, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Attached hereto as <U>Exhibit H</U> is a true, correct, and complete copy of the Supply Agreement. The Supply Agreement is in full force
and effect and is the legal, valid, and binding obligation of Seller and UT, enforceable against Seller and UT in accordance with its terms, except as may be limited by general principles of equity (regardless of whether considered in a proceeding
at law or in equity) and by applicable bankruptcy, insolvency, moratorium and other similar Laws of general application relating to or affecting creditors&#146; rights generally. Seller has not received any written notice from or on behalf of UT
challenging or threatening to challenge the validity or enforceability of the Supply Agreement or any obligation of UT thereunder. Seller has not breached, and is not in violation or default under, any of its material obligations in the Supply
Agreement. To the Knowledge of Seller, UT has not breached, and is not in violation or default under, any of its material obligations in the Supply Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14 <U>Solvency</U>. Seller is Solvent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15 <U>Tax Matters</U>. No deduction or withholding for or on account of any tax has been made or was required under the License
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16 <U>Disclosure</U>. To the Knowledge of Seller, except as set forth in the Disclosure Schedules, as set forth
in Seller&#146;s electronic data room maintained at Debtdomain.com and made available to Purchaser at least two Business Days prior to the date of this Agreement, or as disclosed by Seller in writing to Purchaser at least two Business Days prior to
the date of this Agreement, Seller has no Knowledge of any fact (other than general economic or industry conditions) that would reasonably be expected to materially and adversely affect the Purchased Assets or the Royalty Product. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE IV </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>REPRESENTATIONS AND
WARRANTIES OF PURCHASER </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchaser hereby represents and warrants to Seller as of the date hereof as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Organization</U>. Purchaser is a limited partnership duly organized, validly existing and in good standing under the Laws
of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>No Conflicts</U>. The execution, delivery, and performance by Purchaser of any of the Transaction
Documents and the consummation of the transactions contemplated thereby do not constitute a breach or default under, or require prepayment under any provision of (a)&nbsp;any applicable Law or any Judgment applicable to Purchaser that would
reasonably be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expected to have a material adverse effect on the legality, validity or enforceability of any of the Transaction Documents, or the ability of Purchaser to perform any of its obligations under any
of the Transaction Documents, (b)&nbsp;any contract to which Purchaser is a party or by which Purchaser is bound, or (c)&nbsp;the organizational documents of Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>Authorization</U>. Purchaser has all powers and authority to conduct its affairs as currently conducted, and to execute
and deliver, and perform its obligations under, the Transaction Documents to which it is party and to consummate the transactions contemplated hereby and thereby. The execution and delivery of each of the Transaction Documents to which Purchaser is
party and the performance by Purchaser of its obligations hereunder and thereunder have been duly authorized by Purchaser. Each of the Transaction Documents to which Purchaser is party has been duly executed and delivered by Purchaser. Each of the
Transaction Documents to which Purchaser is party constitutes the legal, valid, and binding obligation of Purchaser, enforceable against Purchaser in accordance with its respective terms, subject to applicable bankruptcy, insolvency, reorganization,
moratorium, or similar applicable Laws affecting creditors&#146; rights generally, general equitable principles and principles of public policy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>Governmental and Third Party Authorizations</U>. The execution, delivery, and performance by Purchaser of the Transaction
Documents and the consummation of any of the transactions contemplated hereunder and thereunder do not require Purchaser to obtain any consent, approval, license, order, authorization, or declaration from, or Purchaser to give any notice to, or take
any action or make any registration or filing with any Governmental Authority or any other Person, except the UCC financing statements contemplated by <U>Section</U><U></U><U>&nbsp;2.1(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5 <U>No Litigation</U>. There is no (a)&nbsp;Action (whether civil, criminal, administrative, regulatory, investigative or
informal) pending or, to the Knowledge of Purchaser, threatened by or against Purchaser, at law or in equity, or (b)&nbsp;inquiry or investigation (whether civil, criminal, administrative, regulatory, investigative, or informal) by or before a
Governmental Authority pending or, to the Knowledge of Purchaser, threatened against Purchaser, that, in each case, challenges or seeks to prevent or delay the consummation of any of the transactions contemplated by any of the Transaction Documents
to which Purchaser is party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6 <U>Funds Available</U>. Purchaser has sufficient funds on hand to satisfy its obligation to
pay the Upfront Payment at the Closing and will have sufficient funds on hand to satisfy its obligation to pay the Milestone Payment if and when it becomes due and payable hereunder. Purchaser acknowledges and agrees that its obligations under this
Agreement are not contingent on obtaining financing. As of the date hereof, Purchaser has no Knowledge of any circumstance or set of circumstances that could render it unable to pay the Purchase Price, and will use its best efforts to satisfy any
conditions to borrowing or other requirements to enable it to have access to funds to pay the Milestone Payment under any credit agreements or other credit arrangements to which it is party, if applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7 <U>No Implied Representations and Warranties</U>. PURCHASER ACKNOWLEDGES AND AGREES THAT, (A)&nbsp;OTHER THAN THE EXPRESS
REPRESENTATIONS AND WARRANTIES OF SELLER SPECIFICALLY CONTAINED IN <U>ARTICLE III</U>, THERE ARE NO REPRESENTATIONS OR WARRANTIES OF SELLER EITHER EXPRESSED OR IMPLIED, (B)&nbsp;PURCHASER DOES NOT RELY ON, AND
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
SHALL HAVE NO REMEDIES IN RESPECT OF, ANY REPRESENTATION OR WARRANTY NOT SPECIFICALLY SET FORTH IN <U>ARTICLE III</U>, AND (C)&nbsp;ALL OTHER REPRESENTATIONS AND WARRANTIES, WHETHER ARISING BY
OPERATION OF LAW OR OTHERWISE, INCLUDING WITH RESPECT TO IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, OR THE PROSPECTS OR LIKELIHOOD OF COMMERCIAL SUCCESS OF THE ROYALTY PRODUCT, ARE HEREBY EXPRESSLY DISCLAIMED
BY SELLER. SELLER MAKES NO REPRESENTATION OR WARRANTY THAT THE ROYALTY PRODUCT WILL BE COMMERCIALIZED IN ANY COUNTRY OR ACHIEVE ANY PARTICULAR SALES LEVEL, WHETHER IN ANY INDIVIDUAL COUNTRY OR CUMULATIVELY THROUGHOUT THE TERRITORY. PURCHASER FURTHER
ACKNOWLEDGES AND AGREES THAT SELLER HAS NO RIGHTS OR RESPONSIBILITIES OF ANY KIND WITH RESPECT TO, AND BY VIRTUE OF THE TRANSACTIONS CONTEMPLATED BY THE TRANSACTION DOCUMENTS HAS NOT BECOME ENTITLED TO ANY RIGHTS OR ASSUMED ANY RESPONSIBILITIES OF
ANY KIND WITH RESPECT TO, THE REGULATORY SUBMISSIONS FOR AND USE, SALE, DISTRIBUTION, MARKETING OR OTHER COMMERCIALIZATION ACTIVITIES WITH RESPECT TO THE ROYALTY PRODUCT, ALL OF THE RIGHTS AND RESPONSIBILITY FOR WHICH IS WITH UT. PURCHASER FURTHER
ACKNOWLEDGES AND AGREES THAT, SUBJECT TO SELLER&#146;S PERFORMANCE OF ITS OBLIGATIONS UNDER THIS AGREEMENT (INCLUDING ARTICLE V (COVENANTS)), SELLER SHALL HAVE NO LIABILITY TO PURCHASER WITH RESPECT TO ANY ACT OR OMISSION OF UT RELATING TO SUCH
REGULATORY SUBMISSIONS AND USE, SALE, DISTRIBUTION, MARKETING OR OTHER COMMERCIALIZATION ACTIVITIES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8 <U>Access to
Information</U>. Purchaser acknowledges that it has reviewed the License Agreement, the Transaction Documents and such other documents and information relating to the Royalty Product and the Purchased Assets and the transactions contemplated by the
Transaction Documents as have been provided to it by Seller and has had the opportunity to ask such questions of, and to receive answers from, representatives of Seller concerning the License Agreement, the Transaction Documents, the Royalty
Product, the Purchased Assets and the transactions contemplated by the Transaction Documents, in each case as it deemed necessary to make an informed decision to purchase the Purchased Assets in accordance with the terms of this Agreement. Purchaser
has such knowledge, sophistication and experience in financial and business matters that it is capable of evaluating the risks and merits of purchasing the Purchased Assets in accordance with the terms of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9 <U>Tax Matters</U>. Purchaser acknowledges and agrees that Purchaser is exempt from United States federal withholding tax on
payments in respect of the Purchased Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE V </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>COVENANTS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Public Announcement</U>. Except (a)&nbsp;for a press release previously approved in form and substance by the Parties and
attached hereto as <U>Exhibit I</U>, or any other public announcement using substantially the same text as such press release, and (b)&nbsp;in accordance with <U>Section</U><U></U><U>&nbsp;5.9</U> or <U>Article VIII</U>, as applicable, no Party
shall, and each Party shall cause its Affiliates not to, without the prior written consent of the other Party, issue any press release or make any other public disclosure with respect to this Agreement or any of the other Transaction Documents or
any of the transactions contemplated hereby or thereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Further Assurances</U>. Subject to the terms and conditions of this
Agreement, each Party shall execute and deliver such other documents, certificates, instruments, agreements and other writings, take such other actions and perform such additional acts under applicable Law as may be reasonably requested by the other
Party and necessary to implement expeditiously the transactions contemplated by, and to carry out the purposes and intent of the provisions of, this Agreement and the other Transaction Documents, including to (i)&nbsp;perfect the sale, assignment,
transfer, conveyance, and granting of the Purchased Assets to Purchaser pursuant to this Agreement, and (ii)&nbsp;create, evidence and perfect Purchaser&#146;s <FONT STYLE="white-space:nowrap">back-up</FONT> security interest granted pursuant to
<U>Section</U><U></U><U>&nbsp;2.1(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <U>Royalty Reports</U>. Promptly (and in any event no later than five
(5)&nbsp;Business Days) following the receipt by Seller from UT under the License Agreement of a Royalty Report, Seller shall issue an invoice to UT in respect of such Royalty Report pursuant to Section&nbsp;7.1 of the License Agreement, and furnish
a copy of such Royalty Report to Purchaser, together with a copy of Seller&#146;s invoice issued to UT in respect of such Royalty Report. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4 <U>Misdirected Payments</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding the terms of the Instruction Letter and the Escrow Agreement, commencing on the Closing Date and at all times thereafter,
if any portion of the Purchased Assets is paid to Seller or any <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party, then (i)&nbsp;Seller shall, or shall use commercially reasonable efforts to cause such
<FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party, as applicable, to hold such amount in trust for the benefit of Purchaser in a segregated account, (ii)&nbsp;neither Seller nor such <FONT STYLE="white-space:nowrap">Non-Seller</FONT>
Royalty Party shall have any right, title, or interest whatsoever in such amount and shall not create or suffer to exist any Lien thereon, and (iii)&nbsp;Seller shall, or shall use commercially reasonable efforts to cause such <FONT
STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party, as applicable, to promptly (and in any event no later than five (5)&nbsp;Business Days) following the receipt by Seller or such <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty
Party, as applicable, of such amount, remit such amount to the Purchaser Account. Seller shall, or shall use commercially reasonable effects to cause such <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party to, notify Purchaser of such
wire transfer and provide reasonable details regarding the Purchased Assets payment so received by Seller or such <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the terms of the Instruction Letter and the Escrow Agreement, commencing on the Closing Date and at all times thereafter,
if any amount due under the License Agreement that does not constitute the Purchased Assets is paid to Purchaser, then (i)&nbsp;Purchaser shall hold such amount in trust for the benefit of Seller or any applicable
<FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party in a segregated account, (ii)&nbsp;Purchaser shall have no right, title, or interest whatsoever in such amount and shall not create or suffer to exist any Lien thereon, and
(iii)&nbsp;Purchaser shall promptly remit such amount to the Seller Account or account of such <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party pursuant to wire instructions provided to Purchaser by such <FONT
STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party, as applicable. Purchaser shall notify Seller or any applicable <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party, as applicable, of such wire transfer and provide reasonable
details regarding the erroneous payment so received by Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If UT exercises any <FONT STYLE="white-space:nowrap">Non-Permitted</FONT> <FONT
STYLE="white-space:nowrap">Set-Off</FONT> against any payment of the Purchased Assets, then Seller shall promptly (and in any event no later than thirty (30)&nbsp;calendar days following the payment of the Purchased Assets affected by such <FONT
STYLE="white-space:nowrap">Non-Permitted</FONT> <FONT STYLE="white-space:nowrap">Set-Off),</FONT> make a <FONT STYLE="white-space:nowrap">true-up</FONT> payment to Purchaser such that Purchaser receives the full amount of such Purchased Assets
payment that would have been paid to Purchaser had such <FONT STYLE="white-space:nowrap">Non-Permitted</FONT> <FONT STYLE="white-space:nowrap">Set-Off</FONT> not occurred. Notwithstanding anything to the contrary herein, to the extent Seller shall
have made a <FONT STYLE="white-space:nowrap">true-up</FONT> payment to Purchaser pursuant to this <U>Section</U><U></U><U>&nbsp;5.4(c</U>) in respect of any <FONT STYLE="white-space:nowrap">Non-Permitted</FONT>
<FONT STYLE="white-space:nowrap">Set-Off,</FONT> any subsequent payment received from UT in respect, and to the extent, of such <FONT STYLE="white-space:nowrap">Non-Permitted</FONT> <FONT STYLE="white-space:nowrap">Set-Off</FONT> shall not be
included in the Purchased Assets, such that the subsequent payment is included in the Excluded Assets. For all purposes hereunder, any <FONT STYLE="white-space:nowrap">true-up</FONT> payment made pursuant to this
<U>Section</U><U></U><U>&nbsp;5.4(c)</U> will be treated as paid with respect to the Purchased Assets for U.S. federal income tax purposes to the fullest extent permitted by applicable Law. For the avoidance of doubt, withholding taxes (including
any withholding taxes deducted by UT from payments under Section&nbsp;6.3 of the License Agreement pursuant to Section&nbsp;7.4(b) of the License Agreement) shall not be treated as a <FONT STYLE="white-space:nowrap">Non-Permitted</FONT> <FONT
STYLE="white-space:nowrap">Set-Off</FONT> and shall be governed by the provisions of <U>Section</U><U></U><U>&nbsp;5.11</U> of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) All remittances pursuant to this <U>Section</U><U></U><U>&nbsp;5.4</U> shall be made (i)&nbsp;without
<FONT STYLE="white-space:nowrap">set-off</FONT> or deduction of any kind (except as required by applicable Law) and (ii)&nbsp;by wire transfer of immediately available funds to such account as the relevant payee has designated under this Agreement
or, for <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties other than Purchaser, as they may otherwise designate in writing (such designation to be made at least three (3)&nbsp;Business Days prior to any such payment). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) A late fee at a rate per annum equal to the U.S. Prime Rate (as set forth in the Wall Street Journal, Eastern Edition, or similar
reputable data source) as of the Payment Date (as defined below), shall accrue daily, calculated on the basis of a <FONT STYLE="white-space:nowrap">365-day</FONT> year, on all unpaid amounts with respect to (i)&nbsp;any sum payable under
<U>Section</U><U></U><U>&nbsp;5.4(a)</U>, <U>Section</U><U></U><U>&nbsp;5.4(b)</U>, beginning ten (10)&nbsp;Business Days after a Party has actual knowledge of its receipt of such payment in error, or (ii)&nbsp;any sum payable to Seller under
<U>Section</U><U></U><U>&nbsp;2.1(b)</U>, <U>Section</U><U></U><U>&nbsp;5.6(b)</U>, <U>Section</U><U></U><U>&nbsp;5.6(c)</U>, <U>Section</U><U></U><U>&nbsp;5.6(d)</U>, <U>Section</U><U></U><U>&nbsp;5.8(b)</U> or
<U>Section</U><U></U><U>&nbsp;5.8(c)</U>, beginning two (2)&nbsp;Business Days following the date such payment was due hereunder (each date in clause (i)&nbsp;and (ii), a &#147;<U>Payment Date</U>&#148;). Notwithstanding the foregoing, Seller shall
not be responsible for any late fee under this <U>Section</U><U></U><U>&nbsp;5.4(e)</U> arising from the failure of a <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party to timely pay any sum payable under
<U>Section</U><U></U><U>&nbsp;5.4(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5 <U>Maintenance of Material Agreements</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Seller shall not (i)&nbsp;forgive, release, or compromise any portion of the Purchased Assets or (ii)&nbsp;amend, modify, supplement,
restate, waive, cancel, or terminate (or consent to any cancellation or termination of), in whole or in part, any provision of or right under any Material Agreement that would reasonably be expected to have an adverse effect on (A)&nbsp;the timing,
amount or duration of the Purchased Assets or (B)&nbsp;the Specified Rights or that would otherwise reasonably be expected to result in a Material Adverse Effect without, in the cases of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
clauses (i)&nbsp;and (ii), the prior written consent of Purchaser. Seller shall perform and comply with all of its obligations under each Material Agreement, and shall not take any action or
forego any action under either Material Agreement, in each case that would reasonably be expected to (x)&nbsp;constitute a breach or default by Seller under any provision of such Material Agreement and (y)&nbsp;have an adverse effect on (Y)&nbsp;the
timing, amount or duration of the Purchased Assets or (Z)&nbsp;the Specified Rights or that would otherwise reasonably be expected to result in a Material Adverse Effect. Promptly (but in any event within five (5)&nbsp;Business Days) after Seller
obtains Article V Knowledge of an action or a failure to act of Seller or UT that would reasonably be expected to constitute a breach or default by Seller or UT under any provision of a Material Agreement and that would reasonably be expected to
have an adverse effect on the timing, amount or duration of the Purchased Assets or the Specified Rights or that would otherwise reasonably be expected to result in a Material Adverse Effect, Seller shall give written notice thereof to Purchaser.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Within five (5)&nbsp;Business Days after Seller receives written notice of UT&#146;s intent to terminate either Material Agreement
(in whole or in part) or any allegation by UT of a breach or default by Seller under such Material Agreement, Seller shall, subject to <U>Section</U><U></U><U>&nbsp;8.6</U>, give written notice thereof to Purchaser. Such notice shall, subject to
<U>Section</U><U></U><U>&nbsp;8.6</U>, (x) describe in reasonable detail such intent to terminate such Material Agreement, breach or default, (y)&nbsp;subject to <U>Section</U><U></U><U>&nbsp;8.6</U>, include a copy of any written notice received
from UT with respect thereto, and (z)&nbsp;describe in reasonable detail the corrective action or actions that Seller proposes to take with respect to UT&#146;s intent to terminate such Material Agreement in circumstances where Seller&#146;s breach
or default has contributed to such intention to terminate or otherwise with respect to the applicable breach or default. Seller shall use commercially reasonable efforts to promptly cure any such breach or default by Seller, and shall give written
notice to Purchaser upon curing such breach or default. In connection with any dispute regarding an alleged breach by Seller that would reasonably be expected to have an adverse effect on the timing, amount or duration of the Purchased Assets or the
Specified Rights or that would otherwise reasonably be expected to have a Material Adverse Effect, Seller shall select and employ counsel reasonably acceptable to Purchaser (and, if applicable, any other
<FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties), or, following and during the continuance of a Royalty Control Shift, reasonably acceptable to the Majority Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Without limiting the provisions of <U>Section</U><U></U><U>&nbsp;5.5(b)</U>, if during the Royalty Interests Term UT terminates the
License Agreement in its entirety or with respect to the Royalty Product pursuant to Section&nbsp;12.3(a) of the License Agreement, then following the License Agreement Termination Date Seller shall, subject to the terms and conditions of the
License Agreement (including Section&nbsp;13.2 of the License Agreement), use commercially reasonable efforts to either (as Seller may elect in its sole discretion) commercialize the Royalty Product in the Territory or negotiate a replacement
license agreement for the License Agreement with respect to the Royalty Product providing for the grant of an exclusive license under the MannKind Technology to make and have made, use, sell, offer for sale, have sold and import the Royalty Product
in the Territory on the most favorable economic terms (to the licensor) reasonably practicable in light of then-prevailing market conditions (any such license, a &#147;<U>New Arrangement</U>&#148;), subject to its agreement to pay to Purchaser the
Seller Commercialization Royalty (with payments being payable to the Escrow Account or any New Arrangement Escrow Account (as defined below), as applicable, no less frequently than provided for under Section&nbsp;6.3 and Section&nbsp;6.4(a) of the
License Agreement). All payments and other consideration thereunder (to the extent that such payments or other consideration would have constituted Royalty Interests) shall be made by the other party to such New Arrangement directly to the Escrow
Account or another escrow account established in connection with the New Arrangement and having terms and conditions mutually satisfactory to Purchaser and Seller (a &#147;<U>New Arrangement Escrow Account</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6 <U>Enforcement of Material Agreements</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Promptly after Seller obtains Article V Knowledge of any breach of or default under a Material Agreement by UT that would reasonably be
expected to have an adverse effect on the timing, amount or duration of the Purchased Assets or the Specified Rights or that would otherwise reasonably be expected to result in a Material Adverse Effect, Seller shall promptly (but in any event
within five (5)&nbsp;Business Days after Seller obtains such Article V Knowledge), subject to <U>Section</U><U></U><U>&nbsp;8.6</U>, give written notice to Purchaser (i)&nbsp;stating that the relevant breach or default has occurred and
(ii)&nbsp;describing in reasonable detail the relevant breach or default. In addition, Seller shall, subject to <U>Section</U><U></U><U>&nbsp;8.6</U>, provide to Purchaser a copy of any written notice of breach of such Material Agreement delivered
by Seller to UT as soon as practicable and in any event within five (5)&nbsp;Business Days following such delivery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to
<U>Section</U><U></U><U>&nbsp;5.5(a)</U>, at any time when no Royalty Control Shift has occurred and is continuing, in the case of any breach or default by UT referred to in <U>Section</U><U></U><U>&nbsp;5.6(a)</U>, Seller shall consult with
Purchaser regarding the timing, manner and conduct of any enforcement of UT&#146;s obligations under the Material Agreement, and shall use commercially reasonable efforts to enforce Seller&#146;s rights and remedies (whether under the Material
Agreement or by operation of Law) and UT&#146;s obligations under the Material Agreement and shall keep Purchaser reasonably updated as to any material developments relating to such breach or default. Following and during the continuance of a
Royalty Control Shift, in the case of any breach or default by UT referred to in <U>Section</U><U></U><U>&nbsp;5.6(a</U><U>)</U>, Seller shall, at the Majority Holders&#146; reasonable direction, (A)&nbsp;use commercially reasonable efforts to
promptly and fully enforce Seller&#146;s rights and remedies (whether under the Material Agreement or by operation of Law) and UT&#146;s obligations under the Material Agreement, including, if reasonably requested by the Majority Holders,
instituting formal legal proceedings against UT, (B)&nbsp;employ counsel, selected by Seller and reasonably acceptable to the Majority Holders, and (C)&nbsp;keep the Majority Holders reasonably updated as to any material developments relating to
such breach or default. The <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties shall reimburse Seller for a portion of the documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs
and expenses (including the fees and expenses of Seller&#146;s counsel) incurred by Seller in an amount equal to their respective Applicable Percentages, as such costs and expenses are incurred (and in any event within ten (10)&nbsp;Business Days
following receipt of Seller&#146;s written demand for payment), in connection with any actions taken or the exercise of rights or remedies by Seller at the direction of the Majority Holders pursuant to this <U>Section</U><U></U><U>&nbsp;5.6(b)</U>.
In the event that Purchaser fails to reimburse Seller for its Applicable Percentage of such costs and expenses within the time specified in the preceding sentence, Seller shall be entitled to recoup an amount equal to the amount not paid, together
with any late fee in respect thereof in accordance with <U>Section</U><U></U><U>&nbsp;5.4(e)</U>, from the Purchased Assets by giving one or more Recoupment Instructions to the Escrow Agent to deduct from amounts deposited into the Escrow Account
that would otherwise be distributable to Purchaser in respect of the Purchased Assets an amount equal to the sum of such unpaid amount and any late fee in respect thereof calculated in accordance with <U>Section</U><U></U><U>&nbsp;5.4(e)</U> and to
cause the Escrow Agent to distribute such amount to Seller. Purchaser shall not object to a Recoupment Instruction given by Seller to the Escrow Agent pursuant to this <U>Section</U><U></U><U>&nbsp;5.6(b)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Subject to <U>Section</U><U></U><U>&nbsp;5.5(a)</U>, at any time when no Royalty Control
Shift has occurred and is continuing, to the extent Seller has the right to join or assume the defense or pursue an enforcement action pursuant to Section&nbsp;9.3(b), Section&nbsp;9.4 or Section&nbsp;9.6 of the License Agreement, Seller shall use
commercially reasonable efforts to defend and enforce any of the MannKind Patents or, if applicable, Joint Patents, to the extent the failure to so defend or enforce would reasonably be expected to have a Material Adverse Effect. Following and
during the continuance of a Royalty Control Shift, if Seller has the right to join or assume the defense or pursue an enforcement action pursuant to Section&nbsp;9.3(b), Section&nbsp;9.4 or Section&nbsp;9.6 of the License Agreement and the failure
to exercise such right would reasonably be expected to have a Material Adverse Effect, then Seller shall, at the Majority Holders&#146; reasonable direction use commercially reasonable efforts to join or assume the defense or pursue an enforcement
action under Section&nbsp;9.3(b), Section&nbsp;9.4 or Section&nbsp;9.6 of the License Agreement, as applicable, provided that nothing herein shall require Seller to take any action or omit to take any action in violation of the License Agreement.
The <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties shall reimburse Seller for a portion of the documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including
the fees and expenses of Seller&#146;s counsel) incurred by Seller in an amount equal to their respective Applicable Percentages, as such costs and expenses are incurred (and in any event within ten (10)&nbsp;Business Days following receipt of
Seller&#146;s written request for payment), in connection with any actions taken or the exercise of rights or remedies by Seller at the direction of the Majority Holders pursuant to this <U>Section</U><U></U><U>&nbsp;5.6(c)</U>. In the event that
Purchaser fails to reimburse Seller for its Applicable Percentage of such costs and expenses within the time specified in the preceding sentence, Seller shall be entitled to recoup an amount equal to the amount not paid, together with any late fee
in respect thereof in accordance with <U>Section</U><U></U><U>&nbsp;5.4(e)</U>, from the Purchased Assets by giving one or more Recoupment Instructions to the Escrow Agent to deduct from amounts deposited into the Escrow Account that would otherwise
be distributable to Purchaser in respect of the Purchased Assets an amount equal to the sum of such unpaid amount and any late fee in respect thereof calculated in accordance with <U>Section</U><U></U><U>&nbsp;5.4(e)</U> and to cause the Escrow
Agent to distribute such amount to Seller. Purchaser shall not object to a Recoupment Instruction given by Seller to the Escrow Agent pursuant to this <U>Section</U><U></U><U>&nbsp;5.6(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Seller shall (i)&nbsp;take any and all actions, and prepare, execute, deliver and file any and all agreements, documents and instruments,
that Seller deems to be reasonably necessary to diligently prosecute and maintain any MannKind Patents or Joint Patents for which it controls prosecution and maintenance in accordance with Section&nbsp;9.2(a) and 9.2(c) of the License Agreement,
including payment of maintenance fees or annuities, in each case where the failure to so prosecute and maintain would reasonably be expected to have a Material Adverse Effect and (ii)&nbsp;not disclaim or abandon, or not fail to take any action
necessary to prevent the disclaimer or abandonment of, any MannKind Patents or Joint Patents for which it controls prosecution and maintenance in accordance with Section&nbsp;9.2(a) and 9.2(c) of the License Agreement, except in each case as would
not reasonably be expected to have a Material Adverse Effect. Following and during the continuance of a Royalty Control Shift, if Seller is not going to take any of the actions described in clause (i)&nbsp;of the immediately preceding sentence
because its failure to do so would not reasonably be expected to have a Material Adverse Effect, or is going to disclaim or abandon, or fail to take action necessary to prevent the disclaimer or abandonment
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of, any MannKind Patents because doing so would not reasonably be expected to have a Material Adverse Effect as set forth in clause (ii)&nbsp;of the immediately preceding sentence, Seller shall
provide written notice thereof to the Royalty Control Shift Representative (the &#147;<U>Seller 5.6(d) </U><U>Notice</U>&#148;), and, thereafter, if elected in writing to do so by the Majority Holders by written notice delivered to Seller within ten
(10)&nbsp;Business Days of the Royalty Control Shift Representative receiving the Seller 5.6(d) Notice, Seller shall take reasonable direction from the Majority Holders as to the matters covered by the Seller 5.6(d) Notice, provided that nothing
herein shall require Seller to take any action in violation of the License Agreement. The <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties shall reimburse Seller for a portion of the documented <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including the fees and expenses of Seller&#146;s counsel) incurred by Seller in an amount equal to their respective Applicable Percentages, as such costs and expenses are
incurred (and in any event within ten (10)&nbsp;Business Days following receipt of Seller&#146;s written demand for payment), in connection with any actions taken by Seller at the direction of the Majority Holders pursuant to this
<U>Section</U><U></U><U>&nbsp;5.6(d)</U>. In the event that Purchaser fails to reimburse Seller for its Applicable Percentage of such costs and expenses within the time specified in the preceding sentence, Seller shall be entitled to recoup an
amount equal to the amount not paid, together with any late fee in respect thereof in accordance with <U>Section</U><U></U><U>&nbsp;5.4(e)</U>, from the Purchased Assets by giving one or more Recoupment Instructions to the Escrow Agent to deduct
from amounts deposited into the Escrow Account that would otherwise be distributable to Purchaser in respect of the Purchased Assets an amount equal to the sum of such unpaid amount and any late fee in respect thereof calculated in accordance with
<U>Section</U><U></U><U>&nbsp;5.4(e)</U> and to cause the Escrow Agent to distribute such amount to Seller. Purchaser shall not object to a Recoupment Instruction given by Seller to the Escrow Agent pursuant to this
<U>Section</U><U></U><U>&nbsp;5.6(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Parties acknowledge and agree that, as required by Section&nbsp;9.3(b) of the License
Agreement, all proceeds received as a result of actions or proceedings undertaken pursuant to Section&nbsp;9.3(b) of the License Agreement shall be allocated between Seller and UT in accordance with Section&nbsp;9.3(b)(iv) of the License Agreement
(for clarity, any such proceeds are not allocated directly to any <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties and would only be included in the Purchased Assets to the extent such proceeds become an element of the definition
of &#147;Royalty Interests&#148;). All proceeds received by Seller resulting from any enforcement activities other than those resulting from actions or proceedings undertaken pursuant to Section&nbsp;9.3(b) of the License Agreement (which are
addressed in the immediately preceding sentence) and undertaken pursuant to <U>Section</U><U></U><U>&nbsp;5.6(b)</U> or <U>Section</U><U></U><U>&nbsp;5.6(c)</U> (regardless of whether such enforcement is initiated by Seller as a result of a written
request from the Majority Holders following and during the continuance of a Royalty Control Shift or initiated by Seller in the absence of any such request), after deduction (and reimbursement to Seller and
<FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties) of all costs and expenses (including attorneys&#146; fees and expenses) incurred by Seller and <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties, as applicable, in
connection with such enforcement activities, shall be allocated to Seller and the <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties in an amount equal to the Applicable Percentage of Seller and each such <FONT
STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party during the time period of the breach that led to such enforcement (in the case of allocations in respect of enforcement activities pursuant to <U>Section</U><U></U><U>&nbsp;5.6(b)</U>) or at
the time of the initiation of the defense or enforcement activity undertaken pursuant to <U>Section</U><U></U><U>&nbsp;5.6(c)</U>, which amount shall be promptly (and in any event no later than five (5)&nbsp;Business Days) paid to Seller and the <FONT
STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7 <U>No Liens</U>. Seller shall not grant, incur or suffer to exist any Lien
on the Purchased Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8 <U>Audits</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Consultation</U>. Following the Closing Date, Seller and Purchaser shall consult with each other regarding the timing, manner and
conduct of any inspection or audit of UT&#146;s books and records pursuant to Section&nbsp;7.6 of the License Agreement. So long as no Royalty Control Shift has occurred and is continuing, the timing, manner and conduct of any such inspection or
audit shall be determined by Seller in its sole discretion; provided, however, that if Seller elects not to request any inspection or audit and no Royalty Control Shift has occurred and is continuing, Purchaser (and, if applicable, any other <FONT
STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties, in the declining order of their Applicable Percentages), shall, subject to the provisions of Section&nbsp;7.6 of the License Agreement, have the right to request Seller to seek such
inspection or audit (the &#147;<U>Requested Audit</U>&#148;). Following and during the continuation of a Royalty Control Shift, Seller shall not request an inspection or audit of UT&#146;s records and books of account without the prior written
direction or consent of the Majority Holders; provided, however that if the Majority Holders elect not to request or consent to any inspection or audit pursuant to <U>Section</U><U></U><U>&nbsp;5.8(c)(ii)</U>, the
<FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties, in the declining order of their Applicable Percentages, shall, subject to the provisions of Section&nbsp;7.6 of the License Agreement, have the right to request Seller to seek a
Requested Audit. Purchaser or the <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party who requested the Requested Audit in accordance with this <U>Section</U><U></U><U>&nbsp;5.8(a)</U> shall be referred to the
&#147;<U>Requester</U>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Requested Audits under License Agreement</U>. Upon the Requester&#146;s request of the Requested
Audit, Seller shall, to the extent permitted by Section&nbsp;7.6 of the License Agreement, provide written notice to UT to cause an inspection or audit to determine the correctness of any Royalty Interests payments made under the License Agreement.
All of the expenses of the Requested Audit that would otherwise have been borne by Seller pursuant to the License Agreement, including such fees and expenses of any independent certified public accounting firm engaged by the Requester in connection
with such an inspection or audit shall be borne by the Requester; provided that, in the event that the Requested Audit reveals an underpayment during the applicable time period of more than five percent (5%) of the amount due, then such costs and
expenses shall be borne by UT in accordance with Section&nbsp;7.6 of the License Agreement. Subject to <U>Section</U><U></U><U>&nbsp;8.6</U>, Seller will promptly furnish to the <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties a
true, correct, and complete copy of any inspection or audit report prepared in connection with the Requested Audit. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
If, following the completion of the Requested Audit, UT is required to pay for underpayment of the Royalty Interests, such payment shall be first used to reimburse the Requester for all of the expenses of the Requested Audit, and the remainder shall
be distributed as the Royalty Interests to Seller and all <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If, following the completion of the Requested Audit, Seller is required to reimburse UT for overpayment of the Royalty
Interests, then the <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties shall promptly upon request (and in any event within ten (10)&nbsp;Business Days following such request) reimburse Seller, or, at Seller&#146;s request, UT on
behalf of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Seller, for the portion of such overpaid amount that was actually paid to the <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties, and shall promptly (and in any event within two
(2)&nbsp;Business Days) after making such payment provide documentation to Seller evidencing that such payment was made. In the event that Purchaser fails to reimburse Seller, or at Seller&#146;s request, UT on behalf of Seller, for the portion of
such overpaid amount that was actually paid to Purchaser within the time specified in the preceding sentence, Seller shall be entitled to recoup an amount equal to the amount not paid, together with any late fee in respect thereof in accordance with
<U>Section</U><U></U><U>&nbsp;5.4(e)</U>, from the Purchased Assets by giving one or more Recoupment Instructions to the Escrow Agent to deduct from amounts deposited into the Escrow Account that would otherwise be distributable to Purchaser in
respect of the Purchased Assets an amount equal to the sum of such unpaid amount and any late fee in respect thereof calculated in accordance with <U>Section</U><U></U><U>&nbsp;5.4(e)</U> and to cause the Escrow Agent to distribute such amount to
Seller. Purchaser shall not object to a Recoupment Instruction given by Seller to the Escrow Agent pursuant to this <U>Section</U><U></U><U>&nbsp;5.8(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Seller-Directed and Majority Holder-Directed/Consented Audits under License Agreement.</U> In the event that, (i)&nbsp;following
consultation with Purchaser in accordance with <U>Section</U><U></U><U>&nbsp;5.8(a)</U>, Seller, not at the request of a Requester, elects to seek an inspection or audit to the extent permitted by Section&nbsp;7.6 of the License Agreement, or
(ii)&nbsp;following and during the continuance of a Royalty Control Shift, Seller receives a direction or consent in writing from the Majority Holders directing Seller or consenting to a request from Seller to conduct an inspection or audit, Seller
shall, to the extent permitted by Section&nbsp;7.6 of the License Agreement, provide written notice to UT to cause an inspection or audit to determine the correctness of any Royalty Interests payments made under the License Agreement. All of the
expenses of any inspection or audit, whether initiated by Seller or requested or consented to by the Majority Holders, that would otherwise have been borne by Seller pursuant to the License Agreement, including such fees and expenses of any
independent certified public accounting firm engaged by Seller (and, if following and during the continuance of a Royalty Control Shift, reasonably acceptable to the Majority Holders) in connection with such an inspection or audit shall be borne by
the <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties in an amount equal to the Applicable Percentage of each such <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party, with Seller bearing the remainder, if any; provided
that, in the event that any such inspection or audit reveals an underpayment during the applicable time period of more than five percent (5%) of the amount due, then such costs and expenses shall be borne by UT in accordance with Section&nbsp;7.6 of
the License Agreement. Subject to <U>Section</U><U></U><U>&nbsp;8.6</U>, Seller will promptly furnish to the <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties a true, correct, and complete copy of any inspection or audit report
prepared in connection with such an inspection or audit. If, following the completion of such inspection or audit, Seller is required to reimburse UT for overpayment of the Royalty Interests, then the
<FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties shall promptly upon request (and in any event within ten (10)&nbsp;Business Days following such request) reimburse Seller, or, at Seller&#146;s request, UT on behalf of Seller, for
the portion of such overpaid amount that was actually paid to the <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties, and shall promptly (and in any event within two (2)&nbsp;Business Days) after making such payment provide
documentation to Seller evidencing that such payment was made. In the event that Purchaser fails to reimburse Seller, or at Seller&#146;s request, UT on behalf of Seller, for such overpaid amount within the time specified in the preceding sentence,
Seller shall be entitled to recoup an amount equal to the amount not paid, together with any late fee in respect thereof in accordance with <U>Section</U><U></U><U>&nbsp;5.4(e)</U>, from the Purchased Assets by giving one or more Recoupment
Instructions to the Escrow Agent to deduct from amounts deposited into the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Escrow Account that would otherwise be distributable to Purchaser in respect of the Purchased Assets an amount equal to the sum of such unpaid amount and any late fee in respect thereof
calculated in accordance with <U>Section</U><U></U><U>&nbsp;5.4(e)</U> and to cause the Escrow Agent to distribute such amount to Seller. Purchaser shall not object to a Recoupment Instruction given by Seller to the Escrow Agent pursuant to this
<U>Section</U><U></U><U>&nbsp;5.8(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Audits of Seller</U><U>&#146;</U><U>s Books and Records</U>. Seller shall keep and
maintain, or cause to be kept and maintained, for a period of at least three (3)&nbsp;Calendar Years following the Calendar Year to which they pertain, full and accurate books and records adequate to reflect all amounts paid or payable in respect of
any Seller Commercialization Royalty and all financial information received by Seller from any Persons with respect to such amounts. For the term of this Agreement and for a period of six (6)&nbsp;months thereafter, upon prior written notice to
Seller, Purchaser shall have the right to inspect, at Purchaser&#146;s expense, those accounts and records of Seller necessary to verify the accuracy of payments made under or on account of any Seller Commercialization Royalty to Purchaser hereunder
or other report or information provided by Seller to Purchaser pursuant to <U>Article V</U> in respect of any Seller Commercialization Royalty. Any such inspection shall occur upon not less than ten (10)&nbsp;Business Days&#146; notice to Seller,
during Seller&#146;s normal business hours and on Seller&#146;s premises. Purchaser shall not be entitled to make any copies of Seller&#146;s records and shall, and shall cause any of its Representatives to, keep confidential all information
obtained during such inspection. If such inspection results in a determination that any payment, or portion thereof, with respect to any Seller Commercialization Royalty that is payable by Seller to Purchaser was not paid to the Escrow Account or
New Arrangement Escrow Account, as applicable, when due, then an amount equal to the underpayment shall be promptly paid by Seller to the Escrow Account or any New Arrangement Escrow Account, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9 <U>SEC Filings</U>. Prior to the submission by Seller or, if applicable, Purchaser, to the SEC of any SEC Documents that
contain any Confidential Information of the other Party, or that contain information related to the existence or subject matter of this Agreement or the identity of the other Party, the Party making such filing shall provide drafts of relevant
portions of such SEC Documents to the other Party within a reasonable period of time, but in any event no less than two (2)&nbsp;Business Days prior to the planned date of such submission. The Party making such filing shall cooperate in good faith
with the other Party to obtain confidential treatment with respect to the portions of this Agreement that the other Party reasonably requests to be kept confidential and to redact any Confidential Information of the other Party therein as requested
by the other Party, unless reasonably advised by counsel that such Confidential Information is required to be included by Law. Notwithstanding the foregoing, a Party making such a filing shall have no obligation to provide a draft of a proposed
filing of an SEC Document or otherwise comply with this <U>Section</U><U></U><U>&nbsp;5.9</U> with respect to a proposed filing of an SEC Document if the description of or reference to this Agreement or to the subject Confidential Information of the
other Party or the identity of the other Party contained in, or attached as an exhibit to, the proposed SEC Document, has been included in any previous SEC Document filed by either Party in accordance with this <U>Section</U><U></U><U>&nbsp;5.9</U>
or otherwise approved by the other Party in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <U>Instruction Letter and UT Consent</U>. Prior to the termination
of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.1</U>, Seller shall not, without Purchaser&#146;s prior written consent, deliver any further directions to UT regarding the payment of the Purchased Assets or agree to any amendment,
modification or termination of the UT Consent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Purchaser and Seller agree that as of Closing, neither the Upfront Payment nor the Milestone Payment is subject to deduction or
withholding provided that, on or prior to the Closing Date, Seller delivers to Purchaser a duly completed and valid Internal Revenue Service (&#147;<U>IRS</U>&#148;) Form <FONT STYLE="white-space:nowrap">W-9.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If any applicable Law requires the deduction or withholding of any tax by the Purchaser from the Purchase Price, the Purchaser shall be
entitled to make such deduction or withholding and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable Law. Except as provided in <U>Section</U><U></U><U>&nbsp;5.11(g)</U>, any
such withheld or deducted amounts shall be treated for all purposes of the Transaction Documents as having been paid to the Seller. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
Notwithstanding the accounting treatment therefor and unless otherwise required by applicable Law, for all U.S. federal and applicable state and local tax purposes, Seller and Purchaser shall treat (i)&nbsp;the transactions contemplated by the
Transaction Documents as a sale of the Purchased Assets and Purchaser&#146;s payment of the Purchase Price (pursuant to <U>Section</U><U></U><U>&nbsp;2.1(a)</U> of this Agreement) as received by Seller for the Purchased Assets in a taxable
transaction and (ii)&nbsp;Purchaser as the direct recipient of the payments made with respect to the Purchased Assets. If there is an inquiry by any Governmental Authority of Seller or Purchaser related to this <U>Section</U><U></U><U>&nbsp;5.11</U>
or <U>Section</U><U></U><U>&nbsp;10.4</U>, the Parties shall cooperate with each other in responding to such inquiry in a commercially reasonable manner consistent with this <U>Section</U><U></U><U>&nbsp;5.11</U> and
<U>Section</U><U></U><U>&nbsp;10.4</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Seller and Purchaser agree that for United States federal income tax purposes, (i)&nbsp;any
and all amounts in respect of the Purchased Assets remitted by Seller to Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;5.4(a)</U> or otherwise under this Agreement shall be treated as received by Seller as agent for Purchaser, and
(ii)&nbsp;any and all amounts remitted by Purchaser to Seller pursuant to <U>Section</U><U></U><U>&nbsp;5.4(b)</U> of this Agreement shall be treated as remittances of amounts collected by Purchaser on behalf of Seller. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) On or prior to the Closing Date, and throughout the term of this Agreement whenever required by Law or requested by the Seller in order
for the Seller to have on file an accurate and valid IRS Withholding Form, the Purchaser shall deliver to the Seller a duly completed and valid (i)&nbsp;IRS Form <FONT STYLE="white-space:nowrap">W-9,</FONT> (ii) IRS Form <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> claiming treaty benefits under a double taxation treaty in a manner qualifying for a zero percent (0%) withholding rate with respect to the payments made to the
Purchaser under the Transaction Documents, (iii)&nbsp;IRS Form <FONT STYLE="white-space:nowrap">W-8IMY</FONT> to which a form set forth in the preceding (i)&nbsp;or (ii) is attached, or (iv)&nbsp;other applicable IRS Form <FONT
STYLE="white-space:nowrap">W-8</FONT> that indicates no withholding is required with respect to the payments made to the Purchaser under the Transaction Documents (or, in each case, any successor or other applicable form prescribed by the U.S.
Internal Revenue Service) (in each case ((i) through (iv)), the &#147;<U>IRS Withholding Form</U>&#148;). On or prior to the Closing Date, and prior to payment of the Milestone Payment if required by Law or requested by the Purchaser in order for
the Purchaser </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to have on file an accurate and valid IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> prior to the payment of the Milestone Payment, the Seller shall deliver to the Purchaser a duly
completed and valid IRS Form <FONT STYLE="white-space:nowrap">W-9.</FONT> Purchaser agrees to notify Seller promptly in writing if (i)&nbsp;an IRS Withholding Form or other tax document previously delivered pursuant to this Agreement becomes
obsolete or ceases to be true and correct, or if Purchaser is no longer legally permitted to furnish such IRS Withholding Form or other tax document, or (ii)&nbsp;payments in respect of the Purchased Assets hereunder cease, or are expected to cease,
to be exempt from United States federal withholding tax because of any change of Law or any act or omission planned, suffered or performed by Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) If any applicable Law (as reasonably determined by Seller) requires the deduction or withholding of any tax on payments to Purchaser by
Seller, then Seller shall be entitled to make such deduction or withholding and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable Law. Any such withheld or deducted amounts
shall be treated for all purposes of the Transaction Documents as having been paid to Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding the foregoing, if
deduction or withholding of any tax is required from any payment by Purchaser to Seller under this Agreement as a result of an action by Purchaser (including, but not limited to an assignment by Purchaser pursuant to
<U>Section</U><U></U><U>&nbsp;10.3(c)</U> or a redomiciliation of Purchaser, or any failure on the part of Purchaser to comply with applicable tax laws or filing or record retention requirements), then Purchaser shall pay such additional amounts to
Seller as necessary so that the net amount received by Seller, after all required deductions and withholdings (including with respect to such additional amounts), is an amount equal to the amount that it would have received had no such deductions or
withholdings been made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Notwithstanding the foregoing, if deduction or withholding of any tax is required from any payment by Seller
to Purchaser under this Agreement as a result of an action by Seller (including, but not limited to an assignment by Seller pursuant to <U>Section</U><U></U><U>&nbsp;10.3(b)</U> or a redomiciliation of Seller, or any failure on the part of Seller to
comply with applicable tax laws or filing or record retention requirements), then Seller shall pay such additional amounts to Purchaser as necessary so that the net amount received by Purchaser, after all required deductions and withholdings
(including with respect to such additional amounts), is an amount equal to the amount that it would have received had no such deductions or withholdings been made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Notwithstanding anything to the contrary in this Agreement, the party making payment (the &#147;<U>Payor</U>&#148;) shall use commercially
reasonable efforts to give the other party notice and the opportunity, in good faith, to contest and prevent such withholding and deduction contemplated by <U>Section</U><U></U><U>&nbsp;5.11(b)</U> or <U>Section</U><U></U><U>&nbsp;5.11(f)</U>. The
Payor shall use commercially reasonable efforts to give or cause to be given to the payee such assistance and such information concerning the reasons for withholding or deduction (including, in reasonable detail, the method of calculation for the
deduction or withholding thereof) as may be reasonably requested by the payee and at the payee&#146;s expense to enable the payee to claim exemption therefrom, or credit therefor, or relief (whether at source or by reclaim) therefrom, and, in each
case, shall furnish the payee, with proper evidence of the taxes withheld and deducted and remitted to the relevant Governmental Authority. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Parties agree not to take any position that is inconsistent with the provisions of
this <U>Section</U><U></U><U>&nbsp;5.11</U> and <U>Section</U><U></U><U>&nbsp;10.4</U> on any tax return or in any audit or other judicial or administrative proceeding unless (i)&nbsp;the other party hereto has consented to the taking of such
position (such consent not to be unreasonably withheld, conditioned or delayed), (ii) the party hereto that contemplates taking such an inconsistent position has been advised by a nationally recognized tax counsel in writing that it is unable to
conclude that the position specified in this <U>Section</U><U></U><U>&nbsp;5.11</U> or <U>Section</U><U></U><U>&nbsp;10.4</U> is more likely than not to prevail if challenged by the tax authority having jurisdiction of the relevant tax, or
(iii)&nbsp;required by a tax authority in connection with the resolution of an audit or examination diligently contested. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <U>Seller</U><U>&#146;</U><U>s Commercially Reasonable Efforts and Judgment</U>. It is understood and agreed that, in
determining whether Seller&#146;s efforts or judgments are &#147;commercially<U> </U>reasonable&#148; with respect to any covenant that specifically references such term in this <U>Article V</U>, Seller shall be deemed to be acting or making a
judgment in a commercially reasonable manner only if Seller would reasonably expect its efforts or judgment not to result in a Material Adverse Effect. For the avoidance of doubt, any act or failure to act by Seller that would not be commercially
reasonable in regard to Seller&#146;s interests or position as of immediately prior to the Closing, but is commercially reasonable when accounting for the effects of the Transaction Documents on Seller&#146;s interests or position, shall be deemed
not to be commercially reasonable for purposes of this <U>Article V</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <U>Change in Name or Organization</U>. Seller
shall provide Purchaser with written notice within thirty (30)&nbsp;days following any change in, or amendment or alteration of, Seller&#146;s (a)&nbsp;legal name, (b)&nbsp;form or type of organization, or (c)&nbsp;jurisdiction of organization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <U>Royalty Control Shift Representative</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Purchaser agrees that promptly and in any event within ten (10)&nbsp;Business Days following the occurrence of a Royalty Control Shift,
Purchaser and the other <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties shall designate and appoint, to serve as the exclusive agent, proxy and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> (&#147;<U>Royalty Control Shift Representative</U>&#148;) for and on behalf of Purchaser and each other
<FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party for the following purposes following and during the continuance of a Royalty Control Shift (including the full power and authority on behalf of Purchaser and each other <FONT
STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) to give and receive notices, requests, instructions,
consents, waivers, directions, information and communications to Seller on behalf of the Majority Holders under this Agreement, including pursuant to <U>Sections 5.3</U>, <U>5.5(a)</U>, <U>5.5(b)</U>, <U>5.6(b)</U>, <U>5.6(c)</U>, <U>5.6(d)</U>,
<U>5.8(a)</U> and <U>5.8(c)</U>; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) to take all actions necessary or appropriate in the judgment of the Royalty
Control Shift Representative (including the execution of any agreement or document) for the accomplishment of the foregoing <U>Section</U><U></U><U>&nbsp;5.14(a)(i)</U>, in each case without having to seek or obtain the consent of Purchaser or any
other <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party under any circumstance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All decisions and actions (including the execution of any agreement or document) by the
Royalty Control Shift Representative on behalf of the Majority Holders (to the extent authorized by this Agreement) shall be binding upon the Purchaser and the other <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties, and neither
Purchaser nor any other <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party shall have the right to object, dissent, protest or otherwise contest the same. Seller shall be entitled to rely on any action taken by the Royalty Control
Shift Representative, on behalf of the Majority Holders, pursuant to this <U>Section</U><U></U><U>&nbsp;5.14</U>, and to act <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> the Royalty Control Shift
Representative with respect to the matters contemplated by this <U>Section</U><U></U><U>&nbsp;5.14</U>, and each such action shall be binding on Purchaser and the other <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties as fully as
if Purchaser and the other <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties had taken such action itself and Seller shall have no obligation to act directly with Purchaser and the other
<FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties with respect to such actions or liability for failing to do so. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
Notwithstanding <U>Section</U><U></U><U>&nbsp;5.14(a)</U>, the Royalty Control Shift Representative shall be entitled to seek further authorization from the Majority Holders prior to acting on their behalf. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Any notice or communication given or received by, and any decision, action, failure to act (including within a designated period of time),
agreement, consent, direction, request, or instruction of, the Royalty Control Shift Representative, and any action taken by Seller <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> the Royalty Control
Shift Representative, that is within the scope of the Royalty Control Shift Representative&#146;s authority under <U>Section</U><U></U><U>&nbsp;5.14(a)</U> shall constitute a notice or communication to or by, or a decision, action, failure to act
(including within a designated period of time), agreement, consent, direction, request, or instruction of, or action taken with respect to, the Majority Holders and shall be final, binding and conclusive upon Purchaser and all other <FONT
STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties; and each Party to this Agreement shall be entitled to rely upon any such notice, communication, decision, action, failure to act (including within a designated period of time), agreement,
consent, settlement, resolution or instruction, or action taken with respect to the Royalty Control Shift Representative, as being a notice or communication to or by, or a decision, action, failure to act (including within a designated period of
time), agreement, consent, settlement, resolution or instruction of, or action taken with respect to, the Majority Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Purchaser
agrees that it shall provide Seller with written notice of the Royalty Control Shift Representative&#146;s appointment (including any replacement or successor, as applicable) pursuant to this <U>Section</U><U></U><U>&nbsp;5.14</U> promptly and in
any event within two (2)&nbsp;Business Days following such appointment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <U>Other Matters</U>. Seller shall not enter
into any agreement with any <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Party that (i)&nbsp;violates any of Purchaser&#146;s rights under this Agreement, including Purchaser&#146;s right to receive the Purchased Assets, its right to
receive copies of Royalty Reports pursuant to <U>Section</U><U></U><U>&nbsp;5.3</U> and its rights under <U>Section</U><U></U><U>&nbsp;5.8</U> or (ii)&nbsp;would reasonably be expected to have an adverse effect on (a)&nbsp;the timing, amount or
duration of the Purchased Assets or (b)&nbsp;the Specified Rights or that would otherwise reasonably be expected to result in a Material Adverse Effect, in each case without the prior written consent of Purchaser.&nbsp;Following and during the
continuance of a Royalty Control Shift, Seller shall not take any action or fail to take any action at the direction of the Majority Holders or Royalty Control Shift Representative that would </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reasonably be expected to have an adverse effect on (a)&nbsp;the timing, amount or duration of the Purchased Assets or (b)&nbsp;the Specified Rights or that would otherwise reasonably be expected
to result in a Material Adverse Effect, in each case without a Unanimous Holder Consent.&nbsp;Purchaser agrees that following and during the continuance of a Royalty Control Shift, Purchaser shall not, individually or by directing the Royalty
Control Shift Representative, direct Seller to take or not take any action that would reasonably be expected to have an adverse effect on (a)&nbsp;the timing, amount or duration of the Purchased Assets or (b)&nbsp;the Specified Rights or that would
otherwise reasonably be expected to result in a Material Adverse Effect. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VI </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>THE CLOSING</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Closing</U>. The closing of the transactions contemplated hereby (the &#147;<U>Closing</U>&#148;) shall take place
remotely by the electronic exchange of documents and signatures (or their electronic counterparts) on the date hereof (the &#147;<U>Closing Date</U>&#148;), simultaneously with the execution of this Agreement, or at such other time or place or in
such other manner as the Parties may mutually agree upon in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <U>Payment of Upfront Payment</U>. At the Closing,
Purchaser shall deliver to Seller the amount equal to the Upfront Payment <I>minus</I> the Fee Reimbursement, by wire transfer of immediately available funds to the Seller Account, without any deduction for withholding or other taxes and without any
other set off or deduction of any kind. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3 <U>Closing Deliverables</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At the Closing, each of Seller and Purchaser shall deliver or cause to be delivered to the other party hereto a duly executed counterpart
to the Escrow Agreement and shall receive a duly executed counterpart to the Escrow Agreement from the Escrow Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At the Closing,
each of Seller and Purchaser shall deliver to the other party hereto a duly executed counterpart to the Bill of Sale, evidencing the sale and assignment to Purchaser of the Purchased Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) At the Closing, Seller shall deliver to Purchaser a certificate of an executive officer of Seller, dated as of the Closing, certifying as
to the (i)&nbsp;attached copies of the organizational documents of Seller and resolutions of the governing body of Seller authorizing and approving the execution, delivery and performance by Seller of the Transaction Documents and the transactions
contemplated thereby and (ii)&nbsp;the incumbency of the officer or officers of Seller who have executed and delivered the Transaction Documents, including therein a signature specimen of each such officer or officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) At the Closing, Purchaser shall deliver to Seller a certificate of an executive officer or other authorized signatory of Purchaser, dated
as of the Closing, certifying as to the incumbency of the officer or officers of Purchaser who have executed and delivered the Transaction Documents, including therein a signature specimen of each such officer or officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) At or prior to the Closing, Seller shall deliver to Purchaser a duly completed and executed IRS Form
<FONT STYLE="white-space:nowrap">W-9</FONT> pursuant to <U>Section</U><U></U><U>&nbsp;5.11(e)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) At or prior to the Closing, Purchaser shall deliver to Seller a duly completed and
executed IRS Withholding Form pursuant to <U>Section</U><U></U><U>&nbsp;5.11(e)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Promptly following the Closing (and in any event
on the same day thereof), Seller shall deliver to UT a duly executed copy of the Instruction Letter. Within three (3)&nbsp;Business Days thereafter, Seller shall deliver to Purchaser evidence reasonably satisfactory to Purchaser confirming, with
respect to the Instruction Letter, the delivery to UT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VII </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>INDEMNIFICATION</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1 <U>Indemnification by Seller</U>. Seller agrees to indemnify and hold harmless Purchaser, its Affiliates and its and their
respective Representatives (each, a &#147;<U>Purchaser Indemnified Party</U>&#148;) from and against, and will pay to each Purchaser Indemnified Party the amount of, any and all Losses awarded against or incurred or suffered by such Purchaser
Indemnified Party, whether or not involving a Third Party Claim, arising out of or resulting from (a)&nbsp;any breach of any representation or warranty made by Seller in any of the Transaction Documents or certificates delivered by Seller to
Purchaser in writing pursuant to this Agreement, (b)&nbsp;any breach of or default under any covenant or agreement of Seller in any of the Transaction Documents, (c)&nbsp;any Recipient Confidentiality Breach by any Person who receives Confidential
Information from or on behalf of Seller under <U>Article VIII</U>, and (d)&nbsp;any Excluded Liabilities and Obligations; <I>provided</I>, <I>however</I>, that the foregoing shall exclude any Losses of any Purchaser Indemnified Party to the extent
resulting from (i)&nbsp;the bad faith, gross negligence or willful misconduct of such Purchaser Indemnified Party, (ii)&nbsp;the failure of any Person other than Seller to perform any of its obligations under any of the Transaction Documents, or
(iii)&nbsp;acts or omissions of Seller taken (or omitted to be taken) pursuant to any written direction to Seller from any Purchaser Indemnified Party or the Royalty Control Shift Representative. Any amounts determined to be due to any Purchaser
Indemnified Party hereunder in accordance with and subject to the terms, conditions and procedures of this <U>Article VII</U> shall (if not otherwise paid) be payable by Seller to such Purchaser Indemnified Party within ten (10)&nbsp;Business Days
following written demand delivered to Seller by such Purchaser Indemnified Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2 <U>Indemnification by Purchaser</U>.
Purchaser agrees to indemnify and hold each of Seller and its Affiliates and any or all of their respective Representatives (each, a &#147;<U>Seller Indemnified Party</U>&#148;) harmless from and against, and will pay to each Seller Indemnified
Party the amount of, any and all Losses awarded against or incurred or suffered by such Seller Indemnified Party, whether or not involving a Third Party Claim, arising out of or resulting from (a)&nbsp;any breach of any representation or warranty
made by Purchaser in any of the Transaction Documents, (b)&nbsp;any breach of or default under any covenant or agreement of Purchaser in any Transaction Document to which Purchaser is party, and (c)&nbsp;any Recipient Confidentiality Breach by any
Person who receives Confidential Information from or on behalf of Purchaser under <U>Article VIII</U>; <I>provided</I>, <I>however</I>, that the foregoing shall exclude any Losses of any Seller Indemnified Party to the extent resulting from
(i)&nbsp;the bad faith, gross negligence or willful misconduct of such Seller Indemnified Party, (ii)&nbsp;the failure of Seller to perform any of its obligations under any of the Transaction Documents, or (iii)&nbsp;acts or omissions of Purchaser
taken (or omitted to be taken) pursuant to any written direction to Purchaser or the Royalty Control Shift Representative from any Seller Indemnified Party. Any amounts determined to be due to any Seller Indemnified Party hereunder in accordance
with and subject to the terms, conditions and procedures of this <U>Article VII</U> shall (if not otherwise paid) be payable by Purchaser to such Seller Indemnified Party within ten (10)&nbsp;Business Days following written demand delivered to
Seller by such Seller Indemnified Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3 <U>Procedures for Third Party Claims</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If any claim or demand made by any Person other than Purchaser or Seller against a Purchaser Indemnified Party or a Seller Indemnified
Party, as applicable (a &#147;<U>Third Party Claim</U>&#148;) shall be brought or alleged against an indemnified party in respect of which indemnity is to be sought against an indemnifying party pursuant to <U>Section</U><U></U><U>&nbsp;7.1</U> or
<U>Section</U><U></U><U>&nbsp;7.2</U>, the indemnified party shall, promptly after receipt of notice of the commencement of such Third Party Claim, notify the indemnifying party in writing of the commencement thereof, enclosing a copy of all papers
served, if any; provided, that the failure to so notify such indemnifying party will not relieve the indemnifying party from any liability that it may have to any indemnified party under <U>Section</U><U></U><U>&nbsp;7.1</U> or
<U>Section</U><U></U><U>&nbsp;7.2</U> unless, and only to the extent that, the indemnifying party is actually materially prejudiced by such failure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that any Third Party Claim is brought against an indemnified party and it notifies the indemnifying party of the commencement
thereof in accordance with this <U>Section</U><U></U><U>&nbsp;7.3</U>, the indemnifying party will be entitled, at the indemnifying party&#146;s sole cost and expense, to participate therein and, to the extent that it may wish, to assume the defense
thereof, with counsel reasonably satisfactory to such indemnified party, and, after notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the indemnifying party will not be liable to such
indemnified party under this <U>Article VII</U> for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of investigation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In any such Third Party Claim, an indemnified party shall have the right to retain its own counsel, but the reasonable fees and expenses
of such counsel shall be at the sole cost and expense of such indemnified party unless (a)&nbsp;the indemnifying party and the indemnified party shall have mutually agreed to the retention of such counsel, (b)&nbsp;the indemnifying party has assumed
the defense of such proceeding and has failed within a reasonable time to retain counsel reasonably satisfactory to such indemnified party, or (c)&nbsp;the named parties to any such Third Party Claim (including any impleaded parties) include both
the indemnifying party and the indemnified party and representation of both parties by the same counsel would be inappropriate due to actual or potential conflicts of interests between them based on the advice of counsel to the indemnified party.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The indemnifying party shall not be liable for any settlement of any Third Party Claim effected without its written consent, but, if
settled with such consent or if there is a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party from and against any Loss indemnifiable pursuant to <U>Section</U><U></U><U>&nbsp;7.1</U> or
<U>Section</U><U></U><U>&nbsp;7.2</U> by reason of such settlement or judgment. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement, compromise or discharge of any pending or threatened
Third Party Claim in respect of which any indemnified party is or could have been a party and indemnity could be sought hereunder by such indemnified party, unless such settlement, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compromise or discharge, as the case may be, (i)&nbsp;includes an unconditional written release of such indemnified party and its Affiliates, in form and substance reasonably satisfactory to the
indemnified party, from all liability on claims that are the subject matter of such claim or proceeding, (ii)&nbsp;does not include any statement as to an admission of fault, culpability or failure to act or violation of Law or rights of any Person
by or on behalf of any indemnified party or its Affiliates, (iii)&nbsp;does not impose any continuing material obligation or restrictions on any indemnified party, and (iv)&nbsp;does not involve any injunctive relief binding on the indemnified party
or its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4 <U>Other Claims</U>. A claim by an indemnified party under this <U>Article VII</U> for any matter not
involving a Third Party Claim and in respect of which such indemnified party would be entitled to indemnification hereunder may be made by delivering, in good faith, a written notice of claim to the indemnifying party (a &#147;<U>Claim
Notice</U>&#148;), which notice shall contain (a)&nbsp;a description and the amount of any Losses incurred or suffered or an estimate of Losses reasonably expected to be incurred or suffered by the indemnified party if known or reasonably capable of
estimation, and the method of computation of such Losses (the &#147;<U>Claim Amount</U>&#148;), (b) a statement that the indemnified party is entitled to indemnification under this <U>Article VII</U> for such Losses and a reasonable explanation of
the basis therefor, and (c)&nbsp;a demand for payment in the amount of such Losses or an estimate of such Losses if known; provided, that the failure to so notify such indemnifying party will not relieve the indemnifying party from any liability
that it may have to any indemnified party under <U>Section</U><U></U><U>&nbsp;7.1</U> or <U>Section</U><U></U><U>&nbsp;7.2</U> unless, and only to the extent that, the indemnifying party is actually materially prejudiced by such failure. Within
twenty (20)&nbsp;Business Days after delivery of a Claim Notice, the indemnifying party shall deliver to the indemnified party a written response in which the indemnifying party shall either (i)&nbsp;agree that the indemnified party is entitled to
receive the Claim Amount (in which case such response shall be accompanied by a payment to the indemnified party of the Claim Amount by the indemnifying party by wire transfer of immediately available funds), (ii) agree that the indemnified party is
entitled to receive part, but not all, of the Claim Amount (the amount so agreed in (i)&nbsp;or (ii), the &#147;<U>Agreed Amount</U>&#148;) (in which case such response shall be accompanied by a payment to the indemnified party of the Agreed Amount
by the indemnifying party by wire transfer of immediately available funds) or (iii)&nbsp;contest that the indemnified party is entitled to receive any of the Claim Amount. If any such dispute described in clause (iii)&nbsp;of the preceding sentences
is not resolved within twenty (20)&nbsp;Business Days following the delivery by the indemnifying party of such response, the indemnifying party and the indemnified party shall each have the right to submit such dispute to a court of competent
jurisdiction in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;10.8</U>. If the indemnifying party does not notify the indemnified party within twenty (20)&nbsp;Business Days following its receipt of a Claim Notice that the
indemnifying party disputes its liability to the indemnified party with respect to the Claim Amount in whole or in part, such claim specified by the indemnified party in such Claim Notice shall be conclusively deemed a liability of the indemnifying
party under <U>Section</U><U></U><U>&nbsp;7.1</U> or <U>Section</U><U></U><U>&nbsp;7.2</U>, as applicable, with respect to the undisputed portion of the Claim Amount and the indemnifying party shall pay the amount of such liability to the
indemnified party on demand or, in the case of any Claim Notice in which the amount of the claim (or any portion thereof) is estimated, on such later date when the amount of such claim (or such portion thereof) becomes finally determined. For all
purposes of this <U>Section</U><U></U><U>&nbsp;7.4</U>, Seller shall be entitled to deliver Claim Notices to Purchaser on behalf of Seller Indemnified Parties, and Purchaser shall be entitled to deliver Claim Notices to Seller on behalf of the
Purchaser Indemnified Parties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.5 <U>Time Limitations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Seller shall have liability under <U>Section</U><U></U><U>&nbsp;7.1</U> with respect to any breach of any representation or warranty made
by Seller in <U>Article</U><U> III</U> of this Agreement only if, on or prior to the date that is twelve (12)&nbsp;months after the Closing Date, Purchaser notifies Seller of a claim in respect of such breach, specifying the factual basis of such
claim in reasonable detail ((i) other than the Tier 2 Fundamental Representations, as to which a claim may be made at any time until the date that is five (5)&nbsp;years following the Closing Date, and (ii)&nbsp;other than the Tier 1 Fundamental
Representations or any breach of a representation or warranty resulting from fraud or willful misconduct on the part of Seller, as to which a claim may be made at any time until the date that is seven (7)&nbsp;years following the Closing Date). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Purchaser shall have liability under <U>Section</U><U></U><U>&nbsp;7.2</U> with respect to any breach of any representation or warranty
made by Purchaser in <U>Article</U><U> IV</U> of this Agreement only if, on or prior to the date that is twelve (12)&nbsp;months after the Closing Date, Seller notifies Purchaser of a claim in respect of such breach, specifying the factual basis of
such claim in reasonable detail (other than Purchaser&#146;s representations and warranties in <U>Section</U><U></U><U>&nbsp;4.1</U>, <U>Section</U><U></U><U>&nbsp;4.2</U>, <U>Section</U><U></U><U>&nbsp;4.3</U>, and <U>Section</U><U></U><U>&nbsp;4.4
</U>or any breach of a representation or warranty resulting from fraud or willful misconduct on the part of Purchaser, as to which a claim may be made at any time until the date that is seven (7)&nbsp;years following the Closing Date). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the extent not performed, and except as otherwise set forth in this Agreement, the covenants contained in this Agreement shall survive
the Closing until the date that is the later of (i)&nbsp;three (3) months after the termination of this Agreement or (ii)&nbsp;the applicable statute of limitations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding the foregoing, any claim for breach of a representation or warranty in respect of which indemnification may be sought
under this Agreement shall survive the time at which it would otherwise terminate pursuant to this <U>Section 7.5</U> until final resolution of such claim in accordance with <U>Article VII</U> and <U>Section 10.8</U>, if applicable, and the full
satisfaction of all liabilities and obligations hereunder related to such claim, if written notice of such claim has been given to the Party against whom such indemnification may be sought prior to the end of the applicable survival period described
in this <U>Section 7.5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.6 <U>Limitations on Liability</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) No Party shall be liable for any consequential (including lost profits), punitive, special, indirect, or incidental damages under this
<U>Article VII</U> (and no claim for indemnification hereunder shall be asserted) as a result of any breach or violation of any representation, warranty, covenant or agreement of such party (including under this <U>Article VII</U>) in or pursuant to
this Agreement, except in respect of a claim for fraud, willful misconduct or breaches of <U>Article VIII</U> or to the extent a court of competent jurisdiction awards such damages to a third party in connection with a Third Party Claim.
Notwithstanding the foregoing, Purchaser shall be entitled to make indemnification claims, in accordance with the procedures set forth in this <U>Article VII</U>, for Losses that include any portion of the Purchased Assets that Purchaser was
entitled to receive but did not receive timely or at all due to any indemnifiable events under this Agreement, and such portion of the Purchased Assets shall not be deemed consequential (including lost profits), punitive, special, indirect or
incidental damages for any purpose of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Other than in respect of claims for Excluded Liabilities and Obligations, fraud, willful
misconduct and breaches of <U>Article VIII</U>, in no event shall Seller&#146;s aggregate liability for Losses under <U>Section</U><U></U><U>&nbsp;7.1</U> or Purchaser&#146;s aggregate liability for Losses under <U>Section</U><U></U><U>&nbsp;7.2</U>
exceed (i)&nbsp;the Purchase Price less amounts in respect of the Purchased Assets actually received by Purchaser and (ii)&nbsp;Seller shall not have any liability for Losses under <U>Section</U><U></U><U>&nbsp;7.1</U> and Purchaser shall not have
any liability for Losses under <U>Section</U><U></U><U>&nbsp;7.2</U>, unless and until the aggregate amount of all Losses incurred by the indemnified party equals or exceeds One Million Dollars ($1,000,000), in which event the indemnifying party
shall be liable for all Losses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.7 <U>Exclusive Remedy</U>. Except in the case of (i)&nbsp;fraud or willful misconduct,
(ii)&nbsp;Seller&#146;s rights to payments or recoupment of payments under any of <U>Section</U><U></U><U>&nbsp;2.1(b)</U>, <U>Section</U><U></U><U>&nbsp;5.6(b)</U>, <U>Section</U><U></U><U>&nbsp;5.6(c)</U>, <U>Section</U><U></U><U>&nbsp;5.6(d)</U>,
<U>Section</U><U></U><U>&nbsp;5.8(b)</U> or <U>Section</U><U></U><U>&nbsp;5.8(c)</U> and (iii)<U>&nbsp;Section</U><U></U><U>&nbsp;10.1</U> (including, for the avoidance of doubt, for purposes of <U>Article VIII</U>), the indemnification afforded by
this <U>Article VII</U> shall be the sole and exclusive remedy for any and all Losses awarded against or incurred or suffered by a Party in connection with the transactions contemplated by the Transaction Documents, including with respect to any
breach of any representation or warranty made by a Party in any of the Transaction Documents or any certificate delivered by a Party to the other Party in writing pursuant to this Agreement or any breach of or default under any covenant or agreement
by a Party pursuant to any Transaction Document. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VIII </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>CONFIDENTIALITY </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1 <U>Confidentiality</U>. Except as provided in this <U>Article VIII</U> or otherwise agreed in writing by the Parties, the
Parties agree that, during and after the term of this Agreement (for clarity, including following termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.1</U>) each party (the &#147;<U>Receiving Party</U>&#148;) (i) shall keep
confidential, and shall not publish or otherwise disclose to any Person any Confidential Information (as defined below) and (ii)&nbsp;shall not use for any purpose other than as provided in this Agreement (which permitted purpose includes the
exercise of any rights or the performance of any obligations hereunder), the terms of this Agreement and the other Transaction Documents or any information (whether written or oral, or in electronic or other form and, for purposes of clarity,
including the UT Confidential Information) furnished (including prior to the Closing Date) to it by or on behalf of the other party (the &#147;<U>Disclosing Party</U>&#148;) pursuant to the Confidentiality Agreement (as defined below) or the
Transaction Documents (such information, &#147;<U>Confidential Information</U>&#148; of the Disclosing Party, provided that the terms of the Transaction Documents shall be Confidential Information of both Parties and UT Confidential Information, as
between Purchaser and Seller, shall at all times be Confidential Information of Seller), except for that portion of such information that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) was already in the Receiving Party&#146;s possession on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis prior to its
disclosure to it by the Disclosing Party, as evidenced by written records (provided, if such information was disclosed to the Receiving Party on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis by a party that is not the Disclosing
Party, such party had the right to disclose such information to the Receiving Party without any legal, contractual or fiduciary obligation to, any person with respect to such information); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) is or becomes generally available to the public other than as a result of an act or
omission by the Receiving Party or its Affiliates or their respective Representatives in breach of this Agreement; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) was
independently developed by the Receiving Party, as evidenced by written records of the Receiving Party, without use of or reference to the Confidential Information or in violation of the terms of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Party hereby acknowledges that the United States federal and state securities laws prohibit any Person that has material, <FONT
STYLE="white-space:nowrap">non-public</FONT> information about a company from purchasing or selling securities of such a company or from communicating such information to any other Person under circumstances in which it is reasonably foreseeable
that such Person is likely to purchase or sell such securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Receiving Party agrees that it shall be and remain responsible
hereunder for any failure by any Person who receives Confidential Information from or on behalf of the Receiving Party pursuant to this <U>Article VIII</U> (including the Receiving Party&#146;s Representatives, Affiliates, Affiliates&#146;
Representatives, and other permitted recipients pursuant to <U>Section</U><U></U><U>&nbsp;8.4</U>) to treat such Confidential Information as required under this <U>Article VIII</U> (any such failure, a &#147;<U>Recipient Confidentiality
Breach</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2 <U>Disclosures to Certain Affiliates</U>. Notwithstanding anything to the contrary provided elsewhere
herein, no Affiliate of Purchaser or their Representatives shall have any obligations with respect to Confidential Information provided to Purchaser pursuant to this Agreement to the extent that such Confidential Information is not actually made
available to such Affiliate or their Representatives. For the avoidance of doubt, Confidential Information provided to Purchaser pursuant to this Agreement may be disclosed by Purchaser to Purchaser&#146;s Affiliates and their Representatives only
as permitted pursuant to <U>Section</U><U></U><U>&nbsp;8.4(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.3 <U>Termination of Confidentiality Agreement</U>.
Effective upon the date hereof, the letter agreement, dated as of October&nbsp;9, 2023, as amended October&nbsp;18, 2023 (the &#147;<U>Confidentiality Agreement</U>&#148;), between Seller and Purchaser shall terminate and be of no further force or
effect, and shall be superseded by the provisions of this <U>Article VIII</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.4 <U>Permitted Disclosure</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Without limiting <U>Section</U><U></U><U>&nbsp;5.1</U> and except as provided in <U>Section</U><U></U><U>&nbsp;5.9</U>, in the event that
a Receiving Party or its Affiliates or any of its or its Affiliates&#146; Representatives are requested by a Governmental Authority or required by applicable Law, regulation or legal process (including the regulations of a stock exchange or
Governmental Authority or the order or ruling of a court, administrative agency or other government or regulatory body of competent jurisdiction) to disclose any Confidential Information, the Receiving Party shall promptly, to the extent permitted
by Law, notify the Disclosing Party in writing of such request or requirement so that the Disclosing Party may seek (at the Disclosing Party&#146;s sole expense) an appropriate protective order or other appropriate remedy (and if the Disclosing
Party seeks such an order or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other remedy, the Receiving Party will provide such cooperation, at the Disclosing Party&#146;s sole expense, as the Disclosing Party shall reasonably request). If no such protective order or
other remedy is obtained and the Receiving Party or its Affiliates or its or its Affiliates&#146; Representatives, are, in the view of their respective counsel (which may include their respective internal counsel), legally required to disclose
Confidential Information, the Receiving Party or its Affiliates or its or its Affiliates&#146; Representatives, as the case may be, shall only disclose that portion of the Confidential Information that their respective counsel advises that Receiving
Party or its Affiliates or its or its Affiliates&#146; Representatives, as the case may be, are required to disclose and will exercise commercially reasonable efforts, at the Disclosing Party&#146;s sole expense, to obtain reliable assurance that
confidential treatment will be accorded to that portion of the Confidential Information that is being disclosed. In any event, the Receiving Party will not oppose action by the Disclosing Party to obtain an appropriate protective order or other
reliable assurance that confidential treatment will be accorded the Confidential Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the other provisions of
this <U>Article VIII</U>, either Party may disclose Confidential Information (other than disclosure by Purchaser of any UT Confidential Information, which is addressed solely in <U>Section</U><U></U><U>&nbsp;8.4(c)</U> and as to which this
<U>Section</U><U></U><U>&nbsp;8.4(b)</U> is not applicable) with the prior written consent of the Disclosing Party or to the extent such disclosure is reasonably necessary in the following situations: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) prosecuting or defending litigation, including enforcing rights or remedies hereunder or responding to a subpoena in a
third party litigation; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) for regulatory, tax or customs purposes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) for audit purposes, provided that each recipient of Confidential Information must be bound by contractual or professional
obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> no less rigorous than those in this <U>Article VIII</U> prior to any such disclosure; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) disclosure to (A)&nbsp;its Affiliates on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">need-to-know</FONT></FONT> basis in order for such Party to exercise its rights or fulfill its obligations under this Agreement and (B)&nbsp;its Representatives, provided that in the
case of each of clause (A)&nbsp;and clause (B), each recipient of Confidential Information must be bound by contractual or professional obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> no less rigorous than those in
this <U>Article VIII</U> prior to any such disclosure; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) as set forth in <U>Section</U><U></U><U>&nbsp;5.1</U> and
<U>Section</U><U></U><U>&nbsp;5.9</U> (which terms shall control in the event of any conflict with this <U>Section</U><U></U><U>&nbsp;8.4(b)</U>); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) disclosure to its actual or potential investors and <FONT STYLE="white-space:nowrap">co-investors,</FONT> actual or
potential lenders and <FONT STYLE="white-space:nowrap">co-lenders,</FONT> and other sources of funding, including debt financing, or potential partners, collaborators or acquirers, and their respective accountants, financial advisors and other
professional representatives, provided, that such disclosure shall be made only to the extent customarily required to consummate, report, monitor or exercise rights or take remedial action in connection with such investment, financing transaction,
partnership or collaboration and that each recipient of Confidential Information must be bound by contractual or professional obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> no less rigorous than those in this
<U>Article VIII</U> prior to any such disclosure; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) in connection with a merger, acquisition or change of control
(including to fulfill due diligence inquiries related to a prospective merger, acquisition or change of control), provided that each recipient of Confidential Information must be bound by contractual or professional obligations of confidentiality
and <FONT STYLE="white-space:nowrap">non-use</FONT> no less rigorous than those in this <U>Article VIII</U> prior to any such disclosure; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) to a permitted assignee in connection with an assignment permitted pursuant to <U>Section</U><U></U><U>&nbsp;10.3</U>
provided that such permitted assignee is bound by contractual obligations of confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> no less rigorous than those in this <U>Article</U><U> VIII</U> prior to any such disclosure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, in the event the Receiving Party is required to make a disclosure of the Disclosing Party&#146;s Confidential
Information pursuant to <U>Section</U><U></U><U>&nbsp;8.4(b)(i)</U> (other than in connection with enforcing its rights or remedies hereunder directly against the other Party) or <U>Section</U><U></U><U>&nbsp;8.4(b)(ii)</U> it will comply with the
obligations of <U>Section</U><U></U><U>&nbsp;8.4(a)</U>, to the extent applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding the other provisions of this
<U>Article VIII</U>, Purchaser shall not disclose any UT Confidential Information to any Person without the prior written consent of Seller except that Purchaser may disclose UT Confidential Information: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) as and to the extent provided in <U>Section</U><U></U><U>&nbsp;8.4(a)</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) to its Representatives; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) to its actual or potential investors and <FONT STYLE="white-space:nowrap">co-investors,</FONT> actual or potential
lenders and <FONT STYLE="white-space:nowrap">co-lenders,</FONT> and other sources of funding, including debt financing, or actual or potential partners, collaborators or acquirers, and their respective accountants, financial advisors and other
professional representatives, provided that such disclosure shall be made only to the extent customarily required to consummate, report, monitor or exercise rights or take remedial action in connection with such investment, financing transaction,
partnership or collaboration; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) to a prospective acquiror in connection with a merger, acquisition or change of
control of Purchaser (including to fulfill due diligence inquiries related to a prospective merger, acquisition or change of control) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that, as a
condition to Purchaser disclosing UT Confidential Information to any recipient set forth in clauses (i)&nbsp;through (iv) above, such recipient shall enter into and comply with written confidentiality, <FONT STYLE="white-space:nowrap">non-use</FONT>
and <FONT STYLE="white-space:nowrap">non-disclosure</FONT> restrictions no less rigorous than those under this <U>Article VIII</U> with respect to such UT Confidential Information during the term of this Agreement and following the date of
termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.1</U> (and, for purposes of clarity, any failure of such recipient to comply with such restrictions shall be a Recipient Confidentiality Breach under this Agreement). Seller
and Purchaser acknowledge and agree that UT is an express third party beneficiary of Seller&#146;s rights and Purchaser&#146;s obligations under this <U>Article VIII</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.5 <U>Use of Name</U>. Except as required by Law and except to the extent
included in SEC Documents in accordance with <U>Section</U><U></U><U>&nbsp;5.9</U>, neither Party shall use the name, trademark, service mark, trade name, or symbol or any adaptation thereof of the other Party, or of any of its Representatives or
Affiliates for advertising, marketing, endorsement, promotional or sales literature, publicity, public announcement or disclosure in any document employed to obtain funds or financing without the specific prior written consent of an authorized
representative of the other Party or individual whose name is to be used as to each such use (which consent may be granted or withheld in such Party&#146;s sole discretion). Notwithstanding the foregoing, each Party may use the name, logos, and
other insignia of the other Party in any &#147;tombstone&#148; or other advertisements, in its publications, marketing, or promotional materials to existing and prospective investors and otherwise on the website or in other marketing materials of
such Party, as applicable, without the other Party&#146;s prior approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.6 <U>Seller Certificates</U>. If any notice,
document, correspondence or other information is specified to be provided to Purchaser pursuant to this Agreement and disclosure of the same to Purchaser would breach the confidentiality obligations owed by Seller to UT under the License Agreement,
as modified by the UT Consent (a &#147;<U>Confidentiality Restriction</U>&#148;), then in lieu of providing Purchaser a copy of such notice, document, correspondence or other information, Seller shall, to the extent permissible under the
Confidentiality Restriction, deliver to Purchaser a written summary, certified by the Chief Financial Officer of Seller or the Executive Vice President, General Counsel and Secretary of Seller, of all information contained in such communication that
Seller reasonably believes is material; <I>provided</I>, that, if Seller is advised in writing by its counsel that providing Purchaser such written summary would reasonably be expected to constitute a breach of the Confidentiality Restriction, then
Seller shall paraphrase or otherwise describe the substance for Purchaser of such notice, document, correspondence or other information to the maximum extent possible while complying with the Confidentiality Restriction. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE IX </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>TERMINATION
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1 <U>Termination of Agreement</U>. This Agreement shall continue in full force and effect until the date on which
Purchaser has received the last payment with respect to the Purchased Assets, at which time this Agreement shall automatically terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2 <U>Effect of Termination</U>. Upon the termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.1</U>, this
Agreement shall become void and of no further force and effect, except for any rights, obligations or claims of either Party that have accrued prior to termination; provided, however, that (a)&nbsp;the provisions of
<U>Section</U><U></U><U>&nbsp;5.1</U>, <U>Section</U><U></U><U>&nbsp;5.4(a)</U> (with respect to the portion of the Purchased Assets payable to Purchaser pursuant to clause (b)&nbsp;below), <U>Section</U><U></U><U>&nbsp;5.4(b)</U>,
<U>Section</U><U></U><U>&nbsp;5.8 </U>(only until the date that is six (6)&nbsp;months after the termination date), <U>Section</U><U></U><U>&nbsp;5.11</U>, <U>Article I</U>, <U>Article VII</U> (but only if a claim under <U>Article VII</U> is pending
on the termination date, in which case <U>Article VII</U> shall survive until the final resolution of such claim in accordance with <U>Article VII</U> and <U>Section</U><U></U><U>&nbsp;10.8</U>, if applicable, and the full satisfaction of all
liabilities and obligations </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hereunder related to such claim), <U>Article VIII</U>, this <U>Article IX</U> and <U>Article X</U> shall survive such termination and shall remain in full force and effect, (b)&nbsp;if, upon the
termination of this Agreement, any payments of the Purchased Assets are payable to Purchaser hereunder, this Agreement shall remain in full force and effect until any and all such payments have been made in full, and (except as provided in this
<U>Section</U><U></U><U>&nbsp;9.2</U>) solely for that purpose, and (c)&nbsp;termination shall not relieve either Party from liability for any breach of this Agreement that occurs prior to termination. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE X </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>MISCELLANEOUS
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.1 <U>Specific Performance</U>. The Parties acknowledge that the other Party will have no adequate remedy at law if it
fails to perform any of its obligations under any of the Transaction Documents and may be damaged irreparably in the event any of the provisions of this Agreement (including, for clarity, any of the provisions of <U>Article VIII</U>) are not
performed in accordance with its specific terms or otherwise are breached or violated (including, for clarity, any actual or threatened breach of <U>Article VIII</U> by Purchaser or Seller, any of their respective Affiliates or any of their or their
Affiliates&#146; respective Representatives). In such event, the Parties agree that the other Party shall have the right, without posting bond or other undertaking, to seek an injunction or injunctions to prevent breaches or violations of the
provisions of this Agreement (including, in the case of <U>Article VIII</U>, threatened breach) and to enforce specifically this Agreement and the terms and provisions hereof in any Action instituted in any court of the United States or any state
thereof having jurisdiction over the Parties and the matter in addition to any other remedy to which it may be entitled, at law or in equity. Each Party further agrees that, in the event of any action for specific performance in respect of such
breach or violation (including, in the case of <U>Article VIII</U>, threatened breach), it will not assert, and irrevocably waives the defense that a bond or other security will be required. For the avoidance of doubt, such remedy shall not be
deemed to be an exclusive remedy with respect to any of the breaches to which it relates but shall be in addition to all other rights and remedies available at law or equity to Seller or Purchaser (as applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.2 <U>Notices</U>. All notices, consents, waivers and other communications hereunder shall be in writing and shall be effective
(a)&nbsp;upon receipt when sent through the mails, registered or certified mail, return receipt requested, postage prepaid, with such receipt to be effective the date of delivery indicated on the return receipt, (b)&nbsp;upon receipt when sent by an
overnight courier, (c)&nbsp;on the date personally delivered to an authorized officer of the party to which sent or (d)&nbsp;on the date transmitted by electronic transmission with a confirmation of receipt, in all cases, with a copy emailed to the
recipient at the applicable address, addressed to the recipient as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">if to Seller, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">MannKind Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">1 Casper
Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Danbury, CT 06810 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Executive Vice President, General Counsel and Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Telephone: (818) <FONT
STYLE="white-space:nowrap">661-5000</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy, which shall not constitute notice, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Cooley LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">10265 Science
Center Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">San Diego, CA 92121-1117 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Matthew T. Browne </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: mbrowne@cooley.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Telephone: (858) <FONT STYLE="white-space:nowrap">550-6045</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">if to Purchaser, to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Sagard
Holdings Manager LP </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;Micha&euml;l Hassan </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&nbsp;Philippe Savard </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&nbsp;Karan Mathur </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&nbsp;Savneet Uppal </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">With a copy, which
shall not constitute notice, to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Sidley Austin LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">2850 Quarry Lake Drive, Suite 280 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Baltimore, Maryland 21209 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;Asher M. Rubin </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Adriana V. Tibbitts </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">410-559-2881</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: arubin@sidley.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&nbsp;atibbitts@sidley.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Parties may, by notice given in accordance herewith to the other Party, designate any further or different address to which subsequent notices, consents, waivers and other communications shall be sent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.3 <U>Successors and Assigns</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The provisions of this Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and
permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement, or any rights or obligations of Seller hereunder, may not be assigned or transferred by Seller
without the prior written consent of Purchaser; provided that Seller may assign this Agreement in its entirety (i)&nbsp;to an Affiliate or (ii)&nbsp;to any Person that acquires all or substantially all of Seller&#146;s business, whether by merger,
sale of assets, or otherwise, so long as (A)&nbsp;Seller promptly notifies Purchaser of such assignment, (B)&nbsp;such assignee expressly assumes all obligations of Seller under the Transaction Documents (and, if such assignee is an Affiliate and
the assignment is not in connection with a sale of all or substantially all of Seller&#146;s business, by merger, sale of assets or otherwise, Seller shall remain liable to Purchaser for its obligations to Purchaser hereunder (and Purchaser shall be
entitled to seek recovery for any breach or default of an obligation hereunder from Seller or from such Affiliate assignee)), and (C)&nbsp;if such assignee, transferee or acquiror is UT, then UT expressly agrees to continue performing its
obligations set forth in the License Agreement in respect of and relating to the Purchased Assets and any Royalty Interests held by the <FONT STYLE="white-space:nowrap">Non-Seller</FONT> Royalty Parties as if such assignment had not occurred.
Notwithstanding anything to the contrary herein, for the avoidance of doubt, without the prior written consent of Purchaser, Seller may grant a security interest in and collaterally assign its rights under this Agreement, including without
limitation, any rights to payment thereunder and proceeds therefrom, to one or more of Seller&#146;s lenders; provided, that no such assignment shall relieve Seller of any of its obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) This Agreement as a whole may not be assigned by Purchaser without the prior written consent of Seller; provided that Purchaser may assign
its rights and obligations under this Agreement in its entirety (i)&nbsp;to an Affiliate of Purchaser or (ii)&nbsp;to any Person (other than a competitor of Seller, as determined by the board of directors of Seller in good faith, provided that in no
event shall any financial investment firm, collective investment vehicle, lenders and other commercial sources of funding be deemed a competitor of Seller) that acquires all or substantially all of Purchaser&#146;s (or any of its Affiliates to which
Purchaser has assigned its rights and obligations under this Agreement in accordance with clause (i)) assets, whether by merger, sale of assets or otherwise, provided that (A)&nbsp;Purchaser promptly notifies Seller and UT in writing (in accordance
with Section&nbsp;15.8 of the License Agreement) of such assignment, including the identity of the assignee, (B)&nbsp;such assignee shall be subject, and agree in advance and in writing, to all of the same terms, conditions and limitations as apply
to Purchaser under this Agreement and the UT Consent, (C)&nbsp;such assignee expressly assumes all obligations of Purchaser under the Transaction Documents (and, if such assignee is an Affiliate and the assignment is not in connection with a sale of
all or substantially all of Purchaser&#146;s business, by merger, sale of assets or otherwise, Purchaser shall remain liable to Seller for its obligations to Seller hereunder (and Seller shall be entitled to seek recovery for any breach or default
of an obligation hereunder from Purchaser or from such Affiliate assignee)), and (D)&nbsp;such assignee complies with <U>Section</U><U></U><U>&nbsp;5.11(e)</U> (replacing &#147;<U>Purchaser</U>&#148; wherever it appears with such assignee and
replacing &#147;<U>Closing Date</U>&#148; with the date of such assignment in such <U>Section</U><U></U><U>&nbsp;5.11(e)</U>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Reserved</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Any permitted assignee of the rights of Purchaser to receive Confidential Information of Seller under this Agreement (and, if applicable,
its rights to receive UT Confidential Information) shall, as a condition to such assignment, agree in writing to be subject to confidentiality and <FONT STYLE="white-space:nowrap">non-use</FONT> obligations no less rigorous than those set forth in
<U>Section</U><U></U><U>&nbsp;5.1</U> and <U>Article VIII </U>with respect to such Confidential Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Any purported assignment
or transfer in violation of this <U>Section</U><U></U><U>&nbsp;10.3</U> shall be void ab initio and of no effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding
anything to the contrary herein, without the prior written consent of Seller, Purchaser may pledge its rights under this Agreement to a lender; provided no such pledge shall relieve Purchaser of any of its obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.4 <U>Independent Nature of Relationship</U>. The relationship between Seller and Purchaser is solely that of seller and
purchaser, and neither Seller nor Purchaser has any fiduciary or other special relationship with the other Party or any of its Affiliates. Nothing contained herein or in any other Transaction Document shall be deemed (including for tax purposes) to
constitute Seller and Purchaser as a partnership, an association, a joint venture or any other kind of entity or legal form. If there is an inquiry by any Governmental Authority of the Purchaser or the Seller related to the treatment described in
this <U>Section</U><U></U><U>&nbsp;10.4</U>, the Purchaser and the Seller shall cooperate with each other in responding to such inquiry in a reasonable manner which is consistent with this <U>Section</U><U></U><U>&nbsp;10.4</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.5 <U>No Personal Liability</U>. It is expressly understood and agreed by Seller and Purchaser that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) each of the representations, warranties, covenants and agreements in the Transaction Documents made on the part of Seller is made by Seller
and is not intended to be nor is a personal representation, warranty, covenant or agreement of any other Person, including those Persons named in the definition of &#147;<U>Knowledge of Seller</U>&#148; and any other Representative of Seller or
Seller&#146;s Affiliates (the &#147;<U><FONT STYLE="white-space:nowrap">Non-Warranting</FONT> Parties</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) other than Seller,
no Person, including the <FONT STYLE="white-space:nowrap">Non-Warranting</FONT> Parties, shall have any liability whatsoever for breach of any representation, warranty, covenant or agreement made in the Transaction Documents on the part of Seller or
in respect of any claim or matter arising out of, relating to or in connection with the Transaction Documents or the transactions contemplated thereby; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the provisions of this <U>Section</U><U></U><U>&nbsp;10.5</U> are intended to benefit each and every one of the <FONT
STYLE="white-space:nowrap">Non-Warranting</FONT> Parties and shall be enforceable by each and every one of them to the fullest extent permitted by Law; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) the provisions of clauses (a) &#150; (c) of this <U>Section</U><U></U><U>&nbsp;10.5</U> shall apply to Purchaser, <I>mutatis mutandis</I>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.6 <U>Entire Agreement</U>. This Agreement, together with the Exhibits and Schedules hereto and the other Transaction
Documents constitute a complete and exclusive statement of the terms of agreement between the Parties, and supersede all prior agreements, understandings and negotiations, both written and oral, between the Parties, with respect to the subject
matter of this Agreement, including the Confidentiality Agreement. No representation, inducement, promise, understanding, condition or warranty not set forth herein (or in the Exhibits or Schedules hereto or the other Transaction Documents) has been
made or relied upon by either Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.7 <U>No Third Party Beneficiaries</U>. This Agreement is for the sole
benefit of Seller and Purchaser and their successors and permitted assigns and nothing herein expressed or implied shall give or be construed to give to any Person, other than the Parties hereto and such successors and permitted assigns, any legal
or equitable rights hereunder; except that UT is an express third party beneficiary of Seller&#146;s rights and Purchaser&#146;s obligations under <U>Article VIII</U> as provided in <U>Section</U><U></U><U>&nbsp;8.4(c)</U>, UT is an express third
party beneficiary with respect to <U>Section</U><U></U><U>&nbsp;10.3(c)(A)</U> and otherwise with respect to Seller&#146;s rights and Purchaser&#146;s obligations under <U>Section</U><U></U><U>&nbsp;10.3(c)</U>,
<U>Section</U><U></U><U>&nbsp;10.3(e)</U> and <U>Section</U><U></U><U>&nbsp;10.3(f)</U>, the <FONT STYLE="white-space:nowrap">Non-Warranting</FONT> Parties are express third party beneficiaries of <U>Section</U><U></U><U>&nbsp;10.5</U> and the
Purchaser Indemnified Parties and Seller Indemnified Parties shall be third party beneficiaries of the benefits provided for in <U>Article VII</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.8 <U>Governing Law; Jurisdiction; Venue; Consent to Service</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL SUBSTANTIVE LAWS OF THE STATE OF NEW YORK WITHOUT
REFERENCE TO THE RULES THEREOF RELATING TO CONFLICTS OF LAW OTHER THAN SECTION <FONT STYLE="white-space:nowrap">5-1401</FONT> OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, AND THE OBLIGATIONS, RIGHTS AND REMEDIES OF THE PARTIES HEREUNDER
SHALL BE DETERMINED IN ACCORDANCE WITH SUCH LAWS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Parties hereby irrevocably and unconditionally submit, for itself and its
property, to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of the Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any
appellate court from any thereof, in any Action arising out of, relating to or in connection with this Agreement, or for recognition or enforcement of any Judgment, and the Parties hereby irrevocably and unconditionally agree that all claims in
respect of any such Action may be heard and determined in such New York State court or, to the extent permitted by applicable Law, in such federal court. The Parties agree that a final Judgment in any such Action shall be conclusive and may be
enforced in other jurisdictions by suit on the Judgment or in any other manner provided by applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Parties hereby
irrevocably and unconditionally waive, to the fullest extent it may legally and effectively do so, any objection that it may now or hereafter have to the laying of venue of any Action arising out of or relating to this Agreement in any court
referred to in <U>Section</U><U></U><U>&nbsp;10.8(b)</U>. The Parties hereby irrevocably waive, to the fullest extent permitted by applicable Law, the defense of an inconvenient forum to the maintenance of such Action in any such court. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each of the Parties irrevocably consents to service of process in the manner provided for notices in
<U>Section</U><U></U><U>&nbsp;10.2</U>. Nothing in this Agreement will affect the right of any party hereto to serve process in any other manner permitted by applicable Law. Each of the Parties waives personal service of any summons, complaint or
other process, which may be made by any other means permitted by New York law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.9 <U>Waiver of Jury Trial</U>. EACH PARTY HEREBY WAIVES, TO THE FULLEST
EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT, OR ANY OTHER
THEORY). EACH PARTY (A)&nbsp;CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT THE OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND
(B)&nbsp;ACKNOWLEDGES THAT IT AND THE OTHER PARTY HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>SECTION 10.9</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.10 <U>Severability</U>. If one or more provisions of this Agreement are held to be invalid, illegal, or unenforceable by a
court of competent jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision of this Agreement, which shall remain in full force and effect, and the Parties shall replace such invalid, illegal, or
unenforceable provision with a new provision permitted by applicable Law and having an economic effect as close as possible to the invalid, illegal, or unenforceable provision. Any provision of this Agreement held invalid, illegal, or unenforceable
only in part or degree by a court of competent jurisdiction shall remain in full force and effect to the extent not held invalid, illegal, or unenforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.11 <U>Counterparts</U>. This Agreement may be signed in any number of counterparts, each of which shall be an original, with
the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when the Parties shall have received a counterpart hereof signed by the other Party. Any counterpart may be executed by
facsimile or Adobe<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> Portable Document Format (PDF) sent by electronic mail or any electronic signature complying with the U.S. Federal ESIGN Act of 2000 will be deemed to be original
signatures, will be valid and binding upon the parties, and, upon delivery, will constitute due execution of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.12 <U>Amendments; No Waivers</U>. Neither this Agreement nor any term or provision hereof may be amended, supplemented,
restated, waived, changed, or modified except with the written consent of the Parties. No failure or delay by either Party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial
exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power, or privilege. No notice to or demand on either Party in any case shall entitle it to any notice or demand in similar or other circumstances.
No waiver or approval hereunder shall, except as may otherwise be stated in such waiver or approval, be applicable to subsequent transactions. No waiver or approval hereunder shall require any similar or dissimilar waiver or approval thereafter to
be granted hereunder. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.13 <U>Cumulative Remedies</U>. The remedies herein provided are cumulative
and not exclusive of any remedies provided by applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.14 <U>Table of Contents and Headings</U>. The Table of
Contents and headings of the Articles and Sections of this Agreement have been inserted for convenience of reference only, are not to be considered a part hereof and shall in no way modify or restrict any of the terms or provisions hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">{SIGNATURE PAGE FOLLOWS} </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have executed this Agreement as of the day and year first
written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MANNKIND CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Steven Binder</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Steven B. Binder</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have executed this Agreement as of the day and year first
written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">SAGARD HEALTHCARE PARTNERS FUNDING BORROWER SPE 2, LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Sagard Healthcare Partners Funding 1 SPE, LLC, its general partner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Sagard Healthcare Royalty Partners GP LLC, its managing member</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Adam Vigna</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Adam Vigna</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Investment Officer</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mnkd-20231227.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 1/2/2024 3:44:26 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:mnkd="http://www.mannkindcorp.com/20231227"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.mannkindcorp.com/20231227"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mnkd-20231227_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mnkd-20231227_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>mnkd-20231227_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 1/2/2024 3:44:26 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>mnkd-20231227_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 1/2/2024 3:44:26 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="mnkd-20231227.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140268861976400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 27, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MANNKIND CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000899460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 27,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-50865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3607736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 Casper Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Danbury<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(818)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">661-5000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MNKD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d575512d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mnkd-20231227.xsd" xlink:type="simple"/>
    <context id="duration_2023-12-27_to_2023-12-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <startDate>2023-12-27</startDate>
            <endDate>2023-12-27</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-12-27_to_2023-12-27"
      id="Hidden_dei_EntityRegistrantName">MANNKIND CORP</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-12-27_to_2023-12-27">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-12-27_to_2023-12-27"
      id="Hidden_dei_EntityCentralIndexKey">0000899460</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-12-27_to_2023-12-27">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-12-27_to_2023-12-27">2023-12-27</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-12-27_to_2023-12-27">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-12-27_to_2023-12-27">000-50865</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-12-27_to_2023-12-27">13-3607736</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-12-27_to_2023-12-27">1 Casper Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-12-27_to_2023-12-27">Danbury</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-12-27_to_2023-12-27">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-12-27_to_2023-12-27">06810</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-12-27_to_2023-12-27">(818)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-12-27_to_2023-12-27">661-5000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-12-27_to_2023-12-27">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-12-27_to_2023-12-27">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-12-27_to_2023-12-27">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-12-27_to_2023-12-27">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-12-27_to_2023-12-27">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-12-27_to_2023-12-27">MNKD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-12-27_to_2023-12-27">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-12-27_to_2023-12-27">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,XP(E@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #.,")8P"_@H>X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)\E*#Z';B^))07!!\1:2V=U@DX9DI-VW-ZV[740?P&-F_GSS
M#4QKHC)#PN<T1$SD,-],O@]9F;AE1Z*H +(YHM>Y+HE0FOLA>4WEF0X0M?G0
M!P3)>0,>25M-&F9@%5<BZUIKE$FH:4AGO#4K/GZF?H%9 ]BCQT 91"V =?/$
M>)KZ%JZ &4:8?/XNH%V)2_5/[-(!=DY.V:VI<1SK<;/DR@X"WIX>7Y9U*Q<R
MZ6"P_,I.T2GBEETFOV[N[G</K)-<WE9<5%SNA%"\4;)YGUU_^%V%_6#=WOUC
MXXM@U\*ON^B^ %!+ P04    " #.,")8F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M ,XP(EBIO>E[/@0  ((0   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9AA;^HV%(;_BI5-TR:U31QHH!T@46@WU%O*"MN5-NV#20Q83>+,=DKY]SM.
M:-+MAA/ZH<3!Y\WC<^S7,8.]5*]ZQ[DA[TF<ZJ&S,R:[=5T=[GC"])7,> K?
M;*1*F(&FVKHZ4YQ%15 2N[[G!6["1.J,!L6]A1H-9&YBD?*%(CI/$J8.=SR6
M^Z%#G8\;+V*[,_:&.QID;,N7W/R>+12TW$HE$@E/M9 I47PS=,;T]L[OVH"B
MQQ^"[_6G:V*'LI;RU39FT=#Q+!&/>6BL!(./-S[A<6R5@..?HZA3/=,&?K[^
M4'\H!@^#63/-)S+^*B*S&SI]AT1\P_+8O,C]K_PXH&NK%\I8%__)ONS;]1P2
MYMK(Y!@,!(E(RT_V?DS$.0'^,< ON,L'%9139MAHH.2>*-L;U.Q%,=0B&N!$
M:JNR- J^%1!G1E,9YI!D0U@:D?O4"',@L[2L-F1MX!IXB.WJAD?!NU+0/R7(
MPROB]RZ([_F=_X:[P%8!^A6@7^AU3NA-Y!M7Y*_Q6AL%)?R[B:A4Z#8KV'E]
MJS,6\J$#$U=S]<:=T0_?T<#[&>'K5'P=3'UTS-D+WPI+")F<LX0W4>(Z3^/Y
M_'$VGY+)\\L"X>I67%U4;PQ5C8K*/L1LV\2#QV]8K#G"<5UQ7)^3GPF0*!;#
MW(KX.WGDAR8B7,F#O_[-33?P$*R@P@I0L6K>KPY98[7P\/[E(P+1JR!ZYT$L
MN!+2KK^(P"INY&E1^EAU;<NN7Z'USRG;+ VERJ0JS( L#<"1B<RAEE!2&362
MXL+3>X3NIJ*[.8?N0<2<S/-DS543"*X!L^GRVNL'UP@/]6H;]<XA6K%W,HN@
MI&(CPC)II_E:)&GGLA-XO5XGP @_&3T]AW <16""^N+C@GR!?N0Y;2QEBR0E
M$Z8SL&>X"1L0AEG;/47=^AO,B6U)159RW[P;X7)3EJYS=<#0:J>G9UE]A58N
M!V!;*/DFTK YA;CF9(6AU69/<;?^/]I":@-N^Z?(3B[3%D4OZ%/,:&F] 5#<
MMXL*CN&5\30*+O!CG_9_PE!JTZ>X;7^1(61EL9,IYALM(D% P3@\-#GU#D!Q
MX_ZJA#$\A=0D29X>/4,W4N%";?LUK9V?X@Z]E+$(A1'IECS!!%>"Q8T\N$HK
M3^WU%#?JA>)%>CBLL'++AC<;,)WGS>9$_7"]-C*_-GT?=^AOR&9:YT#6!M@B
MVPI8>[Z/&_22A[FRRX_Z:[(2)FY<?BTB=H3%YB_#UPN2,47>6)QS\KUWY5%B
M[5_OF$*!/[WLXW:]4BRR$V]Y2-:R<=JU"#S-'Z<826WV/F[,5>KNW\,=2[?\
MY'M]B]!\O)R.?\.8:I?WSW+Y^X2KK<W2+Z!@=G8*9BQM?*-N$3PYT]Q/)TI[
M.G]B]HF:Q'P#0MY5#QQ;E0?>LF%D5APRU]+ D;6XW'$&J\!V@.\W4IJ/ACVW
M5C\[C/X%4$L#!!0    ( ,XP(EB?H!OPL0(  .(,   -    >&PO<W1Y;&5S
M+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L
M)VEU9=V'L<VAR=T]NKM'=R>9KEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT
M7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//
MEI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC
M**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QK
MRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)
M8Q1\V .7\@%:^*VZBMU7)/3B4PEM(+#52?2$1C&$"0K$OXP68E^$O?VML*01
MC\9][/QN]*!_[XSC]Y97HA_TOIKS8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C1
M6/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_
M-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+
M_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5
MUOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*(BO4
M9X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM
M\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/
MFD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !
M0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( ,XP(EB7BKL<P    !,"   +
M    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*
M19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>
M-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS
M#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C
M(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ SC B6!PX9>H_
M 0  / (   \   !X;"]W;W)K8F]O:RYX;6R-4<MNPD ,_)75?D 34(M41+B4
M/I"J%I6*^Y)UB,4^(J\#+5]?)U%4I%YZ\GILC6=F%^=(QWV,1_7E74B%KIF;
M>9:EL@9OTDUL(,BDBN0-2TN'+#4$QJ8:@+W+IGD^R[S!H)>+D6M#V743&4K&
M& 3L@!W".?W.NU:=,.$>'?)WH?NW ZT\!O1X 5OH7*M4Q_-+)+S$P,9M2XK.
M%7HR#'9 C.4?>-N)_#3[U"-L]A]&A!1ZE@MAA92XW^CYC6@\@2P/7<OQ"1T#
MK0S#,\6VP7#H:,1%=F6CSV&L0XAS^D^,L:JPA%4L6P^!AQP)7"<PI!J;I%4P
M'@H]KB@3K'H,+"&I=1BH9+=S*J?7=G#-(O<J0YJC#&AM!^&C6@L5!K!O<B )
M+LF5&U)=Z7FFMW>3>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0    ( ,XP(E@D
M'INBK0   /@!   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.
M@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4
M=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[N
MF:*<//Y#='7=:7PX_;(X\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF*
M*I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    " #.
M,")899!YDAD!  #/ P  $P   %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0
MA:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>
MCQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[
ME.O5,[1R;ZEXZ7D;3?!-F<!B63R-PLQJ2AFC-4H2U\7!ZQ^4ZD2HN7/08&<B
M+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:
M8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X
M(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA
M/UY_ 5!+ 0(4 Q0    ( ,XP(E@'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ SC B6, OX*'N
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ SC B6)E<G",0!@  G"<  !,              ( !S $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " #.,")8J;WI>SX$  ""$   &
M            @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ SC B6)^@&_"Q @  X@P   T              ( !@0P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " #.,")8EXJ[',     3 @  "P
M    @ %=#P  7W)E;',O+G)E;'-02P$"% ,4    " #.,")8'#AEZC\!   \
M @  #P              @ %&$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ SC B6"0>FZ*M    ^ $  !H              ( !LA$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ SC B6&60>9(9 0  SP,
M !,              ( !EQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  X1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d575512d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d575512d8k.htm">d575512d8k.htm</File>
    <File>mnkd-20231227.xsd</File>
    <File>mnkd-20231227_lab.xml</File>
    <File>mnkd-20231227_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d575512d8k.htm": {
   "nsprefix": "mnkd",
   "nsuri": "http://www.mannkindcorp.com/20231227",
   "dts": {
    "inline": {
     "local": [
      "d575512d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "mnkd-20231227.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "mnkd-20231227_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mnkd-20231227_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2023-12-27_to_2023-12-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d575512d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2023-12-27_to_2023-12-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d575512d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.mannkindcorp.com//20231227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-24-000161-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-000161-xbrl.zip
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MY^2,C^K8G<GH,W<<YIG/T*5M1(!PX,]?==,?('U_-#T <GS+^EPA>H,V'0)
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M9A<4+4;Y73$B7>:*1R0;-B)Q5\N@KG^;.D6/NZ@MN +5$3#/ ;(' B@_#-V
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MN,,'[N=S3XQ%/](],3;OKB=&N9O"(U*YJY*V^19$V'R&ZC>3$<8KPC0*QJ:
MJCD%_(0H+M^L3"Y'B'44/>%#DJ<G5!S\9I72.[M1V" 8X0D5I[Q9G>S-;!@U
MJ&F>E,RL2KKFJ+OM?8G&47S:F."\>D*IXC>K0SK0,UU_O-T0$WX$/3@YIH9
M#8;@GY@\K4H2YP$DCE\]Z.3-P]@F>^V7^;^WWU;CS>K0)QPA!5#*+&295:L^
MQE1"D"4Q$=MW1R/,*I!Z_?=L>-ID?O/5DXI/K PEPO99$)^&7A1[>\$D])+T
M0="1/S%A6I6$E<IV8@?O-!E[1V?1*'=PJ.>-P9F?F$BM2D">>P0U;?X]MV^I
MPPWVJ%_H]N[^46_OCT;VYN9Q[&?HX*UIGK<K QW<'B=9%)\VIG*>4'KF[<K
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M+'0ZIQ+J0OE"MZVP,L.9-K[!UZ$[G#TKM."#TRB9P7? &:#89CB%DSV)!CB
M:1#S?Z_IX^I]^K*_=ZSOYK,H#U]DTV 0_@:J(PVFO_R^O?]7;^?%YH=U_].O
M^%W4 K0(H#TIHA>'/@CCHL<L_$)V%HY!3X.,OIB. ZR:I+=9+\U@J<"JY$T>
MTQ$4IPMC AS;09D#"_B<C$ CC1?);#RTO#G8EL"SA=EL"8=^,]PZ7!_W:TV>
MO6U0/7" 4N_O,$A+AX]4;GX1CL$S6]O<6F<C!;QZD%Z0IR@9>B'[Q"!E*DOF
MO=K\B*$:4,4HKKA2I(FB%.YPYWTF?6#'J671^R',6$FOK0M)[X7QT'XG#^S5
MIF3FE*4^#JI?Z56^49Y)?C>^!\0__#F-5*@Z)??7XI-L/+QN=A$#>-Z=.:I-
M3HIYJU9H4B3(MS.?MXCT>!#SH8.Y.I-*AM46\,G&T09;_D@]<X@W ER;^'74
M!YL?WK^E]$" Y3=H"30YA<DTI B?9&^OZ8YN?BCXHP]$X5FM,6!#B!.QD-ZX
M@0B^?P@B6-O[XW9F^.JAS? 0G.DT*B:I;C3'MTW/4:"U= P+8)G;$L_'&'7<
M>HXZWJ6X%9#<%??8T'PQ4U]4>IZ#"^W6_*#!EX;3&*HT0N'O*R:9A1*S(_P-
M?LT#%0-^>Y3AM*:S-)L)M >_SD]TT@!1#'_C2,(TN*10OUJE$G('8P;LFB.6
M!=OM6/$KY^<!F>D9?D9!A/ZE=W)<&DZYE*5)1:8K4<**Q?X>C<$M.LUAI,?I
M+(.%VZ/+&*YF6)QDH+  ($$A/R<X;=A^*%?6S O4Z5%KR;AJK,ZW$93LG+9;
M]J)>/WRWW?1))$05R>D!A0263BS.O^6V*$*\%JTW/3]L43O4!WW)*QS$>L'L
M7CV4>2D&S4CP=_N@(4]52_!;FNQ6XY/%$XD @WW.4MS:S%A(&Y?2+SN=>H_U
M2Y(,:6MWTMFIU[%P3X(LQ<BK3JB0=AY<4E(&]4V3LPJQ@#^:].%RO$7O9TLG
MGYJ\@[Y$X7B!LJQURU^]?Y!N.=;ASL97\L2+Z>_-!SFQ/SJ=@]+Y@F,2IG1;
M,[[;&)ID\J5@_D53M*S1A. F,G*MG\14F'&48T<TS@WD\&ZR_>!_&YTIL5'B
M>J/YQDFPO)R6PUF<ZJ^J/7/F90,+8QU#Q\\0M99' W@!&#V8LT68GD?J)AGY
M[9;&=N84AD^]<3)0<$S\/2LH7^7H\DL[]Y3-IFD0*P-4?V6=@*632""!$9G7
M/,T(L0C@*J#D)NFEUT^&!'.<I6"6H<^:2I;,Y.8$;@B&7CJ(R/(+U0WC(U@U
MRL:"*OT'1H5I-M_+@Y^4RK;>A-E'%X;*<, ,WS2:Q0.5L*-$&UNCA$1.K,6W
M_0Q*V!P$2%@A-QV#F>!ZT*NG$/%Z\\PR1HQD^,>B(&U2%JO*^2N]6062'#,R
M"Y8'/*KE3>C/35\%O<.CV[G9WFQL;JX%C5]M,!_P"O.SLV1,8HGWPBU.,&Q\
M@O].(C@X?-"6M9*+5]W;EPNNNL<8VGOU'-J[&X&;#4\K Q6LK_F/B"XG_,=%
MB@4; 2'@^0_I;$R7#RA]5.QPR4;Q/W+!^+!PT53L-JR#R%7 YB)(ASZC3 98
MRB2 KYB:>#3H%_QI0] JBECG@-;@PAWA'8%X%[P1A^#Z8@ &#B@";&Q3 B[6
MD87V0?M#?PL1/0Y:;=VWPD$*/N B!/PY@#D3'IJ/F6/=;O 5OG<&!L,Y%Q1B
MU<:H4$DQ& =XM?L*M5\W;[5P 0&1%-R(/4/5?<R:/!L1%N*.[(P2AH\LIEF.
MA79H4(&24U4U$4$\1$9YKL%M('X0(/BB?_EB0&02#MI'*C"HE%+C>LQ$[>E-
M9WW8=2P(A!.5&;LO_(E66-;DU>/(?K%V?!Y:\Y;DOMVZ5<&_ E+T&E+OW:;0
MMUMW(O6+T7+W)/0GQWZ=X+=;CN0WHO1W@XOE2MQT71O,=AQ<9+9W*$5I\/&Z
MK^H%,[H>Z7_8-5/UQ;#A>)^21%7ZQ10R-7!0+"@W15C*VX4?1YCN21&"R=5B
M*4E LZM9+&(Q:]MNU1;3B(-EZK()$!L/-1&&!4T&%XS3)$<8&[%0>@C2VWSO
M>]^"2X'\T"<?_"+1!L/Y7EK?W'Q-'\$?_CV+0_GLK?JL,TVCL4"]Z+,MCGJZ
M3]WB/S6IPTL&?Z4&5]\*B%=D/ [ZBD#$(!?M1%3=.E=N$5?#XY$/I.R>\XXP
M/XH),(2)?ZL5=TEH)":3D0H%Q3::I5Q;RS_W]7/P:U@N0<-U:B GR9#U?BD,
MAB&T)%4#<U-L^#RK,KO\]XI)P92O,2SB+)C &2<D-^F; GK4!CXO<%[?X+\;
M+1<NTW387=(+,#XCBV&0CB,LPH$530:#&;4268L$$4S?H @GAK",$1"6(;-@
M@(?<>JL\$K.A@FIG]H44T^FQPL=3"QQ2,N7$N>MA;VV\ GNYULG&_<;,S=6G
M4/$LP?4'F1*Y GD*ICWO<W)-WBQ1&)<N$[:IN-CX4I=T^7#,TOPT0"J!*5FI
M8-E=3O$4#C1H (O%)>L>$GF 1ZP?IV):AO%@-NFG 9$(@(S&WAK?ZQQ@-4<:
M+OQDR@]EAAQ8.P:E@ST:4@4 _S,-1[,,([;,<@"W78#A8JX>-[5H<J%;M2>D
MKU15R10>@]P&!%&T1JQLX1](%Y6DXDQ[%V#'9@G;M&ZQ4\+K%BH0"9=E#,-^
M+E%AU1&:G^PE.G]K1X:)YT'QQ&#D/1B'RD*A_Q9+"L/>65@$\+-0JE(Y^M:4
MQD(KF=ERNES*%#_R%ZK+MU?XYF#I;PZ7_.9[5:%&IN#B;P_DVRE>.$A6DX%&
M"%6:G:\WE]>@8);#!3K$XZN*?!37%IXHT<A%1Z>J!N$QQ@U?/\<-[T89)UD9
M HAG'JRES T1*DZ708**&?T]O%&,<<,^8"R"YQ"[B!T58$M6=(0"F$8:AY<9
M:PQO%(88)T!^';3<=;32TE2DRF*\,AN\NKX%_Y ";[>^)N,AM<PH.IQL:N,*
MDHF*<<#0LA#\Q=[\7A*_4'$;]M'M$FCT#R5M4G3 *JN(,T.,A6H>[M.0R4S>
MO/R7L@[F5"\W:8IJTL0;YE'>/DC(@)[=<3@XBY-Q<KHT_+LXP7</=(+I#RXQ
M <$$:R$87W=^#[/&Y!L2 Z'QUAEB]YS0ZY)[4!&#.@L-KQUYC"H^J"B'W%/H
M>V"Y\^0#&+Z\)9"W"%*$ 1'M%C%?42@3%C@:LG4)1B\LYB"49GR%\.HQTA@R
M=Y>WDPQF@CQ.JY<81M-?<C2>]3YQ4Y#RD"U0"G(9C:Y8H)89EZK)K"*]@.$-
MEAV>&*-F=*4'6QX;V;5<\NMA\3=MU'F"I:Y.(""@5U3S-<+@AFIP<<V@<B03
M._4%]DW)M)G+?JB?"M-F,#EZIN%59XT%S-SKQDTH+;</MJ^@G^H^R&(4K5J,
MAW%6:[F!:L1 E0H7:8(>Q&SX8KR>6GVYL05J9BTZ7Q0D:&B.T7 [F)8VB3_V
MOH Y%1,[ 544-#]00^P^KU!@(&V:.2I;0QM='S'G5W'PTD&%M5M4,4'>'X?A
M8\I+\-%VG?-MN((BENLC%6^ICA=W9J>PMH40O"E?]74,%(L3X'30$XI!TP<%
M7OP6C6%<20QW]7G59H41Q6ETW-*P(!^?P8S0[O8ZOAL8K/K.YX<QR0,.",V9
MIO>?;U[Z+U_2__/6]",JY^W->?"Z7I1VZS]?OUGRD9_G/K)!/T\/=NDR@(+)
M^FX13+G9:=G;6JVQ.#VI$RR5/!IO?6;V-H^M(08?21RQQ!1"^E *+QS6$!ML
M@+_6^7JRF)9^3)E\Q)W NN;C0IOY)Y+'9MX^2".2-*'YLQ?!/[Z"&D6[_1M_
MV&[M8+(-U.O:?V[Z'U[J [3^>,-K;Y[#:_=VXCZ7/<1H!"X?L<M@:=]HW:M6
MP,BG2_Q6@[,H/&=J\?)9+:9Y7Y*LO^.S\QC.:GD"[1;.H/*T'E\D^K3B6I6.
MJV=.ZY;_JGQ:'XHBWJX2BW9K&;G KU3?KYAK<"5FH0" ]ZGR02XS$F:=?F()
M&/Z2EUHM_!?<S?IU?^6_*:U[,[81?M8QN;;;PIR_D=S. YJ:5UL!_^AGNE0$
M_0!C[EAFKX+H"W]U%.8O]D<CC8^K2(KHH <_#,R^.=1R\+AD--($=@/NURY<
M^@/RPA!1-I0"%D)1RS\**5Z;>)O(S;BLB.$W7,FB(&Y,R4?,6"HMK2K,W5RO
M8AE(+AS.2"J-\25?37F"P.J,9\8*'J<9+ON=P4]*-C@TA)@T/@O'PS*#NW-+
MJ,2&U3?#:I!!EQQSTZL7YL$/<(WU[ ?!>$# /)B<47!8K31 G**-S GM]"J,
MPWR]T!JE*AAT08R<DHK57N(2",W;D$A]-=?G=^OO8ALH A\B?_S:2,:OL+F+
MU@5K JH79MUUB0,/;3_5),IRC-YMO)Z+N%D\PP>O=^9F[BICCL7LGG7VK-A/
ME(/QIWLY9#[=Q=-<\,T"+RIF_Q=I\]=2+Z"CG QPP1A5*("1A>56;Q@L8<+
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MJ"(VJ3M*FUQ 5]7YRB@+Z"$(N0%G(=!\#".-GE;/7R\TB"Y8 >79&ML$ZR+
M';%34X65]()QELCE%PHACCR*L,LJ J>6IT%%?QC^[PRT*AHDL*:WAIIX_P X
M%]74;BWVZT[J,<8.WSW'#N]&U,0RWTZHN;MW=!:-*NKB%I7*MEMK'5T])5^B
M6CH4V6PV*5&,+!4 <1@]3'BFIG@6/1OMD-U"Z:Z5W#>C55C&-R__Y1.V9NUS
MY;Q/CKVUG^HO P+:9,1B58#RF2"1,WRQ+A&J<5GYE+309$(>[=:/]%5G2LU2
M95(/\!)PTDZIVRSQ1XSD*X62.<<O72*?_>IAD.A7RG7AMKNE)/Z;C<W7S2?Q
M2P)5BAJ92E60%0=39JAJ"K9#N[40@[I&8#ABNECX757C9$7)/XC S"EM6V?'
MF:"N@GBM/D'(?E3UCK<;K^IQ3&L.]HJ"!NW6*?L_4IR)%B,L60E;Q[Q40_-/
M?-2%Q97,.+M:XA^$6/7G0*QL.CHFNP8O=)8+6$>A V\":)N+BA1(F^GKBX/%
MA0"%P$IP+1 &%-A\7O>3[6T](25B0^RY$_4YL 5"2&7 -'1-P2-MURM_H2!P
M2GH+$ENQW^\VZJOLF0#&*O6]U%P\DV!(3>+'43A3MYT:$1$ "5920L71!"MT
MX3X"[3O%8EHF):316GIV7MVRHVD)/:X3PSDUI.:*<\1IYI>-@K'+AXV"?/$@
MK )>L+[9!Y=*!]ZDG>_#F@,JC,K@NM0Y#'B.4NM T#XG++C$JJ@.Q_P,9NI;
M]) BB]M#NE464\Q5E6^]WFH21K,(V:FM.U\#L$V$8 T<;FH=ETR4RL% 7P;_
MB; 1^/V(?D#<9CZ#OR/0TD0] /\Z#R]QUP60#C^)<F;KLOG'N!I(#+O *R0F
MJVQ%A%E+P4@UFX' 1!W_'>6:KP$9;UBXGA9;=Y156H/YS2'JA4%A DD).9C"
M+GVJB3^H+A6#*!W,)FC.#L*LR6J?@L52$I7CR_,@2[R=@]ZGHY,#<W^:M[U[
M R\_1W;803!^01[>;S!P> =X+^ TP\]@ 7.,#259'L71>!TV]BP82]^UY()H
MWQU4D;*?N$ =7H75 B G5H\>7$G./=B/]B*T40AFA+O/N(]PQ@U;8&^PL@'1
M")\^__ZIAZYO#W;\\^\/0$EK(ZL2*V829YDJ;6>2P4R5:W"XCH]":BPTNW*#
M^!UU-T>Z_:6)_?+68ZUM]Y;L6K_\X8  ^*6/AW/L0+(,K+0AT09@($YV?H)'
M4-S&PF/#.6;U0[B+#XEE^[KXFH?9.>NH6ZH/9,PM]F\3'@?5H*_[$]1V?!J2
MX< -C1YOC.[]<XSNK@3*D/N4]2%8#4)6[YL6P'0]3S(F1K<)GH4#?JA)FZRL
M1,C8$><S]&<3<#HMA>.6^0AR FV7G"GU=0MWST'3D@\;Q>O%PC,P!D(WZ%7J
M6F#B;[HT#!:ET4->[-;P**!%LL+,G.J)<;='?,6WE6I0G*P/8)HW@4]UR="5
M%F-70U$I4-P#A5 M NF4@_]HZ%.-H NP0?-?')6<^_U)>(ZI1FKB<RYL9C&%
MN3%LE6^VO,-BX(J_S9/&MS7K+1^AZJ?UMM?_PU77'QE\EL!L2OFL)!) ,X+[
MI,+YAI$/ISX)?H1>*C_79JS#WKR\'7N1S,9#[!T%:OPL %^ACQ@7T^SR+."B
MPY P91(>32/FM%YR(S4(#50_E6,UOR6P)_,1LN1Q20*$X[N\XFB_K5VEX\O<
M2"OID_22VK[P?Q8ZOQ!N[L:M902RC*^9*O^VW&!F77>SKTT++">Y[=:U1?<*
M\?O[EES_6O?:E>02/7;&51*'BAKHHI0IAJRMS Z)+J^.61?LGE2,G=?$R;,*
M#8[XV&ATX_4<1D.SILU?A4M@(1DZ>&4P9-.]TH^0 [5L <U#1*E<C*"7P5-P
MX<N*QH@,(OJ2SLQ057H0I4AO.],]-U16V0$M86 *Y"/(588=OYDG6%EG(,5C
MT\W>!N1B  S^%R7+^8;[!HL+5ZQOHG.D\6'"FT[/G(&V6V:D**MCS*/KH<H@
M^8Q))S#;K0&EIJI$^O0F4[)86 A\ Z6\^G2^\%=H4X*I@!R]63*>21)A0LTE
MAA:)KOT8#?/&L#)URV%W3W_>#\=(*R1(<1XUK>HLE9<CFL%:4/C%94*!)_T6
MI<W55&2B+ H\@7AH;XJ>$ _>XM@MR *.,(RQ>PCE_!S@ D?9 V%;H00*_R#H
MHV,*@^!?+O@A)6?)D"S/"%M\2 <0UIB(P\NCG-<>]*0FQ(?93E#+#H)I1-**
M.)6P>E+J$L4ULO;872+?EF>;<UD[Z]SLFJ.=A055OF62PLG :E%N^8$RIE9B
MPSMV</KF;>V6_3K.5E0>K"!S6PA:%[TFD,!*VEENRJ.L ^)S4E7H>/#[K"@&
MLAA.\-\+?T99SA!)WBA\CV^PE*7'PU;$GK4_Q&:!>DT%&/@HQ:J+(HJYG"7[
M5*9."P-GRH\W(O?A.2)W-_<J=Y0$"3HDQNXRUD8AUPK==N@46.3;8F*U6X?2
M;G(.6*2>I]1%%O-=2J=3#U/%WGP"U1E3LG9@@V0J[.-NJ/XJ^<(WG"ZD=\)+
MW:4($+2K\N&<H 2M6>Y!5%R%^@X1@AD\EY6OGN/5QO^^\4A6@<J\,I9E0CDE
MZO-:DNC-+=5I<5%=B]UJ[^X:!#9H)(-[DD;88LPU^SF*M4P>ZD.]>]KDM,ZB
M]&JU725JY ^O'_C$O&VDS[LE'.<[:L/7L,=V',&)VO2^@&L>"-6(#5H%2ZU2
M!:3N=[A#L9!786FG@ :6*2Y]Q05,WMJGWN]=-,80S_31V[>X4! GL+ZHZ=HK
M]G[I.7L)U5R!/85WY5(_?J5_+%0K_.J/7M?IE\)/6[2UKS9>Z\?M7PA/S)(#
M>:]_N5WH';H;7"P[FP_Z(1A,H=HDM$4/E-?Q+<!NK,L^;?,E?M!NX?,J^L\N
M]PRSRR?;VX4!+*[3A0>\>@#\HG1<MF[YN'CV:5DL6F_T0CH,0<2F9:DJ1XR7
MW>FW]A':C523-OXU?,^;^^MW]J\_I\D/V&&VAKPO89@M>W8VS4&^)SY7&-=R
M,FC69R?*!N,D [>.?MZH4%8UY:F00SN+SH6(B@C8_12IFZFX(Q@+&<')L6IB
MHND@K4K/=HN;.S=XC8%*J<; Q!$UF+),UNUD2&4F)F1?[AXM80ZBJV/&TPOO
M[R3]\9&$5Q6HL+,A(8=1=9!3ZBG1-%# "#11P0CF$(("?M,S,XZ,V%@$5/J^
MP@B/0LT'3"%QZ>4T*OQMH?C'<&C,3]2I$=-KB?Q1/QC\>#&;JA^6>O,J-&$Q
M77N*"@^K.9=VB;#\5WJC8@27])UAM5EJ=Q'RZ?T# \R&T<"&N;J<A*;ZB@WQ
MTMXSE85WAR)GY?R=\98;MX8%>2E0_0J'8J7P4=LR2H<G_$(C".T6)MYO1Z@V
MM"YN3"7 W*-),LL\;LA9UX;)MUE8:AISXHK/]/-4JR:)+MZ\],_.-N@P0I,W
MRLD4!!1F6.X2].A+^1$5:<W'9FEU%$+=V;95QLCKP!$'1>TS7B57GKW6>.JV
MW,%^7!&=*V2O&L\F_2AXO''>S9?/@=Z[D<[CDMR)S!V#1 53PM)CV8_%4AIX
M.Z#3+[ \PV$OU=3@H.:Q-P=R1>!GQ:*,)DD5V+#4Y"A@56HPYR*2#2<-C-HZ
M*P2/+%IH?0X[<!UBZQ$K9)G974SC2XTNK1N74X58SWH_9/^ C14,2L9>/SP+
MQB,<)4Q['A9BK;IB2T7$U?5.(6V%Q;5>R% L"JM>*["];AJKXFLJUHR%RW17
MM9:M#,KE#'!FA647K4V11$0!==&2&]C;0@"B1F^3XSG=';'9(OI%W*O""H]7
M=W=<&!K') GE\SFMC"V?@CP/$(*-UJ6%)OUW,U'%0CAW"X=T.),";5PGFQMH
M S2;@!Q"BH# FRT9$70#V48%^_:W>;5]=4B^FR'W@G5,[R.>M&@ 26$;5^HJ
MTUMA=ND$XZ\(?63D7[3'@F>5Z3+;K3\ZG8./-]W8J\^_O^Y=P$"TBIT$V6 V
MADGXWBC$=J,QU1C&<#^!Q)Y2CU%)UN/DK%K64/8[94?D/#0/9M7!/\X^WOA4
M7WV6@W4:G&E%P?.ENX4G$U"ZBV!RXTN%0$.:Q]DXX),Z'1.K.%5#J-7B)\BN
M-S&QX3I7E(<$>9!ADV"R)DM245T*6T2>_#0-<W/'T?9EN&$971>($B%^1$5W
M#E_5U1+6LV%1?E7/_WCCJMRKSSU<M_: AR22R&/RG0]A*V4IJ @N@H?"QMHB
M0. 34F6L=J.18,Q-7&)ZEB+?,3]7"EJ$RXJN1%F,^S_&HW6XUTGI&F6DD_9^
M04;PV):H SQ5R*./L_LC"BG8/S.E/[A8Y;B'SN:J#"X- TY/J7=P=6:WII,3
M[YARP]9L$E2LC0[9'>,C+I$7&HE8A#(8_2]MS63VH C%Y)2#VAV15/F1K?O8
M4HK#G]RF1\J?2-14)96G[_2<RT$:D)/3HK[ <2-!!!\!-1M:-OS8WMEVRPII
M<32IW&!,5MHMID4+W_X76+;C8*#E#V0J#@:YX.1Y8R702-Q$")_3T4;8@Q)1
M744+I [638]#K]?K49!1D@#ZX[\XQJL7@];"6@FZW-0R$(V]B?$5F'EYQ UL
MYEG59@IJL$*EY8F[ORX4T_4EVZV2,[GPK/'W)-L@? 9<)XW-+&@'35")SY#P
MDDA)/P$021=5)CXDG<BO=K9-(271C4!"P6A M[9J=*&:4F4N<#AV^V%$8:9N
ML<<8N-E\#MS<ZN&*V+I &U;?]^.QF!#5IXNJ(\AN!#UH;'_D;=&*@TH K(?2
MDQHS&_XQDU0F%&LSUX+BPUK^C$()M585T=?-,F5HHE=K(B&\@G2.V6QU\QQ(
M2G%QEHP9L4[D)*QTK..M,R6B@5D]B(;7A E2'<_NLZ4N10%A<,U5HO( OKSE
M(:CP??M)&>'B"Z.NM\":,(]_K*MV@8$S)K><V$T=BT? &.Q Y=0"16.$.AKO
M?S() @L52O<@J>(Q56+HOX"1J(GO+:G'!S@Q%?.QRXYD"9=J+ED4V#RQOL0?
MH8,^KG@^HKAMVC-U[L@XN'??;;R.1R0-/9L[+,JDF!UI1)@^: 3'+"-!Y;]0
M#IG-9J*\44S[7"M@?JTCD8Z04JQM2%4E'+VC HAVZ[,J>-@)+GTERL7?:BE2
ME8R^I!IE]%HO\NCI;SQ\_1<U^D!5A-CC=W[O)8KU<X L<:A+W4&25ZZ*_LP+
MB-(%WT#> _QL?#DWDKCU^@[NX\[A<6][MPOVYQRM?A>& !BY!R>'VU\[1UVO
ML[?C'75VN^W6_A?O^&O74W_9\3I'1]WC(Z[<;S*8N+6QB7:Y;B5$2C<8AQ]U
MH-AT%[IY//A:\<&3J0@B7VL5'#I@!0RML%)!J4JTEP64Z;X4R9<VDZE\A3B^
MG!@YR[C5;8$?,I4/D/.;@JEL& ](VY,2U?1C56RN#H$8JUO#($8)%;=.U'"!
MC; U,XUU3(7[PFTH&8+=*$0WVJ*[S<_ )>//D4XID*C3*#A/4KL72,H!EA+6
MP4"9G%:@WVTJ$95,02/U-*$NR!$I-E)_69XDK&PH=B$-3HJ-:T$'4I!>+:RZ
M9RK8T/2"7UHTMU(1H%>:W^VS<ZMA&7Y-5JBT8.9BC0BT4FZ&?-\QXN8K[->I
M_$QOT!25@EQVTR#2Y6*C&=;4P4F$VXGSI9YJ\Y(1ZJW22S7'+Y 6R,[N@_#Q
M5CL]TXT011F93"FU9[<)JO?CT/L*LH E8E^B$>)SP8E@KQ8S;^!4_^?FFY?^
MRY?T_]:]-7SO8K0&N,)NQYXOR2S5;SJ&PY'AE,Q+7E>_X L<Y\,PFO2QV*_P
M"D(T$#;"'86Y:9D C8.EJ?T4YV@KK3,*Q:;&HKHX8\X^6/18['03X3/./R-H
ML4>"XD3!+U1&!RJ(ODT'(QFZKS2;=$#3OAK7]F54U<[1#V$NT%Z.M^8FJ9UE
MK&N$M[Y1TC2JGK>J+K^XT)]ZOT^B>$;P6OI":;NL$GPIUU+-J:+8X94-S@/P
MS*CE+IECL)(7J,;T"> AZ/2R,-YLF,M/: OD>)3:0Y6N.01"IQA BE&[RF$U
MJX&?C2X=7)0. 3EO(O$NO4PNA[BTOBA%>,/ 8<-,Z]KF&Q$(VW3,+/(8 E)0
ML=HT+U^5A2FXIZ>+5=_"MD@.DGUZ:E9 5BF,I" WQNZTQ.F:8O8<W"YUGRU>
MAF+;+BNM;+41&_R(DXMQ.!0N?+H&Z?N/.-BU]1SL6G#;7NEV;;= #:4PN+'C
M3F:,DE5<[&NDYA&38G*'!03+NBKIFVD>275;#L,)Q<HH4K!8GS!7I4W7QF8:
MW?=P7#&>R]5_[=:\<T,N9O'9H.Z)"KQTW.5#LQIF]LZZ%%:BN H;7L^V;>64
M9Y7'.BR-#C3!"+0UN?+R4Z,=0E;3BY\"UDB2FOMN&J4ZGD-6=5%W^?57E<&L
MEVY42Z5=[\;QW M'Z6\:=)".(W4M@-)JM]9>+5#FNE-&R?JHU<26"EYZ>W0K
MC277%N2A.IE9!GLO*J(Q6%O?FU7?S54] SMLL53^J6)7M8F'R6]R8Z[PKL_U
M[_H\YUT@U/"R#>0B-@S0A$.XRLC%UK_JRV6B[ R#D @KD?P9'#03:)(O%\[X
M,!R#99AF-M>5*W)SM!3;V97G[+J'F?P7Z3^C<KO>*?K"H%M@.ED8_N R_0RI
M?9BI1S2,74E097=<L<S#;N/2DZ-]'@KI1KMEUE!K/=0\ZN98I( HRT!VN]5@
MAH/[!9L4^3QB"GH,A: @F4V]&HZL8DOG>4/ :XE\4+/W=B=7]#I.N1L#'7Q<
MZC$U> :7"+=%5Q9)[OL:W91?ZUZGG*ZOB%W@F(1E*V%0UP0L'6\61Q2SAZDK
M@8T,GD]CBG1!F2A]]OTD$Z"[;4S!^> [L? ST>Z\X\R,8X+)?3H<S':OJ&XL
MY]HL4$U4QEO#W #B**W&9_,[%Z[7[;NTF.*Z$ XL:,:;A8*@TM.XH)Z[N73$
M:7>5(5$-<5EVHU6<C@V9RAU22QHJ%(S0N2DAQ2A_'HU-V.2*,Z6GJJEF-C><
M?K,-63;>BN^=@08]IY-A^2TZ%(=BRAJI>ALK99+G4J_&YNI723*"FBXT838G
MVFH89#VHI'D)^HFK@$XEJ=:K5L79ZM( :9&B"9.B2^MH9A0+LMN:%WO<04X3
M9$,\C+VJ.2YGPJA)ENU.@M0:I$F=$*"0Q*Z/41(*>^4IC'HKA4SWQRGJ7)<2
M;:^2@(IP3-D R&;]221<6-J92.POLK'<;G5_AH,907CW5:=2$W&A12Y]0=Z!
MRLBR,L+1B$H8\$Z'FV*:CR^UQ6&/PQ?D>\5/76!:@/QY 35Z"KVU33'#(RI0
M)*X^5##$LPQ.2#@]2^)HX$W"D!9*P>_IS>4IP,4DS@<%CEY6^AK<#)QOBKX0
M[6L_<T+<![*H$[(0:U8KH)M777952V(\H0B+_M=>S1L/ A*L\<@ I+!58DU,
M'H#^.9V*D-\ZD_K0D?OR&O"EZZ_,/TR;+Q7KD0F8%1=B,9^D/7B\X;,P1E,X
MU$]R*;,9X$4S+8(">9$)D:.F22W;KZX@C.KB3EN)96#^1#Z(#/U?86DHC:MF
MOQ]QS>"KYVC<;5<K]!@)<L: _=AV1912I\O8Y+6*':2TF6;R6LS>XV93G)1K
M/U2TF#Z17LY"GQ);XQ!5M$,B&H'S>IZPL;#T .KR9U)O?:5$M:^924W!7<DQ
M4/EJF+E.6,])5-\L16WG:/=$;\EL8WB6[=$@LVJV3+++>1UE.RD:,U(\#*S?
M/'AP"@\)6=\$M'WC!!D/R$&KLONX/QCE!5BO%J@>\$-#,V -DW_93]*48FX;
M7E> 697I![1<,?078%-PG7^;!#^C"7A:DH<S6&,LE"M09.B69Q(/S86'PFXM
M"V_*U8%P<8::MM8F8ET%T98R3G>QP(0A.XJ66^SI:RTZQ4J$'@L'>(J-PK2G
M)I#M?A#_2&?3?'#).&ZZU.+!I>KK283>EI7*OX;#0>S"<'.GR:D3Q](0#IM3
M962IP:(.U,!2;.B<2@!/Y?OMRY]=3[K\APS506*E+)NE05Q,34;%&)6/1L8T
MDL1%Y4C\JVEB]Z3+&8D8E,H6'?5O%MPK@MKDV<II2Y"+37Y'Y"M%V%!F3K1>
M#Q4B'=FQ *LC=15'O)8WK(#(BXERS?#O$CK&(9828&$Q&OY,':(7J#:*4YA!
M!?N,' TF^Y0#@"CBVK.DCYTOOUUTJE0$ATU6U9]63%1,@#&3,!;!1:5B<>I9
MF]M@9&N[U"YKN]">K :^&O="$ODT:&QL)%SB%<PO&>?*F'19G';KCT6+FD&9
M58^A4*K1!.N:NF:"E4VI"?K8)#8D&=1!4F]Z0GHI3:9I)+A@)0/TZ]*^%O/8
M[@C;+6N()D*@6OOBZQ&:(3%,V#QTFT[=R_VJ.ZUB=16, +C)IBEO#->^)II.
M4NL *UM"WPLL$68"P@V'@4BIIQR/&5+&@VBWL".VKJ%5V'HN)5BWY\Q+,25V
MGF9+P[>X-'POP56>82OO?<,,SLX@*'^42&3IUF5C!LE?QKNY#2Q5'R0#O 1M
MFU[:0:0H4R@Q.CX,V%.%&(R1Y!BX9)8J)4/AHG$6:I0U'-^6Z6.ZD[J7O=6G
ME(K\X;_P>HZ%RUZ$";GCB4MP?$G%9HHRDQX+!TY$C*T=N398UM;<*KS% YW#
M4;&^X74H6(3!79N 'UGD+9IW[?*FH5 <"LE!&DX"XFFO_ZV]8BH\7%XK7V'Z
M!@BMDJNE@,#Y*4" W<+;"F*GX5@-GXY7GC5HA2KD<[$_7U_9$JYL6@>R*I*>
M1=I&)U&W\8RUC8,5?9M!NSGVM1TDL4KU*F%X?@4X60\&?XVUE HVR\<7[H42
M?K9FF\V"N3OZ&*,FKY^C)G=XTE[C2>,SA3@ 6UCEP%5"Y#*#D>,(BX\L2SH9
M44<%7RBJPEX2H*-)#1:(8GR'2#UW:XCG$<64>HN+!M9%AW*ZK:8:9#NZ!0=N
M5W%SQ T26EJ'XT&5'+@>Z37:AY-I^BL\D%2,:A-#;1!' @*B>TYJ!%3%?NE-
MU#K=3EOG1(@[+=/L89/PV)CI9)Y:[=85_Q^%N"ELCD6&R%L$]Q@94#WAB722
M+F7LN%Y)4;=B;^JZYU'%<CDQ@B4ZOLWG%[RT"[P6Q:U?*TY3(U7<N$?G9=8H
M3B:N/4]>@VE!Q-8J@;3KGMN&<2#P8Y5/N.JZ:5Q[L5-K 4S#-%0E^#!O>['+
M#Q\4Q4WE.KV$IF/:*:NETHUW1M.2U358JSY/((Q#M5R8)S?'E<K]U"JE"#^Z
M=VZL@H9]0WP*NG^Z&RNMG'<%!.BZQZM_J:'JL)UXYD>6ZBJB=ZZCN*Z2M&=.
M>)T=I^EIME5J&J]3[*>G&*K**\;D.^.H64)5 >;4.6:6[YTE)C$@> ZK"^.5
M4#6*,LAZ5&4KP,KG,W].M3*G5HH:0C!?YD$7&Z%W%>C)\3Q[_HZK.GOSSM\=
MU74>=@\.NT=@CW6.>_M[1U3>^;US>-C9.^YUC[S]+]Y1=W>W>ZBK.N]5/71U
ML;G="MD7Z++0 D;"N6M(UKTCTVE<]E8B95:G+HM6/RO)6=F.(N)?OIBRW^;(
MR#*4<C=3DZ^XO+6V_04J1!54SX@(4/-\>K HZ,'3U_%@G(-Q/422,MW8C-&J
M!)I0\91VR_+M@PM:'<4B:K^*'CYFYY_N%@S^2HNG!#Q,TP /0Q%!(>AG>BGC
M>SB.H?9!_Q"K8KD^#(/;&IJK<U7XP3@9.!D Z9ZGW'CE*EZ09D#DA\"1\5N!
M>33V@64^U#.9E 1+9%;R$JTF?46-P 7XE'L(HO%,U]B#&JU>'(5^(HDD18C_
MJN\:AVK25R@&$*D(C!OFF$MTID%?"ACU_H9!/:3 [ P13QQZ7;I)FK[O7^G(
MGM5_!:7WF!#)A,; TRXX:+: ,.R+_%IN?FQ>^$ ;3IBNFTTF2CC8)*]/EN:B
M,T!P<3\TA>QYE!!"T8TRR@C01V/A(.$%'\(Z?<3E/Y83I"*XFD^V]KGXP;]G
MPU-.^I@KW$)=PG\*SV?.AW[*X!;N'J#_I+PP'%F>V2=#@H YQ]W[<#/;S3SG
M#HTXO2I&]9%2U+JIICP#_-&4H;4#V70RQGTWF3H,1\%L#(M.(U:N ^<AT707
MDQU/>S"5VFIB8T\96<_'2+575(_#?B)4/LTQ)$7-;MAK[;G1XA%JU&7!TKEC
MS?>HF=\'*)7C<6"'R\:AP=6OV96D%37;J55L:N+3$W5Z=6AKK9"(J"#EU0*A
MU7.[)5+A"(71WK+G+IMPL66;5G**U447MF.]\IB PV8.(W+*X2V\]\R(Q]LO
MO47YU#.C%VV11$@6JC56EB@*"7MSU&V5,I*@C4^U1/@*&KY8I2Y2E(\R(OCF
M.2)XA_<7Q=X7M "SS#&\Z"E5IUTK=3L@;#"YD+"<I',9UZ>O'3%]2'$'(VP5
M37$H+OG!8(NVC9Q#C,$P["P"PHR_%,UEW:3TL9U)F=MX'0OBU87%5W2H+VCG
MJ0NNXX2 8WP=APM02W(1+V\7S$\FU)@#RPW"=_K5ES"9"H[2M8BEK&&T6V89
M%*B?'R-KR9AXF9CCG$HZ7JY(Q1A^&HS%B.<8;\0)T*H$G;\(?5/ YA(A&48[
M?8OS2S)F1)+"PSL-8TH83U,0NF@J_-UXPR+"F#$T6'! 1H=*<2LR#:E7L<$]
MB,8&@X)5/C^&65%=1)'!"?D62@C)-Q/+&4+*4#A=L#\SJG=5"6^RP0+2[=2T
M'0:"K3A4_S$Y)#(UI&90LZ0!T0"L^9+X.=.?SF #!MXT@?][N7%CHK:;JBE.
M7)C6@@65=*KH;%B0.)=W%;X>!7\L&"8)ME68CW\4[@[!-R_ *M9!(]=UXW6*
MDOU4U-/HXFG7 *.Q:2%?N48'B >A-E8]S*(OJEJ'#:]G%28[ >MV2^-L"K7F
M;&5P!I,(BQW&)T,%97$_S:76N\.-6X!;=?9M(0:X=N,:3IZ_XH#SE3HCBG_:
M;E5<1/XM>ZAV9GQI/U5Y-R:HF?0%%'2I7!Z?P53G>'M(3 +='>*7"NP)LV6.
MI=,!WU^(*O.M-AOP>%U9I^O@Z0MY\$,HK33$=Z(^@FLA(MX&^0/",^#PZ%)6
M9T<ZVAQR8#L'4ITCEQ/Z&DZ7%[NNBUL.VKU;O&VVFX1? ?-[7]!L6:*AW?L7
M?ZH$C=E>7<Z"+:/@0X*CJ9!3]R<<F_B4FV%S/8WE7-.O=&L0Z98R=#B'AMO!
M5'VA^:C-6XG:V"T_Y5AP26&<>!U>^&DH!DFJ(<-_:NH8RS1!,@809@K)<9L7
MUT!IMZR]7<8_](VS/<#L1AB?<I0#B]2E>"Q4W MP?H67XEH'D!+L\R$L%?ZX
M9[GCQF5F9]4XJNU6P5,%E8N!$3*;:MQ52\X7IV0:5\'O6)K:+>D!J_)@9(K)
M/Z0C;,%NH3P;J)385C-6.DDJ\^W@#99Y25K67'C?R&3$1FWQ.+SD<?U7,)E^
MA".WX>WN;B.<#N]$++]6&2RJX[: F!(D&N@33F$6FI+%5E;!3[8H#%FZ3AO?
ML?>X8]7]IJT=T@=6;94$ .&$8UP0 U+<MD8'ARCHYI0"<SVN"O;Q<72_'F#,
M:IYF$=0E.[51? XVG7*-BBAF'-:9PJ135:I22A+!QS3#J70N\2L'4ZQZ4%>6
M"M_ZB@2?KDBY>A56#@>;S3@[0!$0HUNJ+T2GW(A;&SC!-OLPW"3^Y;M^ORQI
M@;I?1ZAEG^PAMUOF$K?&] 3C<6^?XW%WJ)D^H&9:T,2^,<[?;T$<_QD91S53
M5/17\%BK7%/]W -45MK34]D9!L%I/=%N\2=4#-2_5,:E\D!4Z$/0NPR$F1,1
M;(8ZEL)K<J5CK31J;5'>B .Q4C3<#X155+M57"J.R*I&:K@&^($5B[.Z$_'7
MA-ZQ:G/*@0/A4V&^N.*KG;))?*1!J3<AH(/UJ@)3L6O=X=$BH?D<)3,,VZB[
MBAAZZ XT(0H5\5-8.PPDI.AV%B]?"IQ4$>E:'JI-IXM7)!C7_50BOGZI?E.P
M/Q;61S]JJ)ZE+EM\$L\ASPJ;:H/:;6DREQ/OJ%TQH2KH5/7$ .[".!!:)Y*(
MT%D 8?+)DW7[>G38C(2M8EAWZJD+@4ZX+;V0?F$EFQ"]X3KX(I709>W#$5\'
M&T>EB6/"&J-42#=$ 6[/;H_"S.H9PUL^6IY63-#?D;.8[99Z:&1G5L!L9$8:
MB:*0/$A_#PPYT\CP/\*?@<D&$Z2$V*O($]8A;NX- 0/1([G*N2-:V?.0E5P!
MP2HE?\;;&1FKT+S?K_3&*3YO&<T5/[0,X@;4?KCN'<^Q\VO [R9U86J3]76&
M;?8&S!N]](7G<[Q-@)[D=9YSI(<=-8,@+Y%%E21W36G'@(T50C.I)794@06.
MB.(1EIXYE<RE)U.57[V)36W7EK*Q[[GAX)6NH*L?!>1L"")*!4T3XL! 6 5^
M9&ZJ)%5E>E02QWQBOUFJR(1Z:E011^.1X#*V4FY^@4E< (QT(+%7+U<6*B/#
M\@\%^U[Y0BK;TIM-E7-ZORU_JMW2Z!LE/A2/C3*GJ!;>P&./;!-ZJDQH@WH)
M+$EGE)&ESO Q1'J+[93P? Q*>E:/?\&X?6S:C'<TWWG#\#P<)U,%EL%8"Z:V
M8<C_YV1Q!1T,VCQ-.&?.O_\2H=%;G33'XXN-D^]PH9J/W&Z^1 >II-,:=(HZ
MJG\EVS^%UM1_,"TA4?PRNP;LFXI'**H-/#U16&SH7D@_H0%1;(VN]8>%_">]
M 3= Y772C+-3J.*LSR"%%6CI"$MS"C* #^7)M5O5H.G<BN0KU)E?U>"5\--R
M%ZW5V/KKA=(S7QUG-,#.*(!'.V2GW<QWZ(G\+2Z"H_L1H^?HQZJOE;.=E34:
M/D^Z^E(O@=T4NKBHM38>;?3IW7/TZ;:=YN-*E1-E\UV2J S@\6T$#UCC537V
M^ V\I.01<P ]ZIMW#^SQ;A/7TV[5 7LL( ^5_M/[%)Y'526H,<L#:?5L*QS-
MR:51/Z5<TT)[$Q5>#,MX%HQ'.!RX1U3R46H'E'DOX]&I24X"D1Q(HCMT8(3U
MEYNRD!UQ@1?GNO"^V%#9^JKP8E?J2C?;KHA^[,<*?;@@H,,Y X1)GK(#::AY
MZ8BT6PKI;9*M5\ C-G A@U]6$ L!- _UL8R38EY+PYM5$R\;A6_/-:H!=&_,
M]7UANV\XF*IUKQ_+_5N*8<D,LA$3A0U1OCPF8"F+*/^VCZVPF<W#NE*E -<'
M*55*[6.IAB"*R:;WC:-Y5<F=,Q\GPN"VC,>"" 6J0*2/5)YR$_/UBA+,J[VY
M3N.)68PL650E,4TRO+A4Q!R_2^TU[3]S+(4SX]C#G?S40(&%2I4S#^%PCRIC
M3,HY\$T3!THX<+L%U3">NEF8NI2*6@15G>(O3'\2I"J-,FF RX>Z@$>I([]9
M&+]:C,5182>0=!V"IB&9ETB+5B*?56FC)6\#>A+?4!8)(YXSO&54Y4E5?;6Z
M>DHW,^,$T&TS,#2W.*=6RLRY]LRQOCED]^JR=UH5_9J_4WBZSHA KF\2&R;S
MP570;HW_ BMBA* ,527@Z\1'YKNT3_9FV'F/BJ1.#>^&"<TYK'9J0P6GR*=!
MAZ+-/-W"?J8 =$KYJ9+;E \O:/EGX?)+.M DAXIK6UC:2DG2MVL]56=-BJGZ
M$"PTAN[W7CY;MXT/56G"4K9/['$RX@+1P]LY6K^X_OJA5OT*T[92; ^3M"!]
MN:I2=M[T;NZ;[OV,1U>,<$O $V4+'C ;89X )0T1UR;V*?7+5B4*L?68P",W
M5Z%'.0\J!E$Q'8"X+J:VMX*G-LRIN)5O,(Q7O\;S[%:5^ (16G8=VBUG(=SA
M#RN6P<9R+[\,;*#0]&UHO"S)NB):%*].&K4J!VN8(EO(!0HC L%G9NDZ!SU/
M]4A/Q 5"WF:-,(/'@-!%6%<TA*L+*_S%F2;:BK,TF9TRSG@\BT^S1PR$>O\<
MBKI5U?*/XY>:4(7NP9,19GI -V!2ZB]H?H&'A ILL3R-0U$7H=V'JD+-OMUX
M-<? RIT&N4[C(,I!4I'V<!;.5Q:YIHPIS,0AA%'3P82OX9"YWLC!VT$W#,U\
MZDBDK'IJ7I,1J".U6C$4AM# ]?*C%)O(M"-;'[I*W!XP%"83DG=0S"/ZM>KJ
M4:0PZJ3P"%CC3:8K>D!7[7A=ZA%4HEZ-)2LRX1DKN]VJ-;,5M:]]G:S9#'%.
MNK[@O[&7(W&YA-F;Y)*1L-H5)=/9AN*O3'JGZC *)JW>QW6"#TG,W.F8K)YE
MW*6% JH%R]RL;@-;/>$HO&9+4W8+)HGD'TW8QG&EL2?FLHZ6"" !J4*&X20V
MQ#(+0E-5":LF9IGPXIO<X#C*I&ZPG'A,M&16Y1V=Q@I4LL8ED00DT$V"+/'#
M!^414O8A?[MTFJ/V8X[/7V(A,[8FK2)XJTS$<TC.Q4;!5^-4BOJ74**'517G
M4:J<7P+SEB*!H545WHD'T7B,' !Z^ZS:]"LL)Z<.*M=S>>0_^%""_E$D<[&W
MUK$ ';+,WM56>>VS]8CB.KN S?H15E4\M5NWC%:Z,;*".+E.MK==H+DK2>%/
M9&_AHN,XF(3<% <1BA$*T=;+EYN:%L 7JF(#3=PV3$+,5%Q\O&3J,&<W#E@H
M#>-6X4U;]IN(,<M 2X]R82_:EDJEP2POOLMA[H*OVE7WA9=M?OA@O\QY@Z$1
M:QP:0UQ42Y%T'B@DH2H#7?BKHS!_L3\:R?>E#Z..FU M,<<XEBAH4J8= ]V'
M1FFZK+TV\\<23]61;7)GI?R<:>$4)4\AP'WMX#8#,=D6,E/G0-F]K+_.E5>I
MK0<@B<0J<QB>8N @P:KR[1+0#3?^FXE@- C@,C%6W7"C>%>]I@YW<VQ2.0J*
MNC/DCHY3!!-0LW<Q=QSX7S72K\A?I8*$\/7!.(K!MAI[.5X@F1-G)"A9))5]
M-6F\JTU)(RN6*56^085>NZ4NP"42Q/.G::)C3NQ9F=.DT+'#-W=>(/OL6Y#^
MX&!A1_@$]&:5?CX/E?9Z8VNIY52\D4@[AM4B5UI<_RG6&WYX#K/=-A[3TE8*
MB,HN0::ZZ5D)K2A3HE?69Q-U>K J.$TFB5;MBY#-^E3-30?=6",47"TS7N^:
MP[4U $8<+!7P9F/S:N?_JKKUIL?_WLOQYD.COU+ C6(<"[#1QM$MA0N.JU"O
M1>PBMT:[ GBQNC^00B0N!"T^&,PB3/QF9&2/$[/8;BT)6C1U$',QBU6PZ@60
MQ=(T;@AKTQ2J%?@V'I[5W_.^L':+!W6;D;T;>R5$(G<DLEUD&>?/'\(PB='K
M./CIQF'VT+8=SC03%2J5LV1,VFJ4I'(*4.O,#(-%#D_1?@D%; G!EBF*K6'Y
M^G7$J.F0%/$TF<"@D#3-D>V: I*Z^*+O?)/ZO!3B75@9E2;@=F%*,?#2!!0.
M=G*3[FZ@7G?"?CY,\+.-@?2KY-#X>0!:LMP"(B?&=G#=+Q+/[5H/.M\ 9X82
M7RHRYB7$[F]Z!Q@"+\3NF$: 5WHC1V#K7NEH,G?=4<A&14)G334)%U,R@:6C
MVV<XR_+TTF(&=/)-]9:-4C)C9DF5*"_^:Z0[J%9%;BNLM[F'^VY;8_PUYRS=
M7V.,=LOMC'%P<KC]M7-D-<>XS]->ZH<]I[>%LJ]J&EMX3E^+FAV^^\86K[FQ
M1;F;A=.(,] &'V*;A-/T>HTM;/T-UA@A\MV(=&/J^_45>R-44D^Z+<,K*>IL
M1N(;$2,K^DF'QE\!ETMF4&)8^$%HW2QX"1VNF<06\VL5&A'8/;D,J-G5EH\U
MM+/U\CFT<X/E_!U3#Z4(@+;)R^E0[?(2\=I\MV=Q1U.Y8JW?6+*::!;UN84E
MJHAHSFL,X2F3OW+_"$U&65"LY?80SA>D0P3F=6WN4COUAYVCM3ZQ)]6T9_"Z
M@JN_>+DH>GYBXI=F0385_U48^ 5F(U12'$(17>VHZNJM]>OWM-CJ96IZ R9&
M<R^BU%>-X^,Z=GW/&C")8%C-:%\U,%MHVBUK@ R>J[VABDMA2@ST./F?<RGX
M+9&K8>%?-&99TV4)^JM?V&Y=_8WS^/WG1=BL/JY5T36G0U]59,T"K4B0S>9V
MO#+I?KME E^^3;OOWMWWR,#?N/)Y?5V>\>O9>M<P\I9B.JX]D07N<><NNP']
MN%_@'_<T_;CSACD,Y%RQ>#\4Y+AVB  :13'L"CXM0YP+KWNQ FE1_\]-N&-O
M)ZU_4]E]LP3=MS;1A?=;<X$,HO,(=GF0(GZ,2D:EK@%7_IQ(TPS.P:+G1?Q<
MBB$EDO'Q^D(F<4L'6KR]+I>X]9V*R#Y;-H8Y&T59DDHV:_ M3$TJOM34>)!L
M='M!NU4C>M=;@8JY*P9UDTOS35"_09)T8B6KNQP;]\<IFOH%U%WF=51PLLJ"
MQ"[DT2#"51O1MV&*9XH)%-8L&UT6+!T*(2H>AI,IZ#CX[8'XQ-)W5UJ*<&1'
M]Q*YUKLTY<.W""[+'%EXU,NB$;\ .WH3"S:69F!C3R8P41455IYFN8[WM97Q
M:"!:1$W2/)D3ZJ<D>+'<'Q2I5XIUHXXPTMV*JGCK($I!W# "Q# VC%\C.LCZ
M6,8\D- J,X=C=$*%%=0"JK=Y!VDTD+P_;<Y,NFWUL:(37$@J2;'VA*GH3)<7
MQ TD:<HM9#2YDMRFVFX,>0!1;AS6 382PW_R]L_=7!-=86O++HG0[U1_,KQ.
MU1Z'3[*B[;GF;REI(^#U!-!PJ**A(G&X-]\Y)!JI7@(F@-O9_G-O__MN=^>/
M+O= [OQQV(7_//[:.?8-$GK_^"M\&3[<@__3];K_@S'BHW9KZ2[*1P?=[=Z7
MWG9G=_=O;WL??M#;Z^YXO3UR3DTG:!R?C^\X['H=^'][^U[Q'?N'U:_H]FB0
M,C9X.'RQ]^U@M]?=\0T@VTQ]9Q]^OK=_#"^ ,>WO^1SJ?K1AL<WGL-C-PF)'
M7T$ZO:^=OT3LOG5W4,) 1D&@0'Z/0=A02/XNB*0ED7^30#G"?M0]]K[L'QY_
MK1-V/#-KV\J,A!'P89M_M'SO^]<N?:]SV#OJ[?WA??Z[W=H_Z![*D+YXNYWO
M.#)ZVO?>4=>' 6SOGNS@E[_#6=&S.MY7YZ1PL+YU\:S "#[W=GLP-WC:E][Q
M'IPNG)'7\0YH,B>[G4-4*0?[1UW\S@F^:_^0-,7!X3Z]A([M;N_/[F[OZ_[^
M#CY]>_\;OJ#7V?6.P'O I\*G^*/#_;\[N_ ^^/'.R3;H(=0$J!(^_ZV.-RSL
M3N]H>[?3@UUJMS[_+5I@0VF#;YT_Z7C/VRM4<E4OA.6!;?C<M88(<D[:"G=_
M>_]D[_B0EJ.S_;77!7G!CZW%..KLPLMWX2^[9J/DU[T]D/7>S@E,VWK0]LDW
M^.5Q[R_41<=?#_=/_OBZ?\*C@^-RV#O>/_S;5MQ?3@[QJ6!%S-'@:C'@)[04
MO3^^\D[@UH-0]6AC9;=Q<'_V4,I<X6 )A17^JW=X?-)5FW0,:WC4V6;A1(W>
M!1GJ''?IJX4O@*Z%"<(>',E0CF%U87'A)@%A.X;!HQ#2R=)#[!P=P4]VY+R5
MA@L3KQTO;6GW#UQ06#60KL_?>D='-%"26_@-R2ANDX]R='S8^WR" _5!;@[_
M[![C&5%GQY$"%B*<U5\\DN))JI9?/-4BVSQ!'(,SJ[]I:-^_]K9!4<ACD<KC
MBCONXVS_+6/AW>?(TI$'N@%>\:VSMTU[V,-E_@PZ6?3+R=X.7?'P<GH>;I>W
M9E2&TEM_@;+:_ZN[!R?H:'W=UQ>\HSQW>TIGP##,%(J+A5O80;T*2RU;A$,[
MH3NY0[N TSC9_HJF1N6&WN9F-NYJ48.ACK)MVZT>N\I5,7O'ZQ!70RK@SZ/P
MHH[P9EZ G2GC,9!+%O'0^4-DAE+B]ZY"S%?B*]0?%C1]JHTA!YD5 M=E%S *
M]-F<CK&J(P;E::98ESZ+)9L19#]XFD0B)C12.G$AN$'X9T;)$ Z\I991?1[:
MO%,P^D&8QJKNXBH+[G"U6I4<-UJZNE<5$,2X8D,<X=!JRDRP&0H3RG:'&/$?
M<#X:72SE]E6.L"+&3@/F4M8B/LB2Y7:+PP<P.BW32#0T/4,(P\ 4_F#>,HVP
M^0 !==DIEI"R+OB;,/Q-GPEL:!!,R8'$;,YY,)Z)\%+%6/:#UW8"3\XE@D[C
M4E^Y\3R;=A _5 (#EXQ?./&H\"<(6RZ<>#%!4:B@$3N\#2E)8<,+$46((7@!
M.605''VWTI/O-H!6?\W;I3L"6NE;E #MS4K)&T8@'7#RJ!/'R0R$VU"D2[&;
MCG8C=!01XWC@A"O2;HS#60YIHLOI?.Y&DJNL#>V^M(L(L,@WF OZ%U?)96;E
MP0;68+T9'5MY4\[P/WQ5AD7'N%R>TC3.V(M]WLHG?'[6XLW&!Z8!26UND+^T
MBX?Y=1TRHII3RGVU6QE&G_GMI)TY)4:?@M92T32+%(K[Z' 7H63&(5*&8RJ,
MNZ2:-%LB)VPD=(7]6@1G9&^=G1]R%G=HT*]EBCNGU;%++< /J;[$,;VQ=-*-
M4P0Z5?]H@S-;S\&9.U1>6YRB2$GJX"J944LG146P1+=QN;:MF+Q?/I""A+"!
M$)7VLN^!19@SH4E(IA<V9%9$%R;V;$IC!("-%B$>0^NAZF#8R!DFGAGRV-'\
M&6A^Q )(T-0*6= _8<\U%B.]"3M *;R*8Q%&6%!%1QS-+WHIZ?A%QJBVJ =!
MBNE$I:QFZ33)0N54Y):JLKA.T""OZ:4^1[4X1=")Z5R#"Z<PWTB9Z9!HMENF
M3YC='@S?IWN9U5%].%!+FYNH"(:7SE>J,S-E*4'$T(&)A25?C5(_4%43+*SR
M[X,)]V(V557^&3?AOC3<FHH(VAHA'.\K)>(;\XK?,("M0#(F1BQ8HE,$H*T)
MRAGO%4[<PAV+DBBU!2,XK.W6VAM9?Z><85U0X-HG0 ]P:CN4BA)L+C,1]KQQ
M!ZE+(%A]J,N7NJHQ6D.*_BRKN()0K9[SZMW<TE%<DM$,7-/L#"Y<71!9]09;
MC#''?BK]3 @3HG_IUKBH64AWNB4GT[0[](812=^0PR5E$*RD"9OLD+J7Y+C6
M&IY?\"=#KT=7"*N[W1#=.*T/N]D@32[LC:>J9,;A"'Q7)=%W KF^P+-#D<QI
M,&1=!2-X*"C#B+/%N%?S.(XH'1K9[(AB "Y%9,(_4?I*AX_82,TQ":]UMWV$
M&%-'APE-8U-]3;>:7'"AG7=F&QKE$/;TQB,KF/&8C$8V9(O8D:K&TEF6ZUKW
M?AB'HRAW@<Y4;YN%4JL]5/5W=J>TBMZ(])ZKSZ+=<J8A"RCT5Y=S&)DOSH(\
M2\)S'K ]2W+GZ#&$6J#;C,G11R-&IE'YB:?Z\+*(*<IKJV7:;>VN+$N[=;O;
M.[W*_>)=]WJY_M9:P</**2@=S-N&84PD(+)W4HQB(YH=%L4-[WI;$PYJMN;Z
M&T/^+@(<1P6P)Q_KBR@-#0$Z V(I,&R/;!CF031&AQ<KX6M#>ZH>)]-QX.&M
M[A-/J(E+IO\0+QF10419S3.M*!!I4R2J.JM%-Y,#_;,O%2-&H@ROHL;=^\YN
MX71C25_B7B@-'?4X**-[5^-@3D>UH]**LU;CR"IV5.5Y:A>AWX[>L.UFTA*1
M$?#,21^9X2M.XUN_3^R(NUYS5&EUXG0+EE3-;;",QL3^5%4J,TS3) Z36:VN
M+!0^/<I@W:OG8-UM<_KTB.A$<1YF-^8\G'LR:U@/;=[I&K]&+@K';U_:",3&
M$TBW\^JE"O,$XS >!JDW1-8$UPQ<,! I$;)8UI?42-?FB%SWU2\X%;#XATB_
M9(6==*<\6Y_2T N91%$77.I%=$N*7%<45'$Q= [1IGZP@ #%ZYXR_\O?(3>F
MU<3;4S7%VBC962 N(!D&+<'5J.DEY3>BN-@FP)8]S(R?AT(,<CL;4@I2+LIL
MO5X;X"?%%FO7/L!+F$FRO%H@F6V]GV'@&CG@95[%)FW6"!VZ=UY8_VJ&Q8V%
MPAA6_1#K>3 P;:B&RXK'G!0*4Y>G2_1D[E.Z/^7?*GW^A9M.FBB[U;5RJ1VK
M$2&2P*+H+ HAD^Q0")F+ _IH=81LV(J17M4WJZ0*T08_V3C:T"@#6 ;LG($
M SU1^3&J$ZH]X,,T5;M8("[;#2YXL:@6_3R)AHK-?)C,^KE?!#+ "TS3 TY?
MEK_!1$NJHSI+I08_W%JC@W>PJG,H0]<=P;,7? D%<EL7KO8K8 2G5-1ELDU.
MEF>A]MG<-/TU;A=6<ZT.J!V8$[DT4B]S=6U*T]&+0^=*NZ62U%]"0\*Y>)&8
M!:<J-<WRQ<KY!S;N7C/,5IJ[JW02U@O9*21!<%P$+%$';W^($ 1$=VB**EU\
MPPZ>.'!!)H&N<7@>L (+0VEGA6DW$DA3"&7WG<$2/SSN-_1]$%5B=Z^RRA]I
M;)>4%C4<_'I<-AO6&DU*_4D@<&K/##O6&0P>;+ZJT)^AYM+]0D0?K#?42[9#
M]BHH4II!X%%_GREY@?%L@O6@W+Z4"O)0Y1ZD2'%^B%];JZ)'^XZ"? 1:!O[P
M[V264CUH-\#V7;'7Y12U70J/)#33&=>Q$S5:!C\:P,@,19,JV]I1+QV&(V)-
MZX=@/Z_[<GI VN"N@H=$6"4/IO9@-E:=D2AB$V11QFFYA=+TZNV;%V"C*U&Z
M# .DZHGI*IW%=%.I#DS%&TL?7M[BB:X5) %?YHH,UADDM/B;??EF'YM*,^04
MHUJ;+RN%CX)MV E&DSH@9SKLKX;[*>X)%9)6!I*V.&+R]YFVR.B'XDP+?::6
MR2SWEYSSVRM\<[#T-X=+?O.]O)T@2XN_/"AOSP4(R%;E[KC>(-5R.FN/=(L8
M&+7:C1(@92A::C"F"+LE?JS"0<5) PW$\UE'"<?&[3/6RSX*F4Y)&E+3([_@
M@X@I461R1C'0VL12YXOE..15#:1U(!E*- (XR]26<*E#NSAM0*'G,3G]W@V/
M9^,@""(C^!808D;9JH:V68.*&DQB.T$3E!DMFR MIT(,('!+U3LRF>#UNTS"
MV=5 V%;;YP[AE^@Z306CY./]0N03/K?<QIL!5HLS6*9'\QIW^\C$/:;:8/J>
MX:]U>RBOSVERZW"V(<$;M2$Q5<?E;?*6HK"\6H>BJS:"6MBBR!KC=;L5%?C$
M%6K55]8#%B.P&_!80\6OGT/%-RNZY7LLJ[K(YF*;K3R#&ZW5!')"!G\I,";X
M6RVA'-VLY6/J%S)DN<)(:UJ==HMO3?M3>23#-ZH>ZI3B+*4)UGZJB/)\DDF3
MJZYAE"03HT(?T:)?RDOFZ)V_C<YHMZ[9&NW_W;O>L8&"_5GNQO!1.J(%" XV
MI7EIP4DE7@[P6Q7.OTBV8=$N!=JHP6MF4$@@$_?[$ON_]+;S,VLV/ZC;^67&
M(*'H2K&P;J$K"L/]R4 !C$G,686V +GP MOQ\@TAA+AGK,;WA4+IR*1)J91;
MW)H.CH*V1KM8&T*U:@K3^V6#9UWGJ<?(T4?;R]%.DJ_%&JE& ;F[X]#PS;?0
MWV^\9:=KZ0WUCG (\HW2ZQ9Y!/I]H)(Q-C1(HW[(B8<"V(BG6K7FM6M06C[?
M*.6KKX@D"RP ;T4K#)5#,7V/W0 '5V,);N__9"SSY\TY+NK)0H6T1A<*\H(.
MM^PW*"@3O\?KM1A?F2^^=?<9.L@.L=$%<;:Y"&9>;@PZ:G'EUD!Q#K.;B6ZQ
MME%B@.;U3B//JER&S2%9W-R"X;(DYE%GHP=XJ>BXXIR39ULQ]BDAQUYPZ"8_
M2,T.L7Z ZNBJGKSA]<@2BUD&#7.@:J1M$"-!S(H"@W?\&*,/;N@"W>C.:;=N
MX=*9WSNI<-]DU!*""_W *$V0$G(&QNS8?@&R6DWS,H?W&G6Q='BG?%.K=V/<
M611FZ[['H7<5E*(:)Y8"E;..XID*/)A*AVT\+,G8.SJ+1FZG*7<R^)!OP3],
MZ/<U&<-=< L=)Z\%1?DNI9/$IJ_A&%?*2KW184G8%&N9U*KT!'N7><>@*\C,
M4SHC8_DK)_RBF)P35#.@<B]5LY:B1BER+=3F"3>W-EYA6*:^0(2@+FX<LCRL
M8RL,0A'YVHMZ?G%=Y9RM1O+NV%]M;-5G./UE=:48-YA#D%%CVH=/HBPW=MVD
M*E=8<WC]NM/2+:Q<<8E=P,*DR-Q+.Q6##YA'!'Q%K@CL0LQ&E+"\6GVM%:*T
MO!I+;3<A]53W'OP&U7:)WQ$B'B!#':_>:W"UJI\R#'QP%B?CY-0F?! \#>:V
M:'E]U%@8-2,D*+Z+"^>8?1'AL@2&FG#Y4'F@U!2GL$S\P21!6&UPGJ2\7:K;
M"XO.FLR;QY^DZ[9*F2*)NURG\/@QQ=E83.(76'X>,)<M]^NS17!-7Y2:=M<*
MDZ."Z!CB/RM2[@@XT9^;$)Y0#KK-%O!J85$K]ZY52[1&&ZV1 ?T0QVPE4VS
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MG%[R=5 F#1&3.#10'3M9*4P&5:,MQ'?PU3<7N;G^[#WM?H3]@*^Q^P;B:$N
MV2YLNHA%1.=UDH"U\5H42 O=TCDN<&(1B;*ZUF^(U'!B_"4@ _/V:H1UP:2@
M X.72C^$ 8X>=:>5#\^QO06G\HJ81R5 BDC6 F61S/$Q,H 'MK-T&SGJJQ4-
M;^\RM-F>Y@3)U>&Y2-JMZMYJJE_')/BA#Y#2!\KL59 SW=A1!6?PK_% T\&5
M>K*A[7I-T)'/N8FY1]4S)[5^?X3/9OD-,H-[N+5=RZ&7E@?-/*+:KH7H)>IJ
M]L#@2S>N[5H"O:24U,.J[7KOD'7<.W^]AF2_V*$8GH1^"T$X_<=?MSGHMC!,
ML4&;5=)LOMW'3XP2R@SHY 2+@X.VNZJLO"\P$?H,%E)TG#H^$AASW%>!=!T&
MJXU5W$*X!-,"!J!_XSX)Q;8]@5<9C[5@\_6($_DE<>BK)E#R ,';!Z8B&I]B
MSH+*A50OG1HF7#=/)O+DF<"3%9*H=\%]#2ZJ0NU0S;AR8LRV\,U91]+77$ +
M4R'7BVAIFG'),MUO(Y'UJL#'E4)HC!=I!L%3A.U</T;OJ\ 8;48_#/2RZQ $
MYP#C2Q,EY K=JC!A=7I4AYX:C1=ZMQ$NY%U_5/%"[^;A0BP5JX\7SCDV&PNC
M-G72<@NA&Z\B<G,;Z;X''KJI]@=9<!^=PU[3"WT)?[W=>F0.>^6&7,?YUOUD
M'H+W?2^U0QBDO37O^[&&.U^]? YWWJRD^]%6C2&K:<-QEX=9-?;>X=2Y5\#'
M<-V@0HVJ5^.CBT'^D7F?-0CRD+%9%5!98CJGM+<B<*&[1K:*^'%^(-N(3?&"
MZ"LIG]:&-,'O@PQE!^O6UE[)_;H=C,&+"U+O;W "LH+-YOP1W\9 =?C3)3Z:
M1X-<^"RMB"]$:2V#.^%F!:G/0[Z)1MSA$G\F^I@$GPN(5<\V<Z"0F5P+2'VS
M-)7Y'$5(Z8)L"E%,Q/7TK8IJ*EU#!5Y6AA=(L:V>)>H9PO<X%( Q!3[F8*.Z
ME)+%1<^BG][:6UGI"<C-6<9G5W@/R(1T&]?K&(=)NQ2/5AGN)88TV8CZV\H*
M$?\'C6$L!!/?W-T?4Q[BL*& 51*-./C FSL@KZ$J2((F>:SAA.):+-PS1XOJ
MWF[4:%<ACPFW0+5.9C,U;L51'.9)!6B@;A1$RLY5ULL,<\/K5#BXO!D$JN6-
M1)5'A61<=E=O^$MEDPEGR4YK_E77C(RY^T)?/>(LF:72(B\N?!7,P@E<5UFU
M/BZ8A!-%^P#>8%3%7F C1A5[J;;C5?"-) *5G4N3@>:8S]H+',<1FMXYGDG\
MJ;65L-5]5EDJ'E!89G0E2TO/%7<<0]%1/M4A4.(1(J2D+97_(_>F7SKIRPDK
M 5DSK:1JA.\BR+0A7;S/=/^_=FM^<[U2)1H1-)L81XTYX018RH5$-*3:R_8J
M'20+X[MY@N.FQ1@?R-KI;GM?J+.G7*4'I%NUK=6'PX$ 6R?P6@*[ZZW4<6Q\
MKM(5\)\[FL2..38Q5*GHYK9M8>]9.DL,0U9K$H13[=?4 ]P+:ZS*!SF4#B88
M5W2F&CC,W# 5EY%<53R0_++RY62F$F#7=J='W!A5^^J< T_APB(%H;J2M5MR
MIC)MOA96)BF^43FU@<V%8Q4+P@;[7K%%G&Y#RCJU-C(@MZA"4H^QB@-4"K5>
ME_&9[=_0A?USYCY(N!$/&2.G"0P2O'],*VNPG#TW>#$K,E?;Y3#5O+9EK[V$
MA0W4Z$O[)>4./IEM KIZ-A:W?Q@,\JM*)BO**%;$!@(R=CJ@BA3-8MH>.PH_
M/(\ROIM5YW(3;ZD=1"'>9U?DPX-V@XL-)#G"5<QRF)OFX $'E5C?L$UO>4<#
M=T_)<HH3JX42 0-%R@.6<\XVP(=3,)=@UO($.O^.D.L&L^0A4GSS_V_O6YO;
M1K(LORM"_P'1NS,A1L!JRV6[7.7>BJ%EVJ4N6?)*<KGK(TB"$JHH0@.0LC4;
M^]\W[ROS9B)!@M:#]HXW8J?+(@GDX^;-^SSG9HUB]I_0&FG<1/;-2?N+"^E+
M!62^*]E$S"%-S,;-1KE-4?LZP2I"5!\K),+<S4HD5JL446/HC')$;)Z-+AC,
M DBG+XHAIN92#F+Q3/7D4NQ5POR5QF3 *[W*KXMR4?N+ 7BC*"1,XDUC^=(6
M ]P59X#BUIK+P8B(J\@N_?=PXG7C_8A[CV%VVKL^S/%^8/@.3N]';D9E0"%.
M12 YW3MM?MK=B] $&FLHM1U&#?_$]W\X\:DA93$]@DMN4]\U)X']QL0@'Q!C
M0674%K+X,O/M,:.P7I;C8E*,,LE&:)N2G^>6\-MM?/YA[WNT\#Z/X!X<D+/L
M,T Z FS?)IF-8_3>#K4(=+(1;.X-3HWC3^H3)?UJ4I6(ITL':L;*_YU1M?4<
M@O'R25'K+C8'*%(RR=9%.25H8[_3A,Z89[-%FY19"=2^AV4NZL7TQF8SJ:KI
MV@C!F')_,W.=G8#YN(#\3'4-7O:.;0P[.#E5;9D0UKE<G>+Z^.BG74EN/?QN
M#J$,GE26RY0;FTA,IIK- ;?ZB5Y\=EWF1BSY!E,IK3#[ C?#*$^#KXDON;W5
MB" P\6[+NUW   Q\]$%I"!0VY-P]_IHJ7_#'^=0Z/I8'^2TDR1!_%X!2%^8V
MP<J.R$7O+])N,B! 9J0;9C'L0#JZM[=S+DQ)4/&"\[2C*RLW:HEB6H<;S?Y\
M;/M S 4*AHYM #DS;G7-8)O.93+C,P8J+!I:/SI^(%'V!P]GCWK;6S&[6U7X
M.!\'O0:<,Z(X$:B2M:(T0IJ_0ZE=J ^[I[O))!\;QXMCRNZ+0+Y-T&N #C-%
M<9:%78IJ@ -4V/9@\+@-H#YXX"R5DBPT?5NW*$OJ;)JWVAC> *R)$S=,Z*@E
M.]WMJR>[>]("VS#3>N2M-</<K+P;0T5?W*PBK"YTE[D)^QCO2O&RHD$S#-Y5
M7!5J7GY<..;Q-C$\#B8D-G"38#$)",D-RHA162UGWH6KS=PT,[(*F72P]??V
MK+&__*M[CW>?VM;QH![$Q0E"U P.-)=\:DH)8](,<?7;6)T8A0*,80S[S-?P
M8&A6C-K5:5J;29-%3ZRR3T!N/\PP27\*1[^VBL'XA0"WYRL >[Y165ON"5;-
M'3*T$#J?SSLG%59D5C.+1><TH)23>LY5X]*(GV+0/)@-G6B13VF;W5GU>#=X
M[GIB;CJN,&:]B0U;U$_+1.#5<#-3Y2B/:%1.'26T B!HULALPG;.>\GQ*ON4
M.C:K<G%N83-:\H(0N$<<#'W_@>WFE?SZJ-[(XX:),%'>3B QA@78X42SXK*N
MR@@^.4T^*AL,3-RX02=.MF=F++.O[2F#=W0VG5,QG:FCT__I4BR9#D]_\6IP
M]&@0HG<#<8.U3@#A<Y9/7$N#F6&YP#(.<_U1')"^AUJ9M2\D5HK)#1.@F[__
M5UZ5K@3U\;_U/$O7W0%AF->[%@6HPFV%JS*/&AV@VHHO6?87!^_^D/6PN?L,
MR=Q]6@&_H,QQ>U2T7W S<R /HWH \,K?P'M.V6CK;*T9H!T=9M;,/3E"/3\K
MO875H>&NZYMT7MYD!U- BJS%HM)")KRLK [7$\5%A'PG4Z/P^07[E5N'(TYH
M#Y$.'2G,CEEJT2*XJCTZI=I5;1QD#U*HDYZR'P=F:,2;GW324E[A$T'>V%)3
M]]DW&R)[\CU$=KN"NNZW5.<;1#2%G^9;(<^IOM2B%UX84T+:WV90:9V1VC!1
M8-1B# M*/B:N'T?R\JI[RQQ!9<E&KW*GD, "EG)GFQTQSW,T*(V616>8$&AU
M#148@$TWQ\SRR/@@N605H8. ^P:XB0#J<";Z_*.R!@ ^\X]I?DZUX[;=RSQ&
M.AO0]^D^&[YH9"6LBN]@Q]LR(IH,):(JGW>'/D%)148>X_YSA7#<X]#7$8;1
MF.R'(VMF #-JT6&5R5P73%1+-0><E$X9Z9*B76:MX"H)+.%-6+V3MACC3N:E
M=V,8A[WU Y&P(+*IGIL%+592^38/Z9.C)4Q??P#2EH\M"Q]R\^2=QP\#J7I0
M-_^\MRIK7TRVM[K(BS8";>&F7  MCFW4WPXAVV?">N0]Q &24TT*UO89CX+U
M!_S*G.KS6?/U2N-VB+_\($#TZ&"8R1EU,2JF#G]:N?JL5X0_CT'BKK)J[GV1
MVG5=,8)NKC,+.<T^8294J@LJ+O,S_P.!IH*;FHJ**#M[? I#SQ%.$958C,=(
M<)"Y@(,K7D585EM16I>NKF5F'! ^?,UHAP#4*[JJL3OA3-_@Y,3#CX\7\38&
M"1Q%K57YNBVJD&8 -&GL6"\R1%OU=4\=YKVXD($ZBQ[\]%UT.'V=E/6JPR?=
MWYXB7_OT26OPFD=O[2@6'KOA\F.GV[K:SYR-RK#=>*<GSKOWEA\W;6NN>>!T
M*'&M,P=1QZ_FT"7+SMS#VE%%\] 9"4(B/IDI,M)FE /PST=JQ<O6L<DQ\W&&
MC8=35CJ-36*RH$(TFU, .!B;5,@G$/%!>8&V&U7*1"_D>G0!HRNOH#YQ,4.>
M'J\&,F5$B#E!#X\M:ZJS<93QY11,F&CKD('M3NEBOCSAII\SC*_!"K4L2[)D
M58+F&FI0<@YG+AU0-61FT.1#"Y-2.ZZ$SLQU9*Q%UU:?88O))%2R'@N+TGSH
MZ#C*R'QN-!!)QV5N+$\LF97N+_@M!XJ7&%-S*G['-.%E=A,P:S>"/#17S"7,
MW1^"IA)8F)R&Z'X#PH'DN^17V<)[N#FH><FHEL*EBU-2B=,BGP!Y$/6=0L%H
M:703;L@0QH?/[.E'$88$1=2@%PZ</=IPVT\O@^*2?Z@X=*W -HMKM#03]J%Q
M[J26PP V@]+-)?B&R\-^^![[NM/;X,^ 1 [3FPQW;FE7L1?9-J\@U50S\QO@
M@T.T=:UD<,<4-W9QL=EG[!-SCJCYBB(#A"HO 9L_S3^QT0ZLI/%E,8,N42+)
M=:1B4@CBU5_H:P?.,T8,:Q_UA@[F7VR*$@"_7:D=!OD@]"->T"&D6)5.DP.=
M(GP1_C!GUWMJE,*XEU*"P]VY/!;;E,&W52T#<9@7:H/LH&SALBJ!SQ(J(N5K
M9U2>SXSLC'%]I3Q><QZS]5- IHH;C;'!!"NAG35GWQD@ W07B<Y%#S 6;+R?
M%G]!_ 0[,7C%X>('2G7C1XQ \>8S!5P-4\QLF(1#$W\NJJ(V8J,+:ZTZ-;^P
M %HB+E[94/#,%A1C8XB6TX6\ <Q-D=O\<V:K>L?&'(>,^O1&;)E\O/D^IKTG
M#K8MWC6\KPV9$V<C#-B0@;/^S\7XW '*'[ \ 0+2'*PXRU_ID+_!<*# 'MKS
M? O[_8!B*I5X],\YZE2)6:HM+#-2) !W-@P9JM'..Z"VGF5B^[-$C_C$<$,#
MLQUCDEU)NM?:V<2?'(-9+0TE&6&?E18_)-O>DGET*L=!KDA'ST(>BM(W%&'&
M9LC(4CF6"_1^\84MQ.^NV3B[+HNQ8&!!SGJ>ZN"R^*6PD"/M#2L0 ^[\;'4+
MT-*$,GH7.9,-+RPN&C91LLJAPF&?R;&9@.1>KKIU4;&C42.%\91S7((5L<Y&
MYVMTJ&DH"=M;[JIH&Q<267L!UXBH;;[9XP=D?J+$@]G"H^P23>7CZCR;<>>J
MAA.0Z+(T._E KV'[N<6?*>!6W/E!VIC'/FR1RGU(QX^T5. _IG.HC",]G 8;
MMI/Q,S%M9&Y):/\S_I[@)E)F:'YSE5-ODYL6Y89&_,WP0M'?_ K4^5/D_XAR
M,OD-TU]'IP!G*D%[V.SD[:"MT-PCYJD54'ZZ)L8&(>:.=.H.P+O&.40.)0^=
M75V5!09= !BT,F8K%[CFGXVY58,=BS5WB$3Y^2;I1H2Z\@O"<&KVS&S+:!Z4
M+KE.A:YB(S$@*;WVZNC\-77EJ;>&1+NQ&MMMMM6;MR6W5;%%FZN[*C_Q+)P%
MV&FJ=\!RVOOY*Z#"L#$JANZ H"AK[#JU+<%@S3E4K)00>*F0[%.&W32I:J1+
MO:@5@P1>+F:%$+"Z=)JWUEAP$0+,QD+^&E,T'J.ODV>[/Y#]9O[X;/>9A?CE
M?P[U/Y^'_QSY_R2^^!1S;XHQBCU@APWTDOZTZ4VE7:50 .2C>45<#+^LJ/_4
MV%C<C Y+;XW*D+9BF:X(3U7^.1\I-^F&U+_<WE**T;/G'(PUXQ 7]85^M4TG
MK?8\H2QZ1UC8O%(XZ0YE+W'.2,T0:J"V>M8=0C[GL99AQ?>=W!0W4A\*ADU1
MF06@&.\W'-%[^CVB=Y?V71^MB!''X0CVBH[L%QXN:3CJ<MEW4,$[%B\$8U-\
M4_Z71&7\AB&'B%M0IFHAU'/W9XE132IWFVJ3;\:YUCLZR&U8601*!U=@78MM
M-V?628WF0-DM^&EM7)/=1F@A]\ UIS<2.&57E>C A7+-WUMCB$0V-UV]N^GZ
M% 1[3Z6%<2Q1@MM;L-=%_>C?C3R;Q7WYR/PCL& C4R9Q!OI)3YYCY=P$:A-K
MRUMSN@XN.].(74K<R]D]"CHX$V"W&I&HM[>*T#R]TU=!8IPD3L^WF-?Y=*+;
MOY?!H(!HD%TH=0PM [X3,.5XQ8!+Z$^+;%A,"_8R(,[%=L'8?+?<")-GLQ.V
MD\'C&@<[J?BH@D%C2% P1*=SXK>5[L%&Y23PB:J]J%C);(B4!&HA.<H$J6#M
M;'"RO:QTA0J=9="L<NVF+"=I&/X,"E(8'8X]_G& -=4S+D+FG!2'.R*ND?6H
MJ.Q9P:I ,*OK?KKAAQ<#'\E-:..V"TCRCPI^NAZ55WG@92R=L,3WG(].)G7G
MLZ*XZ,T! ,C9K%5@X#ZO4$BPD&N5A#1JEE:)2'(+"8$1Z2T/-%X:/[2N7!G9
M)F?9-+77%9/22VP*C35?1R,BY=V$/(R2?NFN48MRUM;TV3"'<'26&((V,/6W
M+[WS(ZWVR\8]4FAV,T.C7=2Y06_/5F[8.D<>\L"X8W<EN9T78GMKB>1V6H@O
M%][-])';$\#ZO+9)=#_C88DWFNF.+U%O%#NFTCRW-R#P56Z,UI%U]6PC88"9
MV?M28SZ,S!,^<D<*A9!T0LUC\SFM9[ "QZB_//RD$$TLP?  D! )DI=KMQ:^
M@EL[D"A%MFKENBBI$H01;QL8'^A@K@Z!QG]'6I,"NK&FIA23RO)52-_2=QUR
MKXS]! &3Z[6:^G^P$5+[EKKCK?U":DE<KU8C+3[T>Z_0^\BP2 93WI3O!>O4
MI@2Q>@3[MU,I"X:JD/'"9A/CK5\PCJ%ZQJDMCCFA295>9EQCT[2-MD.VOB64
M225;$6P[3WQV:;1O6O(E!"Z[!E&<.R.VO"RSY:!PIWB59X+W0J-5S'(MT27S
MC$Y.C%KD;S9P^NQ[X/1V;<!WKP*2A]8 V-+RY2H@2S[,LEEQ"9BE=(0L@F0#
M6DF9+K?FQ(N OZ>(KV ,(>)WHJ)J1PC9.8<D[H_&$ =M4E91I:/6^NL7!TXB
MW?Y&6&9)/7EZ#\JJ?W)VL'\X2'X_6!;4N0\U"7"7OPZ2_</CTX.CMV@-;+;F
MYODN8G!R%9IM"$E&C(LA)?^M"'!0 VS.AM]OHQ[G=]R@P*.]#PKOLL1Z. [[
M(^UL51J?#RI*;(_XV'7L@K./+MP">J=W*,]:5/J76!\'H/[&JNM) QH"FS/Y
M5G2@"/^A1FM\O^(2:'AG.4$$V&)9+T\5VJTE-6(L;"4%LI%!@1S,F!Q'X1C'
MS[E2DNMH)-@+[2:7"Z:6HQIX# ]\->#)SW>Q[/:] Y0((%!)COISK\)19Z\:
M\!*V$#./=KN%$*O_./C%:+>%<7@.*&3W)@>J,Z:9H]T8PK95++N3O K+,#.H
MQ:8:1F.]6PQ^'HEE;K"W$\94I5LHTIED81ERU_['/Y1\.^ (E9.)W\?$"<^_
MS-9L?%]_2/2AH.V!)=HD,F\@1ERI9.N*8QB6(EA!=YH#^O#X%KQF!D;SHG.>
MC[5"0?,&?F;YMC2;$;U97,TECTG:GF)S$YK/:R.YF^;176/1OVAMY5>O"N*)
M/LV 6\0CH<P)2A0#MZZEV6OG;3%L-I6["02W#5I'P^HP.?2(J3B0!@!O'"AG
MF)@/:);2<#T6Z$">N7T7/0?1V""?RJOKL'*$:L"%1'#/5#6P4;[NZO5WW@5#
M[2_/L;4/T33*L88<E?2;V.?$#M H^[ (]A2F8Z 7--T5^\Q2/ ].NFI3A>(!
MUE:9L['B [;"CXJ9><S0B)IC:I#%KN0_]2I\NF [W,HR=4%:_=(V3!W<F@MM
MB+-JJ)WC,L=;P67D(X/9A$R/FS*]^DKO*-,6-<Z5X-"JE)4?062AW]Y:)?6B
M4CKOK2KR_V^YO3EN;PM"7C?U%4'"M$LHN& ="B(TA-D:D=F]/:;H_(8+$)]_
MCZ/=-5#7,J'NHK^:0FWL(2W5#9"VVPCM P-.O9?L6,!ERCY @W;<N#(S6^=G
M5#&S7Y637KN&^' 6,?VNK#IN<O#LXI)B385'O^KGYN:*&W2U<K(H!BI651M+
MIX:FDK(*V#61':RB"-HG)#(+4MO-05.6UYHQ..\OVM.["6UM(K9U</1Z\.[H
MX,W!?O_LX/CH*XAO_4CQK0/SK,N9HRRR-J67,77(DP5_GVQ%.-O&'J@NL35?
M62*0 .Q/)@B%Q%Y_X4S1HK)2 Z9.R/BY P8 $+$YF!HK?G:\YJA@?M5K7"),
M*6A*SJ 2(>5P P,? <@(%J&T/TW'6:!^0>.@'Y8UM"1EG[(*J#_X'12\PKZT
M,:7I&95QR"4KJJZ@\;K4=DASW+N879?3:RKY.+LH*AG6/H"6F.%4!04?%W/+
MU 919.Q[A<G;0#<,'&XW<DZYG,"N,J.Z9,#+B1!!8^U-L%9;WCA;:>NU5B:@
MAKW7D2V%3M".)JI:-_T98&!HDD'$7+562,-W6>FR^,D:$TE=!RA\]<1R46A2
M.TA=OJ*A,*$$43VC.<R!C=K[!>RU:X?"K2FCP/0N/V[[@@\.#ESQL7$MW.@&
MGYG([I"K6@L^6\>V K=^"2% X:>!*& *?[@H/P%X//W;HC^XEANZ'G)Z/LZ0
MI9V%9^F1T9T">+ ]B=3>Y#"ST$_GE7E!,LO/$3V!@L!P4B>+:7)9U("TL2!T
M5O\4-0>0!BZK!5F;Z*WB("2 3KB4$WO3(B7(M>Z64DG:<A$*H":R$1T0@6S5
M_C&50>W0IX(%-,SI[WXI#[Q74OXNI>[L+\<[OF1SN.6J2[:=\$4%#4[ALW*,
M<&$)[Y:I-(6;&T,T18PK2_2%80GSFEI!J]0,!5:.\C&F,V*]\W1$6&QWB@DJ
M3Y=U \S2'E(6QSB65PE4A\9D8%00J]#N47X9.,-VJQIW0?.E&XYP_TB9BX@Y
M8,>,%H'77+W,*HC$12-& 9XM @ND(U94R5J6 3]^J5E@#92.]D'SF0 #=S_6
M0=OXOP[+8'M+3 /O'N]PJ=[%+=YX9^QECI+"@Q._HD7$*_0++GBSX2MN^&3E
M!1]"F$;N^/NYK-MDRK^I P&!&^Q.;NIVB6Z]IN_A0DY6W<?J#KN+.]EK).[<
MI&.O\+9%ZWXGMVYZRWW,!.0;O) ]I.FEHK,>4LB2^]CB2:]2O]]PG/3'[W'2
M>[22L [@O3L+4.[0N(XW613 Y N$G(KW+9X"N<?C'I&GO6S,ARR8;)5_D;4;
M3$&K@C%"G.766+5F412TV"*K$<- 3?-S95HA?J(;#R74?6(/,@SX6_"I4)+4
M]-3(HVX(+!F>U3U8_>.N@"&NPNHW=K9KY&P.'^>=JLX,Q-)& ^0*9^1WFB#V
MV&QD+2;4:1'KD/EB]#O5/%5D)O9<#F.GB?D+![\S&Z8F4'%S;0/O!& ?C1$-
MWHC92\N2JXT8UXU46QH;!CUNC L-<[A'$-276QHBW[.WJ&OVE=8=J!BCWGVZ
M)9LKWJ4_8>WM9;#2E&&4IJ'I16B);=M10]4K%;E=<F$H@N/E")2JG =>S4UH
M&J"2IG0'-0P1%3C8Z*'TP7SD%"\]NN0BDE 43 $369Z(B")E&!8Q1D(.'3JB
M?A3<H)97HB"JYL14.AV:WY5V'*!",F-D8'.&N4:$,/A:89P02/K;3#@@4#=%
M1"38F% $EI[5]>(RYW3*!!YII\[(U((%NR27XQTWN_P,@TT*A[6,K;N*K$GK
M@\1NQ]I3A$LHXT-WBF79LC/L)!SM:2YOA9:M^$%N,TPGC I"*(&VJ((W!MGG
M:VC"G1&/%GOLPYNV2;9 Q@93TW>L@H8$N2#PRYEQ*^?LWFRH&.M M=?& @NQ
MH]H&BE+E"+*$;MNGF0@C07CB%Q4\9LXA(-F"[2VYP$2&K1' IRUZINRU%Y,(
M0HS.O'JFAIA)?=32:?IEQPK!7:@W@L&G?L- Y+6 \DR'8DR4AR([\B2%?8U1
M-< !,0J?V2NQ?D:M)U94NRVXA1[0J)@P+H#4I \+BO:UBTO8PEI :4 V=C_O
M<1F0,>Q*R!VOO2549>?'JR;X,#M"KIK'-+PL [6.#.&)&@5-_&>\;@GQ=<[A
M'<AS&[-5SJF@P@[S^2> YC9ON$R&6$K):7\ ZR;+3%YJRZR"2>R"9_;P#<YG
M\;5VG7Y.S8JV=(W>$EMJ;CEUV>2NK!M.?]"JB!J 2+KHD<S ZJ&OET@*.+<L
M[@1;X"#J!#[NRKS6[-&D_>*(!:;CXA1&A&TTS7T7%^0>70%BI<AJI4/TLCO@
MY]WDJ&S=P+1;OVAT%5+IE/*W'%$6P!.!  YXDD5MW,#JW&;6C/Z5$G\H1S$'
M:@:Z+&(!1IRRN#5>4&;9<?80#KZV$*TS-Y(SS<Z<"W2U7MNIW G!,J??;KCG
MQ?=PS^W:2UN$/)7F(^S$)**;U&6S^1I#%JK%S,9*@>.33QVP$61+[9-F3@S[
M/SD CG%9I@9:<HO/H;D[(NBDV8QF=TXQT EA>(J]M8JL-PG_$F":,V0D@N3L
M$!W"'Y?(L#VW%SHJ#Z [%8*V.9&LC86XU#P84S]&KRRF5W90#?1Y\Q="2> ?
M"7TT=UKJK/[VUO"FD7>):Q:X78*U5BD"-YM+ ![FO!1VR8*&$S=<0YU1BFU>
M%0(V-HN_F9-0ENQ<+1QD]'+^U9]&BC GP Q&"ELNJK2-N1S.Z.'K)(/@Z%.'
MNZ'CH'V6)0P_MH9@5GEN+)YFY4#>ER1#^9IH7CDMQ]#:AAI[R'Z-$^'N<F'.
M*PFH<GI!R+8TNUD6P8>AE0@L0W69ZP@IS@;1XLR/O29,F@\_U>)<H>'O\KR
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MP%+Q<TS<Q;N])8";H@X:!S7L8.4;;3D(L-%SSE'R;9&7Z,\_-+;&J$<9#G@
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MQ(9'G6/#[?9.$]H& J5>4GU)>#?HQ.O$>,>%-ER.$0#3>+'I)2_^.D*F&5>
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MC';QCTL^;'J88+IAP!Y(.U!+<E8AQFT"ME@Y2;T$5!PP?\DX&!C)?8CZ> Y
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M8V8\NXL<ZA:1(,75-$JEB=T;VD'&Y*NB]!\2RE X3D8%I_99$^-R M0*/B0
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MC[^_.G[]A_GCKV?O#G_Y?U!+ P04    " #.,")8Z][N>$$#  !7"P  $0
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M2J&4N(13H;@J!)?PI2?\)YRI(H'W4L+4PRRQM&ANL$PZJW>VS&UQA15__0J
MTJ5LKLAD4TTBGX<N#7<S(Q-M%JQTAKEEC8R48M)"(XIH /U_W ,,U<%+[ HX
MYW860+W$IV<\0%3JNEQS4W&EKH4J"VWJ4*20]RS[:P J4:PP@9;%(EGH&T:"
M30=>+AX/)!N-QHQZPE&N<0"10EWO0'CQC-ICZ.0!Y'8< .GAX2$+T@U*I5N/
MH+/^AK7"H,V=,V+6.#S5ICK!.6\DH1KU7\.EF LL@Q;U:H7*K>FL:SAN%N@N
M>(6VY@4^.=W46(_%1G13]NW3^9?0<]&Q!P"$-A15K8V#MAO/=1%F9$=*_:^X
MKT3LK^(TB\=I0L8B4(\RWU)&8"\FTA?X6416W;$W$;NMB_TA]H=MWA_O_6=G
M8'.P??R'/O[T[5[Q/U@,/X&)5A<O)3/8;L^OB>*B:)=7>]R_+O?(%_5FOQE\
M'M[L=+RY2CJOP2=-NW;!T9 )KVNAYKJ[HDO?Q'G?R5.<0UAA.3>%T1)W+SI6
M&UVC<8*6_?TPM :N#,XGD=_Y<;]GODL^2VC/]"H/'*R/EQ<S@J \OZ?78YUP
M'GSNQ>#E]&IRN3+MVV$26<J['(SG+PZW-OC4< EB:<.'LFV/^O- Z\G!>S^7
MI '^\'5ZMON-6#T2S/$[K72U;(F>Z*+Q;U'__5Z5'Q716YY1=YDJ4(M T&LR
M)?7O>ZFOB/942Z3_<2*T<#KR'_J;UUL8'KDJH34' WM';-/(IOW&8OF/.@[G
M@LNBD:O$=^!.8Q=PLV3[(^^9;<=UMWW1^E%FF[/<W0QGOKUJ=P[]_ %02P,$
M%     @ SC B6&YW.L]?!@  O4,  !4   !M;FMD+3(P,C,Q,C(W7VQA8BYX
M;6S-G&]OVS80QM\/Z'>X>6\VH+)CIQA0HVF1.<D0+&V"QMV&#4,A2XQ-3.89
MI)S8WWZD_C1R3,E2>)KRHJDBW3UWC_,[AI;MO/NP649PSZ3B*$YZP_Y1#Y@(
M,.1B?M);*\]7 ><]4+$O0C]"P4YZ6Z9Z']Z_^N[=]YX'9Q>7G\"#11ROU'@P
M>'AXZ(=W7"B,UK&65/T EP/PO#Q^,OT"OZ?EQO"91<Q7#):^BIF$7]8\"L>C
MH]'Q\&@XZH^*:9+Y1@]"/V9C& Y& QWW!H[';]Z,1S_#S4<X3T0$3/F2%3-Q
MM95\OHCAQ^ G2)+.4 @616P+%USX(N!^!+=YPZ_A4@1].(TB^&S2E.Y2,7G/
MPGZF&G'Q[]A\F9G>X=5W /I!%"HY=](S#T7V2&QF,NJCG.M>CXX'>4KO,6.S
ME_)PG"0,W[Y].TBN%J,5M\5J\>'@SX]7M\&"+7U//_CZAQ5D910?J^3\%0;)
M(UBC02B-,-]Y>9AG3GG#D7<\[&]4V'MO"F:/CC]CT94^@L3#6&+$*@J;RTGU
M7A8?;U<ZGFUB)D*6*7_3QB"+6DAVEZH:]!))Q8+^'.\'(>,&D&-SX)D#T^$/
M^INO$]2TG\Y4+/T@WJT7F8<(97XR,7'2LR0-=ALR<:<RV-'R99#KZ,,#_K.(
M08#ZY[:*O40Q3[^3N+1VD95#R\6OT2RRMFE(TD=FN)GPOMP>\IH*%8U)IG M
M-5Y-?K2)G_>),OR=:__S;O!8^Z6TJI<0Q:Z:]NN&Y+F(>;S]S.;<%!+Q)W_)
MZI)IS^T(T$HC6![C@FNY'A&U:0%XK "FA#.[[?5=1+AI\VX@GR[U>JW_Q1>1
M/Z]+\).DCM"UMXZ6BRZP6H2(*/VF#$;:F<X6&BUB6;=;BG5UHLM(/[K4.XG-
M;VS;;&'=2^YT92VS@A5![FNK59!V<<U*0%(#=!&BY;65UBWK:X/^W9 ^PV!M
MYF:JNZ]+\FY.1P!;&\?]:RZX[NL049H+@U%V1I.^S2*1-7NEP?"&28[AN0C/
M]-/RICP^2>X83+L5K BB0-4B2,UL6@)T#3!%R/!MH74KQ[7[I]@L7(H Y0IE
M<JOD-M;U)KC6:_MV@F'#YV0'I#K=2-2SB;53W#<9->1IMQP[!2&I"%E),#6)
M=B#_@R_+?N3YYBB&Z()'[--Z.6.RV<04\SH=#XL!M%]W!_^I%BWE1AU2>2*@
MJ?NUT%NK:0I0I_[F,M2_8_@=3V^./X?:4I%.$3YD#6L$N\-=*4Q+NBX%N[5H
MN6_5BF4(GN&'8B1.PU ;4-E_5URP8;-QL IT.@I5EO! H/L(E(K2XI_IO\X/
MP%2":T&UCVG-A@7]9W@A1'^B#Z_E%!_$L\ OIK\$["UV;- _AI$A_U2R)>!-
M&4 )IA M[-0&JE"OYX(0\^1)P;6\D7C/1=#PN6V9QDL OLR8C?HGL63H6W5;
MXC]]=J?1R:O1#D$K5JHFH8$?PG&X017[T5]\U?Q&CUWA)8R"W91M$'8BR<;
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M8)^>W!RQ;_990%/R#5!+ 0(4 Q0    ( ,XP(E@$-8W1FQ$  'QR   .
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H9"TR,#(S,3(R-U]P<F4N>&UL4$L%!@     %  4 0 $  (/C      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
